University of Wisconsin–Madison

Publications, Presentations, Leadership, Service, and Awards

  • PUBLICATIONS
    1. Launer BM, McVary KT, Ricke WA, Lloyd GL (2020). The Rising Worldwide Impact of Benign Prostatic Hyperplasia. BJUI International. PMID – 33124118; DOI: 1111/bju.15286.
    2. Anzia LE, Johnson CJ, Mao L, Hernando D, Bushman WA, Wells SA, Roldán-Alzate A (2020). Comprehensive Non-invasive Analysis of Lower Urinary Tract Anatomy using MRI. Abdom Radiol. PMID – 33040167; DOI: 1007/s00261-020-02808-9.
    3. Vellky JE, McSweeney ST, Ricke EA, Ricke WA (2020). RNA-binding Protein DDX3 Mediates Posttranscriptional Regulation of Androgen Receptor: A Mechanism of Castration Resistance. PNAS. PMID – 33106406; DOI: 1073/pnas.2008479117.
    4. Ruetten H, Sanhu J, Mueller B, Wang P, Zhang HL, Wegner KA, Cadena M, Sandhu S, Abler LL, Zhu J, O’Driscoll CA, Chelgren B, Wang Z, Shen T, Barash J, Bjorling DE, Vezina CM (2020). A Uropathogenic coli UTI189 Model of Prostatic Inflammation and Collagen Accumulation for Use in Studying Aberrant Collagen Production in the Prostate. AJP-Renal. 2020 Nov 2; PMID – 33135480; PMC – PENDING; DOI: 10.1152/ajprenal.00431.2020.
    5. Vellky JE, Ricke EA, Huang W, Ricke WA (2020). Expression, Localization, and Function of the Nucleolar Protein BOP1 in Prostate Cancer Progression. Am J Pathol. DOI: 1016/j.ajpath.2020.09.010.
    6. Vellky JE, Ricke WA (2020). Development and Prevalence of Castration-resistant Prostate Cancer Subtypes. Neoplasia. PMID 32980775; PMC7522286; DOI: 1016/j.neo.2020.09.002.
    7. Bauer SR, Scherzer R, Suskind AM, Cawthon P, Ensrud KE, Ricke WA, Covinsky K, Marshall LM (2020). Co-Occurrence of Lower Urinary Tract Symptoms and Frailty Among Community-Dwelling Older Men. J Am Geriatr Soc. DOI: 1111/jgs.16766
    8. Wei P, Hao L, Thomas S, Buchberger AR, Steinke L, Marker PC, Ricke WA, Li L (2020). Urinary Amine Metabolomics Characterization with Custom 12-plex Isobaric DiLeu Labeling. J Am Soc Mass Spectrom. 2020 Jul 17; PMID: 32678615; PMC7484200; DOI: 1021/jasms.0c00110.
    9. Popovics P, Awadallah WN, Kohrt SE, Case TC, Miller NL, Ricke EA, Huang W, Ramirez-Solano M, Liu Q, Vezina CM, Matusik RJ, Ricke WA, Grabowska MM (2020). Prostatic Osteopontin Expression is Associated with Symptomatic Benign Prostatic Hyperplasia. Prostate. 2020 July [Epub 2020 May 1]; PMID: 32356572; PMC7485377 (available on 2021-07-01); NIHMS1600763; DOI: 1002/pros.23986.
    10. Ruetten H, Cole C, Wehber M, Wegner K, Girardi N, Peterson N, Scharpf B, Romero MF, Wood M, Colopy S, Bjorling DE, Vezina CM (2020). An Immunohistochemical Prostate Cell Identification Key Indicates that Aging Shifts Procollagen 1A1 Production from Myofibroblasts to Fibroblasts in Dogs Prone to Prostate-related Urinary Dysfunction. PloS One. 2020 Jul 29; 15(7): e0232561; DOI: 1371/journal.pone.0232564.
    11. Bartolone SN, Ward EP, Wang Z, Zwaans BMM, Chancellor MB, Bjorling DE, Lamb LE (2020). Micturation Defects and Altered Bladder Function in the Klotho Mutant Mouse Model of Aging. Am J Clin Exp Urol. 2020 Jun 25; PMID: 32699807; PMC7364365; DOI: pending.
    12. Fraser MO, Smith PP, Sullivan MP, Bjorling DE, Campeau L, Andersson KE, Yoshiyama M (2020). Best Practices for Cystometric Evaluation of Lower Urinary Tract Function in Muriform Rodents. Neurourol Urodynam. 2020 Jun 8; PMID: 32511810; PMC – PENDING; NIHMS1603287; DOI: 1002/nau.24415.
    13. Joseph DB, Henry GH, Malewska A, Iqbal NS, Ruetten HM, Turco AE, Abler LL, Sandhu SK, Cadena MT, Malladi VS, Reese JC, Mauck RJ, Gahan JC, Hutchinson RC, Roehrborn CG, Baker LA, Vezina CM, Strand DW. (2020) Urethral luminal epithelia are castration-insensitive cells of the proximal prostate. Prostate Aug;80(11):872-884. PMID: 32497356
    14. Taylor JA, Jones MB, Besch-Williford CL, Berendzen AF, Ricke WA, vom Saal FS (2020). Interactive Effects of Perinatal BPA or DES and Adult Testosterone and Estradiol Exposure on Adult Urethral Obstruction and Bladder, Kidney, and Prostate Pathology in Male Mice. Int J Mol Sci. 2020 May 30; PMID 32486162, PMC7313472; DOI: 3390/ijms211113902.
    15. Dietz C, Rueden CT, Helfrich S, Dobson ETA, Horn M, Eglinger J, Evans III EL, McLean DT, Novitskaya T, Ricke WA, Sherer NM, Zijlstra A, Berthold MR, Eliceiri KW (2020). Integration of the ImageJ Ecosystem in KNIME Analytics Platform. Front Comput Sci. 2020 Mar 17 [Epub ahead of print]; PMID: 32905440; PMC7469687; DOI: 3389/FCOMP.2020.00008.
    16. Zwaans BMM, Wegner KA, Bartolone SN, Vezina CM, Chancellor MB, Lamb LE (2020). Radiation Cystitis Modeling: A Comparative Study of Bladder Fibrosis Radio-sensitivity in C57BL/6, C3H, and BALB/c Mice. Physiol Rep. 2020 Feb;8(4):e14377. PMID: 32109348; PMC7048381; DOI: 14814/phy2.14377.
    17. Thomas S, Hao L, DeLaney K, McLean DT, Steinke L, Marker PC, Vezina CM, Li L, Ricke WA (2020). Spatiotemporal Proteomics Reveals the Molecular Consequences of Hormone Treatment in a Mouse Model of Lower Urinary Tract Dysfunction. J Proteome Res. 2020 Feb 28 [Epub ahead of print]; PMID: 32108482; PMC733919, DOI: 1021/acs.jproteome.9b00451.
    18. Turco AE, Thomas S, Crawford LK, Tang W, Peterson RE, Li L, Ricke WA, Vezina CM (2020). In Utero and Lactational 2,3,7,8-tetrachlorodibenzo--dioxin (TCDD) Exposure Exacerbates Urinary Dysfunction in Hormone-treated C57BL/6J Mice Through a Non-Malignant Mechanism Involving Proteomic Changes in the Prostate that Differ from Those Elicited by Testosterone and Estradiol. Am J Clin Exp Urol. 2020 Feb 25;8(1):59-72 [eCollection 2020]. PMID: 32211455; PMC7076297.
    19. Maguire M, Larsen MC, Vezina CM, Quadro L, Kim Y-K, Tanumihardjo SA, Jefcoate CR (2020). Cyp1b1 Directs Srebp-mediated Cholesterol and Retinoid Synthesis in Perinatal Liver; Association with Retinoic Acid Activity During Fetal Development. PloS One. 2020 Feb 6;15(2):e0228436. PMID: 32027669; PMC7004353; DOI: 1371/journal.pone.0228436.
    20. Wegner KA, Mueller BR, Unterberger CJ, Avila EJ, Ruetten H, Turco AE, Oakes SR, Girardi NM, Halberg RB, Swanson SM, Marker PC, Vezina CM (2020).Prostate Epithelial-specific Expression of Activated PI3K Drives Stromal Collagen Production and Accumulation. J Pathol. 2020 Feb; 250(2):231-242 [Epub 2019 Nov 28]. PMID: 31674011; PMC7071816 [Available on 2020-11-01]; DOI: 1002/path.5363.
    21. Wu H, Liu B, Yang K, Winston-McPherson GN, Leisten ED, Vezina CM, Ricke WA, Peterson RE, Tang W (2020). Synthesis and Biological Evaluation of FICZ Analogues as Agonists of Aryl Hydrocarbon Receptor. Bioorg Med Chem. 2020 Jan 7 [Epub ahead of print]. PMID: 31952965; PMC7077633 [Available on 2021-03-01]; DOI:1016/j.bmcl.2020.126959.
    22. Ruetten H, Wegner KA, Kennedy CL, Turco AE, Zhang HL, Wang P, Sandhu JK, Sandhu SK, Morkrid J, Wang Z, Macoska J, Peterson RE, Bjorling DE, Ricke WA, Marker PC, Vezina CM (2020). Impact of Sex, Androgens, and Prostate Size on C57BL/6J Mouse Urinary Physiology: Urethral Histology. Am J Physiol-Renal Physiol. 2020 Jan 6 [Epub ahead of print]. PMID: 31904290; PMC7099510 [Available on 2021-03-01]; DOI: 1152/ajprenal.00540.2019.
    23. Ruetten H, Wegner KA, Zhang HL, Wang P, Sandhu JK, Sandhu SK, Mueller BR, Wang Z, Macoska J, Peterson RE, Bjorling DE, Ricke WA, Marker PC, Vezina CM (2020). Impact of Sex, Androgens, and Prostate Size on C57BL/6J Mouse Urinary Physiology: Functional Assessment. Am J Physiol-Renal Physiol. 2020 Jan 6 [Epub ahead of print]. PMID: 31904290; PMC6843040 [Available on 2020-10-01]; DOI: 1152/ajprenal.00540.2019.
    24. Farahmand S, O’Connor C, Macoska JA, Zarringhalam K (2019). Causal Inference Engine A Platform for Directional Gene Set Enrichment Analysis and Inference of Active Transcriptional Regulator. Nucleic Acids Res. 2019 Dec 16;47(22):11563-11573. PMID: 31701125; DOI: 1093/nar/gkz1046.
    25. Uchtmann KS, Taylor JA, Timms BG, Stahlhut RW, Ricke EA, Ellersieck MR, vom Saal FS, Ricke WA (2019). Fetal Bisphenol A and Ethinylestradiol Exposure Alters Male Rat Urogenital Tract Morphology at Birth: Confirmation of Prior Low-dose Findings in CLARITY-BPA. Reprod Toxicol. 2020 Jan; 91:131-141 [Epub 2019 Nov 19]. PMID: 31756437; PMC7339120; DOI: 1016/j.reprotox.2019.11.007.
    26. Vellky JE, Bauman TM, Ricke EA, Huang W, Ricke WA (2019). Incidence of Androgen Receptor and Androgen Receptor Variant 7 Coexpression in Prostate Cancer. 2019 Dec; 79(16)):1811-1822 [Epub 2019 Sep 10]. PMID: 31503366; PMC7339117; DOI: 10.1002/pros.23906.
    • Ruetten H, Wegner KA, Zhang HL, Wang P, Sandhu J, Sandhu S, Morkrid J, Mueller BR, Wang Z, Macoska J, Peterson RE, Bjorling DE, Ricke WA, Marker PC, Vezina CM (2019). Insight and Resources From a Study of the “Impact of Sex, Androgens, and Prostate Size on C57BL/6J Mouse Urinary Physiology”. Toxicol Pathol. 2019 Dec; 47(8):1038-1042 [Epub 2019 Oct 29]. PMID: 31662055; PMC6910975 [Available on 2020-12-01]; DOI: 1177/0192623319877867.
    1. Macoska JA, Uchtmann KS, Leverson GE, McVary KT, Ricke WA (2019). Prostate Transition Zone Fibrosis is Associated with Clinical Progression in the Medical Therapy of Prostatic Symptoms (MTOPS) Study. J Urol. 2019 Dec; 202(6):1240-1247 [Epub 2019 Jun 12]. PMID: 31188728; PMC7339116; DOI: 1097/JU.0000000000000385.
    2. Cunha GR, Sinclair A, Ricke WA, Robboy SJ, Cao M, Baskin LS (2019). Reproductive Tract Biology: Of Mice and Men. Differentiation. 2019 Nov-Dec; 110:49-63 [Epub 2019 Sep 6]. PMID: 31622789; PMC7339118; DOI: 1016/j.diff.2019.07.004.
    3. Bhandari RK, Taylor JA, Sommerfeld-Sager J, Tillitt DE, Ricke WA, Vom Saal FS (2019). Estrogen Receptor 1 Expression and Methylation of Esr1 Promoter in Mouse Fetal Prostate Mesenchymal Cells Induced by Gestational Exposure to Bisphenol A. Environ Epigenet.2019 Aug 22; 5(3):dvz012 [eCollection 2019 Jul]. PMID: 31463084; PMC6705189; DOI: 1093/eep/dvz012.
    4. Liu TT, Rodgers A, Nicholson TN, Macoska JA, Marker PC, Vezina CM, Bjorling DE, Roldán-Alzate A, Hernando D, Lloyd GL, Hacker T, Ricke WA (2019). Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing. J Vis Exp. 2019 Aug 14; (150), e59802; PMID: 31475976; PMC7328372; DOI: 3791/59802.
    5. Lloyd GL, Marks JM, Ricke WA (2019). Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms: What is the Role and Significance of Inflammation? Curr Urol Rep.2019 Aug 3; 20(9):54. PMID: 31377881; PMC7339114; DOI: 1007/s11934-019-0917-1.
    6. Dalghi MG, Clayton DR, Ruiz WG, Al-Bataineh MM, Satlin L, Kleyman T, Ricke WA, Carattino M, Apodaca G (2019). Expression and Distribution of PIEZO1 in the Mouse Urinary Tract. Am J Physiol-Renal Physiol. 2019 Aug 1; 317(2):F303-321 [Epub 2019 Jun 5]. PMID: 31166705; PMC6732449; DOI: 1152/ajprenal.00214.2019.
    7. Liu TT, Ewald JA, Ricke EA, Bell R, Collins C, Ricke WA (2019). Modeling Human Prostate Cancer Progression in Vitro. 2019 Jul 20; 40(7):893-902. PMID: 30590461; PMC6642366; DOI: 10.1093/carcin/bgy185.
    8. Sehgal PD, Bauman TM, Nicholson TM, Vellky JE, Ricke EA, Tang W, Xu W, Huang W, Ricke WA (2019). Tissue-specific Quantification and Localization of Androgen and Estrogen Receptors in Prostate Cancer. Hum Pathol. 2019 Jul; 89:99-108 [Epub 2019 May 3]. PMID: 31054895; PMC6642018; DOI: 1016/j.humpath.2019.04.009.
    9. Turco AE, Cadena MT, Zhang HL, Sandhu JK, Oakes SR, Chathurvedula T, Peterson RE, Keast JR, Vezina CM (2019). A Temporal and Spatial Map of Axons in the Developing Mouse Prostate. Histochem Cell Biol. 2019 Jul; 152(1):35-45 [Epub 2019 Apr 11]. PMID: 30976911; PMC6685201; DOI: 1007/s00418-019-01784-6.
    10. McLean D, Rutkowski DR, Liu TT, Hernando D, Ricke WA, Roldán-Alzate A (2019). MRI-based Method for Lower Urinary Tract Dysfunction in Mice. Am J Clin Exp Urol. 2019 Jun 15; 7(3):153-158 [eCollection 2019]. PMID: 31317054; PMC6627546.
    11. Wang Z, Guzman EC, Nimunkar A, Keil KP, Vezina CM, Ricke WA, Macoska J, Bjorling DE (2019). Void Sorcerer: An Open Source, Open Access Framework for Mouse Uroflowmetry. Am J Clin Exp Urol. 2019 Jun 15; 7(3):170-177 [eCollection 2019]. PMID: 31317056; PMC6627548.
    12. Hao L, Thomas S, Greer T, Vezina CM, Bajpai S, Ashok A, De Marzo AM, Bieberich CJ, Li L, Ricke WA (2019). Quantitative Proteomic Analysis of a Genetically Induced Prostate Inflammation Mouse Model via Custom 4-plex DiLeu Isobaric Labeling. Am J Physiol-Renal Physiol. 2019 Jun 1; 316(6):F1236-F1243 [Epub 2019 Apr 17]. PMID: 30864837; PMC6620594; DOI: 1152/ajprenal.00387.2018.
    13. Ricke WA, Bruskewitz RC, Liu TT (2019). Targeting a Fibrotic Bottleneck May Provide an Opening in the Treatment of LUTS. Am J Physiol-Renal Physiol. 2019 Jun 1; 316(6):F1091-1093 [Epub 2019 Mar 13]. PMID: 30864837; PMC6620586; DOI:1152/ajprenal.00102.2019.
    14. Vellky JE, Ricke EA, Huang W, Ricke WA (2019). Expression and Localization of DDX3 in Prostate Cancer Progression and Metastasis. Am J Pathol. 2019 Jun; 189(6):1256-1267 [Epub 2019 Mar 27]. PMID: 30926334; PMC6547056; DOI: 1016/j.ajpath.2019.02.011.
    15. Affas S, Schäfer FM, Algarrahi K, Cristofaro V, Sullivan MP, Yang X, Costa K, Sack B, Gharaee-Kermani M, Macoska JA, Gundogdu G, Seager C, Estrada CR Jr, Mauney JR (2019). Augmentation Cystoplasty of Diseased Porcine Bladders with Bi-Layer Silk Fibroin Grafts. Tissue Eng Part A. 2019 Jun; 25(11-12):855-866 [Epub 2018 Oct 26]. PMID: 30191762; PMC6589503; DOI: 1089/ten.TEA.2018.0113.
    16. Liu TT, Thomas S, McLean DT, Roldán-Alzate A, Hernando D, Ricke EA, Ricke WA (2019). Prostate Enlargement and Altered Urinary Function Are Part of the Aging Process. 2019 May 13; 11(9):2653-2699. PMID: 31085797; PMC6535061; DOI: 10.18632/aging.101938.
    17. Almanza D, Gharaee-Kermani M, Zhilin-Roth A, Rodriguez-Nieves JA, Colaneri C, Riley T, Macoska JA (2019). Nonalcoholic Fatty Liver Disease Demonstrates a Pre-fibrotic and Premalignant Molecular Signature. Dig Dis Sci. 2019 May; 64(5):1257-1269 [Epub 2018 Dec 5]. PMID: 30519850; PMC6512804; DOI: 1007/s10620-018-5398-4.
    18. Macoska JA, Wang ZY, Virta J, Zacharias N, Bjorling DE (2019). Inhibition of the CXCL12/CXCR4 Axis Prevents Periurethral Collagen Accumulation and Lower Urinary Tract Dysfunction In Vivo. 2019 May; 79(7):757-767 [Epub 2019 Feb 27]. PMID: 30811623; PMC7269149; DOI: 10.1002/pros.23781; NIHMS: 101632.
    19. Lloyd GL, Ricke WA, McVary KT (2019). Inflammation, Voiding and BPH Progression. J Urol. 2019 May; 201(5):868-870 [Epub 2019 Jan 25]. PMID: 30694937; PMC7339115; DOI: 1097/JU.0000000000000049.
    20. Wegner KA, Mehta V, Johansson JA, Mueller BR, Keil KP, Abler LL, Marker PC, Taketa MM, Headon DJ, Vezina CM (2019). Edar is a Downstream Target of Beta-catenin and Drives Collagen Accumulation in the Mouse Prostate. Biol Open. 2019 Mar 18; 8(3), pii:bio037945. PMID: 30745437; PMC6451354; DOI: 1242/bio.037945.
    21. Joseph DB, Chandrashekar AS, Abler LL, Chu L-F, Thomson JA, Vezina CM (2019). Epithelial DNA Methyltransferase-1 Regulates Cell Survival, Growth and Differentiation in Developing Prostate Buds. Dev Biol. 2019 Mar 15; 447(2):157-169 [Epub 2019 Jan 16]. PMID: 30659795; PMC6469356; DOI: 1016/j.ydbio.2019.01.011; NIHMS1519785.
    22. Joseph DB, Chandrashekar AS, Chu L-F, Thomson JA, Vezina CM (2019). A Folic Acid-Enriched Diet Attenuates Prostate Involution in Response to Androgen Deprivation. 2019 Feb; 79(2):183-194 [Epub 2018 Oct 8]. PMID: 30298636; PMC6420320; DOI: 10.1002/pros.23723.
    23. Joseph DB, Strand DW, Vezina CM (2018). DNA Methylation in Development and Disease: An Overview for Prostate Researchers. Amer J Clin Exp Urol. 2018 Dec 20; 6(6):197-218 [eCollection 2018]. PMID: 30697577; PMC6334199.
    24. Henry GH, Malewska A, Joseph DB, Malladi VS, Lee J, Torrealba J, Mauck RJ, Gahan JC, Raj GV, Roehrborn CG, MacConmara MP, Reese JC, Hutchinson RC, Vezina CM, Strand DW (2018). A Cellular Anatomy of the Normal Adult Human Prostate and Prostatic Urethra. Cell Reports. 2018 Dec 18; 25(12):3530-3542.e5. PMID: 30566875; PMC6411034; DOI: 1016/j.celrep.2019.11.086; NIHMS1517612.
    25. Hill WG, Zeidel ML, Bjorling DE, Vezina CM (2018). The Void Spot Assay: Recommendations on the Use of a Simple Micturition Assay for Mice. Amer J Physiol-Renal Physiol. 2018 Nov 1; 315(5):F1422-1429 [Epub 2018 Aug 29]. PMID: 30156116; PMC6293303; DOI: 1152/ajprenal.00350.2018.
    26. Nicholson TM, Nguyen JL, Leverson GE, Taylor JA, Vom Saal FS, Wood RW, Ricke WA (2018). The Endocrine Disruptor Bisphenol-A is Implicated in Urinary Voiding Dysfunction in Male Mice. Am J Physiol-Renal Physiol. 2018 Nov 1; 315(5):F1208-F1216 [Epub 2018 Jul 18]. PMID: 30019933; PMC6293302; DOI: 1152/ajprenal.00582.2017.
    27. Hao L, Shi Y, Thomas S, Vezina C, Bajpai S, Ashok A, Bieberich CJ, Ricke WA, Li L (2018). Comprehensive Urinary Metabolomic Characterization of a Genetically induced Mouse Model of Prostatic Inflammation. Int J Mass Spectrom. 2018 Nov; 434:185-192 [Epub 2018 Sep 22]. PMC6414212; DOI: 1016/j.ijms.2018.09.017; NIHMS 1013142.
    28. Wegner KA, Abler LL, Oakes SR, Mehta GS, Ritter E, Hill WG, Zwaans BMM, Lamb LE, Wang Z, Bjorling DE, Ricke WA, Macoska J, Marker PC, Southard-Smith EM, Eliceiri KW, Vezina CM (2018). Void Spot Assay Procedural Optimization and Software for Rapid and Objective Quantification of Rodent Voiding Function, Including Overlapping Urine Spots. Amer J Physiol-Renal Physiol. 2018 Oct 1; 315(4):F1067-1080 [Epub 2018 Jul 4]. PMID: 29972322; PMC6230749; DOI: 1152/ajprenal.00245.2018.
    29. Shea MP, O’Leary KA, Wegner KA, Vezina CM, Schuler LA (2018). High Collagen Density Augments mTOR-dependent Cancer Stem Cells in ERα+ Mammary Carcinomas, and Increases mTOR-independent Lung Metastases. Cancer Lett. 2018 Oct 1; 433:1-9 [Epub 2018 Jun 20]. PMID: 29935374; PMC6064659; DOI: 1016/j.canlet.2018.06.025.
    30. Abler LL, Vezina CM (2018). Links Between Lower Urinary Tract Symptoms, Intermittent Hypoxia, and Diabetes: Causes or Cures? Respir Physiol Neurobiol. 2018 Oct; 256:87-96 [Epub 2017 Sep 18]. PMID: 28923778; PMC5857412; DOI: 1016/j.resp.2017.09.009.
    31. Cunha GR, Vezina CM, Isaacson D, Ricke WA, Timms BG, Cao M, Franco O, Baskin LS (2018). Development of the Human Prostate. 2018 Sep-Oct; 103:24-45 [Epub 2018 Sep 4]. PMID: 30224091; PMC6234090; DOI: 10.1016/j.diff.2018.08.005. Review.
    32. Joseph DB, Chandrashekar AS, Abler LL, Chu LF, Thomson JA, Mendelsohn C, Vezina CM (2018). In Vivo Replacement of Damaged Bladder Urothelium by Wolffian Duct Epithelial Cells. Proc Natl Acad Sci USA. 2018 Aug 14; 115(33):8394-8399 [Epub 2018 Jul 30]. PMID: 30061411; PMC6099915; DOI: 1073/pnas.1802966115.
    33. Ruetten H, Wegner KA, Romero MF, Wood MW, Marker PC, Strand DW, Colopy SA, Vezina CM (2018). Prostatic Collagen Architecture in Neutered and Intact Canines. 2018 Aug; 78(11):839-848 [Epub 201 May 8]. PMID: 29740846; PMC6356104; DOI: 10.1002/pros.23641; ISSN 1097-0045; NIHMS1003000.
    34. Hao L, Wang J, Page D, Asthana S, Zetterberg H, Carlsson C, Okonkwo OC, Li L (2018). Comparative Evaluation of MS-based Metabolomics Software and Its Application to Preclinical Alzheimer’s Disease. Sci Rep. 2018 Jun 18; 8(1):9291. PMID: 29915347; PMC6006240; DOI: 1038.s41598-018-27031-x.
    35. Coriano CG, Liu F, Sievers CK, Liang M, Wang Y, Lim Y, Yu M, Xu W (2018). A Computational-Based Approach to Identify Estrogen Receptor Alpha/Beta Heterodimer Selective Ligands. Mol Pharmacol. 2018 Mar; 93(3):197-207 [Epub 2018 Jan 4]. PMID: 29295894; PMC5801554; DOI: 1124/mol.117.108696.
    36. Patalano-Salsman S, Rodriguez-Nieves J, Colaneri C, Cotellessa J, Almanza D, Zhilin-Roth A, Riley T, Macoska J (2018). CXCL12/CXCR4-Mediated Procollagen Secretion Is Coupled to Cullin-RING Ubiqutin Ligase Activation. Sci Rep. 2018 Feb 22; 8(1):3499 [Epub 2018 Feb 22]. PMID: 29472636; PMC5823879; DOI: 1038/s41598-018-21506-7.
    37. Ritter KE, Wang Z, Vezina CM, Bjorling DE, Southard-Smith EM (2017). Serotonin Receptor 5-HT3A Affects Development of Bladder Innervation and Urinary Bladder Function. Front Neurosci. 2017 Dec 12; 11:690 [Epub 2017 Dec 12]. PMID: 29311772; PMC5732969; DOI: 3389/fnins.2017.00690.
    38. Wegner KA, Cadena MT, Trevena R, Turco AE, Gottschalk A, Halberg RB, Guo J, McMahon JA, McMahon AP, Vezina CM (2017). An Immunohistochemical Identification Key for Cell Types in Adult Mouse Prostatic and Urethral Tissue Sections. PLoS One. 2017 Nov 16; 12(11):e0188413 [Epub 2017 Nov 16]. PMID: 29145476; PMC5690684; DOI: 1371/journal.pone.0188413.
    39. Liu F, Ma F, Wang Y, Hao L, Zeng H, Jia C, Wang Y, Liu P, Ong IM, Li B, Chen G, Jiang J, Gong S, Li L, Xu W (2017). PKM2 Methylation by CARM1 Activates Aerobic Glycolysis to Promote Tumorigenesis. Nat Cell Biol. 2017 Nov; 19(11):1358-70 [Epub 2017 Oct 24]. PMID: 29058718; PMC5683091; DOI: 1038/ncb3630.
    40. McLean DT, Strand DW, Ricke WA (2017). Prostate Cancer Xenografts and Hormone Induced Prostate Carcinogenesis. 2017 Sep-Oct; 97:23-32 [Epub 2017 Sep 8]. PMID: 28923776; PMC6413512; ISSN 1432-0436; DOI: 10.1016/j.diff.2017.08.005.
    41. Keikhosravi A, Liu Y, Drifka C, Woo KM, Verma A, Oldenbourg R, Eliceiri KW (2017). Quantification of Collagen Organization in Histopathology Samples Using Liquid Crystal Based Polarization Microscopy. Biomed Opt Express. 2017 Aug 29; 8(9):4243-56 [Epub 2017 Oct 3]. PMID: 28966862; PMC5611938; DOI: 1364/BOE.8.004243.
    42. Liu Y, Keikhosravi A, Mehta GS, Drifka CR, Eliceiri KW (2017). Methods for Quantifying Fibrillar Collagen Alignment. Methods Mol Biol. 2017; 1627:429-51 [Epub 2017 Aug 24]. PMID: 28836218; PMC6343484; DOI: 1007/978-1-4939-7113-8_28.
    43. McAuley E, Mustafi D, Simons B, Valek R, Zamora M, Markiewicz E, Lamperis S, Williams A, Roman B, Vezina CM, Karczmar G, Oto A, Vander Griend D (2017). Magnetic Resonance Imaging and Molecular Characterization of a Hormone-Mediated Murine Model of Prostate Enlargement and Bladder Outlet Obstruction. Amer J Pathol. 2017 Aug 18; 187:2378-2387. PMID: 28823870; PMC5762949; DOI: 1016/j.ajpath.2017.07.014.
    44. Wegner KA, Keikhosravi A, Eliceiri KW, Vezina CM (2017). Fluorescence of Picrosirius Red Multiplexed With Immunohistochemistry for the Quantitative Assessment of Collagen in Tissue Sections. J Histochem Cytochem. 2017 Aug; 65(8):479-90 [Epub 2017 Jul 12]. PMID: 28692327; PMC5533271; DOI: 1369/0022155417718541.
    • Strand DW, Costa DN, Francis F, Ricke WA, Roehrborn CG (2017). Targeting Phenotypic Heterogeneity in Benign Prostatic Hyperplasia. 2017 Jul-Aug; 96:49-61 [Epub 2017 Aug 4]. PMID: 28800482; PMC566834; DOI: 10.1016/j.diff.2017.07.005. Review.
    1. Shishkova E, Zeng H, Liu F, Kwiecien NW, Hebert AS, Coon JJ, Xu W (2017). Global Mapping of CARM1 Substrates Defines Enzyme Specificity and Substrate Recognition. Nat Commun. 2017 May 24; 8:15571 [Epub 2017 May 26]. PMID: 28537268; PMC5458078; DOI: 1038/ncomms15571.
    2. Le B, Powers GL, Tam YT, Schumacher N, Malinowski RL, Steinke L, Kwon G, Marker PC (2017). Multi-drug Loaded Micelles Delivering Chemotherapy and Targeted Therapies Directed Against HSP90 and the PI3K/AKT/mTOR Pathway in Prostate Cancer. PLoS One. 2017 Mar 28; 12(3):e0174658 [Epub 2017 Mar 28]. PMID: 28350865; PMC5370140; DOI: 1371/journal/pone.0174658.
    3. Mulligan WA, Wegner KA, Keil KP, Mehta V, Taketo M, Vezina CM (2017). Beta-Catenin and Estrogen Signaling Collaborate to Drive Cyclin D1 Expression in Developing Mouse Prostate. 2017 Jan-Feb; 93:66-71 [Epub 2016 Dec 2]. PMID: 27918915; PMC5285411; DOI: 10.1016/j.diff.2016.11.002.
    4. Drifka CR, Leoffler AG, Mathewson K, Mehta G, Keikhosravi A, Liu Y, Lemanik S, Ricke WA, Weber SM, Kao WJ, Eliceiri KW (2016). Comparison of Picrosirius Red Staining with Second Harmonic Generation Imaging for the Quantification of Clinically Relevant Collagen Fiber Features in Histopathology Samples. J Histochem Cytochem. 2016 Sep; 64(9):519-29 [Epub 2016 Jul 22]. PMID: 27449741; PMC5006137; DOI: 1369/0022155416659249.
    5. Hao L, Greer T, Page D, Shi Y, Vezina CM, Macoska JA, Marker PC, Bjorling DE, Bushman W, Ricke WA, Li L (2016). In-Depth Characterization and Validation of Human Urine Metabolomes Reveal Novel Metabolic Signatures of Lower Urinary Tract Symptoms. Sci Rep. 2016 Aug 9; (6):30869. PMID: 27502322; PMC4977550; DOI: 1038/srep30869.
    6. Rodriguez-Nieves JA, Patalano SC, Almanza D, Gharaee-Kermani M, Macoska JA (2016). CXCL12/CXCR4 Axis Activation Mediates Prostate Myofibroblast Phenoconversion Through Non-Canonical EGFR/MEK/ERK Signaling. PLoS One. 2016 Jul 19; 11(7):e0159490 [eCollection 2016]. PMID: 27434301; PMC4951124; DOI: 1371/journal/pone.0159490.
    7. Liu TT, Grubisha MJ, Frahm KA, Wendell SG, Liu J, Ricke WA, Auchus RJ, DeFranco DB (2016). Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor Beta (Erbeta) Response to 5alpha-reductase Inhibition in Prostate Epithelial Cells. J Biol Chem. 2016 Jul 8; 291(28):14747-60 [Epub 2016 May 13]. PMID: 27226548; PMC4938192; DOI: 1074/jbc.M115.711515.
    8. Gharaee-Kermani M, Moore BB, Macoska JA (2016). Resveratrol-Mediated Repression and Reversion of Prostatic Myofibroblast Phenoconversion. PLoS One. 2016 Jul 1; 11(7):e0158357 [eCollection 2016]. PMID: 27367854; PMC4930165; DOI: 1371/journal.pone.0158357.
    9. Jeong CH, Gao L, Dettro T, Wagner ED, Ricke WA, Plewa JM, Flaws JA (2016). Monohaloacetic Acid Drinking Water Disinfection By-Products Inhibit Follicle Growth and Steroidogenesis in Mouse Ovarian Antral Follicles In Vitro. Reprod Toxicol. 2016 Jul; 62:71-6 [Epub 2016 May 2]. PMID: 27151372; PMC4905796; DOI: 1016/j.reprotox.2016.04.028.
    10. Bauman TM, Vezina CM, Ricke EA, Halberg RB, Huang W, Peterson RE, Ricke WA (2016). Expression and Colocalization of Beta-Catenin and Lymphoid Enhancing Factor-1 in Prostate Cancer Progression. Hum Pathol. 2016 May; 51:124-33 [Epub 2016 Jan 19]. PMID: 2706770; PMC4830919; DOI: 1016/j.humpath.2015.12.024.
    11. Bauman TM, Ricke EA, Drew SA, Huang W, Ricke WA (2016). Quantitation of Protein Expression and Co-localization Using Multiplexed Immuno-histochemical Staining and Multispectral Imaging. J Vis Exp. 2016 Apr 8; (110):53837. PMID: 27167094; PMC4913774; DOI: 3791/53837.
    12. Ricke WA, Lee CW, Clapper TR, Schneider AJ, Moore RW, Keil KP, Abler LL, Wynder JL, López Alvarado A, Beaubrun I, Vo J, Bauman TM, Ricke EA, Peterson RE, and Vezina CM (2016). In utero and Lactational TCDD Exposure Increases Susceptibility to Lower Urinary Tract Dysfunction in Adulthood. Toxicol Sci. 2016 Apr; 150(2):429-40 [Epub 2016 Feb 9]. PMID: 26865671; PMC4900134; DOI: 1093/toxsci/kfw009.
    13. Thomas S, Hao L, Ricke WA, Li L (2016). Biomarker Discovery in Mass Spectrometry-Based Urinary Proteomics. Proteomics Clin Appl. 2016 Apr; 10(4):358-70 [Epub 2016 Feb 11]. PMID: 26703953; PMC4888976; DOI: 1002/prca.201500102. Review.
    14. Keil KP, Abler LL, Altmann HM, Bushman W, Marker PC, Li L, Ricke WA, Bjorling DE, Vezina CM (2016). Influence of Animal Husbandry Practices on Void Spot Assay Outcomes in C57BL/6J Male Mice. Neurourol Urodyn. 2016 Feb; 35(2):192-8 [Epub 2014 Nov 12]. PMID: 25394276; PMC4428995; DOI: 1002/nau.22692.
    15. Bauman TM, Becka AJ, Sehgal PD, Huang W, Ricke WA (2015). SIGIRR/TIR8, an Important Regulator of TLR4 and IL-1R-mediated NF-kB Activation, Predicts Biochemical Recurrence after Prostatectomy in Low-Grade Prostate Carcinomas. Hum Pathol. 2015 Nov; 46(11):1744-51 [Epub 2015 Jul 29]. PMID: 26344417; PMC4661098; DOI: 1016/j.humpath.2015.07.015.
    16. Gamat M, Malinowski RL, Parkhurst LJ, Steinke LM, Marker PC (2015). Ornithine Decarboxylase Activity is Required for Prostatic Budding in the Developing Mouse. PLoS One. 2015 Oct 1; 10(10):e0139522 [eCollection 2015]. PMID: 26426536; PMC4534462; DOI: 1371/journal.pone.0139522.
    17. Wynder JL, Nicholson TM, DeFranco DB, Ricke WA (2015). Estrogens and Male Lower Urinary Tract Dysfunction. Curr Urol Rep. 2015 Sep; 16(9):61. PMID: 26156791; PMC4732275; DOI: 1007/s11934-015-0534-6; NIHMS753980. Review.
    18. Greer T, Hao L, Nechyporenko A, Lee S, Vezina CM, Ricke WA, Marker PC, Bjorling DE, Bushman W, Li L (2015). Custom 4-Plex DiLeu Isobaric Labels Enable Relative Quantification of Urinary Proteins in Men with Lower Urinary Tract Symptoms (LUTS). PLoS One. 2015 Aug 12; 10(8):e0135415 [eCollection 2015]. PMID: 26267142; PMC4534462; DOI: 1371/journal.pone.0135415.
    19. Begley LA, Kasina S, Shah RB, Macoska JA (2015). Signaling Mechanisms Coupled to CXCL12/CXCR4-mediated cellular Proliferation are PTEN-dependent. Am J Clin Exp Urol. 2015 Aug 8; 3(2):91-9 [eCollection 2015]. PMID: 26309898; PMC4539110.
    20. Bauman TM, Ewald JA, Huang W, Ricke WA (2015). CD147 Expression Predicts Biochemical Recurrence after Prostatectomy Independent of Histological and Pathologic Features. BMC Cancer. 2015 Jul 25; 15:549. PMID: 26209327; PMC4514016; DOI: 1186/s12885-015-1559-4.
    21. Bjorling DE, Wang Z, Vezina CM, Ricke WA, Keil KP, Yu W, Guo L, Zeidel ML, Hill WG (2015). Evaluation of Voiding Assays in Mice: Impact of Genetic Strains and Sex. Amer J Physiol-Renal Physiol. 2015 Jun 15; 308(12):F1369-78 [Epub 2015 Apr 22]. PMID: 25904700; PMC4469884; DOI: 1152/ajprenal.00072.2015.
    22. Keil KP, Abler LL, Altmann HM, Wang ZY, Wang P, Ricke WA, Bjorling DE, Vezina CM (2015). Impact of a Folic Acid-Enriched Diet on Prostate and Urinary Function in Mice Treated with Testosterone and Estradiol. Amer J Physiol-Renal Physiol. 2015 Jun 15; 308(12):F1431-43 [Epub 2015 Apr 8]. PMID: 25855514; PMC4469891; DOI 1152/ajprenal.00674.2014.
    23. Theberge AB, Yu J, Young EW, Ricke WA, Bushman W, Beebe DJ (2015). Microfluidic Multiculture Assay to Analyze Biomolecular Signaling in Angiogenesis. Anal Chem. 2015 Mar 17; 87(6):3239-46 [Epub 2015 Feb 26]. PMID: 25719435; PMC4405103; DOI: 1021/ac503700f.
    24. Moses MA, Henry EC, Ricke WA, Gasiewicz TA (2015). The Heat Shock Protein 90 Inhibitor, (-)-Epigallocatechin Gallate, Has Anticancer Activity in a Novel Human Prostate Cancer Progression Model. Cancer Prev Res (Phila). 2015 Mar; 8(3):249-57 [Epub 2015 Jan 20]. PMID: 25604133; PMC4355219; DOI: 1158/1940-6207.CAPR-14-0224.
    25. Nicholson TM, Moses MA, Uchtmann KS, Keil KP, Bjorling DE, Vezina CM, Wood RW, Ricke WA (2015). Estrogen Receptor-α is a Key Mediator and Therapeutic Target for Bladder Complications of Benign Prostatic Hyperplasia. J Urol. 2015 Feb; 193(2):722-729 [Epub 2014 Aug 25]. PMID: 25167991; PMC4305478; DOI: 1016/j.juro.2014.08.093.
    26. Powers GL, Hammer KDP, Domenech M, Frantskevich K, Malinowski RL, Bushman W, Beebe DJ, Marker PC (2015). Phosphodiesterase 4D Inhibitors Limit Prostate Cancer Growth Potential. Mol Cancer Res. 2015 Jan; 13(1):149-60 [Epub 2014 Aug 22]. PMID: 25149359; PMC4312503; DOI: 1158/1541-7786.MCR-14-0110.
    27. Bauman TM, Vezina CM, Huang W, Marker PC, Peterson RE, Ricke WA (2014). Beta-Catenin is Elevated in Human Benign Prostatic Hyperplasia Specimens Compared to Histologically Normal Prostate Tissue. Am J Clin Exp Urol. 2014 Dec 25; 2(4):313-22 [eCollection 2014]. PMID: 25606577; PMC4297327
    28. Bauman TM, Nicholson TM, Abler LL, Eliceiri KW, Huang W, Vezina CM, Ricke WA (2014). Characterization of Fibrillar Collagens and Extracellular Matrix of Glandular Benign Prostatic Hyperplasia Nodules. PLoS One. 2014 Oct 2; 9(10):e109102 [eCollection 2014]. PMID: 25275645. PMC4183548; DOI: 1371/journal.pone.0109102.
  • ABSTRACTS
    1. Turco AE, Oakes SR, Keil-Stietz K, Chathurvedula T, Girardi N, Schneider AJ, Gawdzik J, Sheftel C, Wang P, Wang Z, Bjorling DE, Ricke WA, Tang W, Hernandez L, Keast JR, Bonev A, Tykocki N, Tanguay RL, Peterson RE, Vezina CM (2020). “A Neuroanatomical Mechanism Linking Perinatal Chemical Exposure to Prostate Smooth Muscle Hyperactivity and Altered Voiding Function.” Society for Basic Urologic Research Annual Meeting, Virtual Meeting, November 11-14, 2020.
    2. Cotellessa JF, Patalano S, Riley T, Macoska JA (2020). “Development of Urinary RNA Biomarkers for Renal Cell Carcinoma Prognosis”. Society for Basic Urologic Research Annual Meeting, Virtual Meeting, November 11-14, 2020.
    3. Joseph DB, Henry GH, Malewska A, Reese JC, Hutchinson RC, Roehrborn CG, Strand DW (2020). “Decoding Stromal Heterogeneity across BPH Phenotypes”. Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU), Virtual Meeting, December 3, 2020.
    4. Ruetten H, Henry G, Strand DW, Vezina CM (2020). “A Phenome-Based Approach for Characterizing Mouse Urinary Pathophysiologies”. Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU), Virtual Meeting, December 3, 2020.
    5. Turco AE, Oakes SR, Popovics P, Rogers A, Sheftel C, Cadena M, Peterson RE, Hernandez L, Hacker T, Bjorling DE, Bonev A, Tykocki N, Vezina CM (2020). “Testosterone and Estradiol Mediate Male Voiding Dysfunction by Reducing Prostatic Smooth Muscle Ppp112b Abundance and Impairing Muscle.” Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU), Virtual Meeting, December 3, 2020.
    6. Ruetten HM, Cole C, Wehber M, Wegner K, Girardi N, Peterson NT, Scharpf B, Romero M, Wood M, Colopy S, Bjorling DE, Vezina CM (2020). “An Immunohistochemical Prostate Cell Identification Key Indicates that Aging Shifts Procollagen 1A1 Production from Myofibroblasts to Fibroblasts in Dogs Prone to Prostate-related Urinary Dysfunction (Poster Presentation). UW-Madison Veterinary Summer Scholars Symposium, Virtual Meeting, August 2020.
    7. Launer BM, McVary KT, Ricke WA, Lloyd GL (2020). “1990 to Now: Critical Global Trends in LUTS/BPH.” American Urological Association Annual Meeting 2020, May 15-18, 2020 (cancelled).
    8. Joseph DB, Henry GH, Malewska A, Wegner KA, Macuk R, Gahan J, Reese JC, Hutchinson R, Roehrborn C, Vezina CM, Strand DW (2020). “Identification of Cognate Proximal Cell Types of the Mouse and Human Prostate and their Enrichment in Human Benign Prostatic Hyperplasia.” American Urological Association Annual Meeting 2020, May 15-18, 2020 (cancelled).
    9. Kenigsber A, Mauc, R, Diaz de Leon A, Roehrborn C, Strand DW, Costa D (2020). “A Multiparametric Magnetic Resonance Imaging (MPMRI) Pilot Study of Prostatic Peri-urethral Fibrosis (PUF), A Possible Alternative Source of LUTS.” American Urological Association Annual Meeting 2020, May 15-18, 2020 (cancelled).
    10. Gheinani AH, Sack BS, Piper M, Atta H, Cotellessa JF, Lambrinos G, Costa K, Doyle C, Patalano S, Cristofaro V, Sullivan M, Macoska JA, Adam R (2020). “Multiomics-based Characterization of Bladder Remodeling After Spinal Cord Injury.” American Urological Association Annual Meeting 2020, May 15-18, 2020 (cancelled).
    11. Popovics P, Awadallah WN, Kohrt SE, Case TC, Miller NL, Ricke EA, Huang W, Ramirez-Solano M, Liu Q, Matusik RJ, Ricke WA, Grabowska MM (2020). “Increased Expression of Osteopontin in the Prostate is Associated with the Clinical Progression of BPH.” American Urological Association Annual Meeting 2020, May 15-18, 2020 (cancelled).
    12. Wang Z-Y, Hou J, Bjorling DE (2020). “TGF-β1 Regulates Expression of Collagen 1A1 in Mouse Urothelial Cells.” American Urological Association Annual Meeting 2020, May 15-18, 2020 (cancelled).
    13. Liu TT, Ricke EA, Strand DW, Dhir R, Ricke WA (2020). “Steroid Hormone Metabolism Mediated Racial Disparity in Men with Benign Prostatic Hyperplasia.” American Urological Association Annual Meeting 2020, May 15-18, 2020 (cancelled).
    14. Ortiz Hernandez CJ, Ricke WA (2020). “Role of Estrogens in Fibrosis and Myofibroblast Phenoconversion of Prostate Stromal Cells.” Duke University School of Medicine Multidisciplinary Benign Urology Research Day 2020, Virtual Meeting, April 24, 2020.
    15. Popovics P, Awadallah WN, Kohrt SE, Case TC, Miller NL, Ricke EA, Huang W, Ramirz-Solano M, Liu Q, Vezina CM, Matusik RJ, Ricke WA, Grabowska MM (2019). “Prostatic osteopontin expression is associated with symptomatic benign prostatic hyperplasia” Duke University School of Medicine Multidisciplinary Benign Urology Research Day 2020, Virtual Meeting, April 24, 2020.
    16. Garvey DR, Uchtmann KS, Peterson RE, Vezina CM, Ricke WA (2020). “Stromal Estrogen Receptor-alpha is Involved in the Development of Lower Urinary Tract Dysfunction.” Duke University School of Medicine Multidisciplinary Benign Urology Research Day 2020, Virtual Meeting, April 24, 2020.
    17. Liu TT, Ricke EA, Strand DW, Dhir R, Ricke WA (2020). “Steroid Hormone Metabolism Mediated Racial Disparity in Men with Benign Prostatic Hyperplasia.” Duke University School of Medicine Multidisciplinary Benign Urology Research Day 2020, Virtual Meeting, April 24, 2020.
    18. Ruetten HM, Cole C, Wehber M, Wegner K, Girardi N, Peterson NT, Scharpf B, Romero M, Wood M, Colopy S, Bjorling DE, Vezina CM (2020). “An Immunohistochemical Prostate Cell Identification Key Indicates That Aging Shifts Procollagen 1A1 Production from Myofibroblasts to Fibroblasts in Dogs Prone to Prostate-related Urinary Dysfunction” (1-min Flash Talk). Duke University School of Medicine Multidisciplinary Benign Urology Research Day 2020, Virtual Meeting, April 24, 2020.
    19. Liu TT, Ricke EA, Strand DW, Dhir R, Ricke WA (2020). “Steroid Hormone Metabolism Mediated Racial Disparity in Men with Benign Prostatic Hyperplasia.” Endocrine Society (ENDO) Annual Meeting, San Francisco, CA, March 28-31, 2020.
    20. Turco AE, Oakes SR, Chaturevelda T, Keil KP, Girardi N, Hernandez HH, Peterson RE, Bonev A, Tykocki N, Vezina CM (2020). “IUL TCDD Increases Noradrenergic Axon Density and Nerve-Evoked Smooth Muscle Contraction in Mouse Prostate.” The 59th Annual Meeting of the Society of Toxicology, Anaheim, CA, March 15-19, 2020 (cancelled).
    21. Popovics P, Awadallah WN, Kohrt S, Case TC, Miller NL, Ricke EA, Huang W, Ramirz-Solano M, Liu Q, Matusik RJ, Ricke WA, Grabowska MM (2019). “Increased Expression of Osteopontin in the Prostate is Associated with the Clinical Progression of BPH.” National Institute of Diabetes and Digestive and Kidney Diseases Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Kansas City, MO, December 4-6, 2019.
    22. Myklebust LM, Liu TT, Ricke WA (2019). “Aging Exacerbates Lower Urinary Tract Dysfunction and Causes Epigenetic Modifications Altering the Sex Steroid Hormone Environment in Mice.” National Institute of Diabetes and Digestive and Kidney Diseases Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Kansas City, MO, December 4-6, 2019.
    23. Ruetten HM, Wehber M, Cole C, Cadena MT, Wegner KA, Romero MF, Wood MW, Colopy SA, Bjorling DE, Vezina CM (2019). “Fibroblasts Accumulate and Produce Collagen in Dogs Prone to Prostate Related Urinary Dysfunction.” National Institute of Diabetes and Digestive and Kidney Diseases Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Kansas City, MO, December 4-6, 2019.
    24. Anzia L, Johnson C, Wells S, Bushman W, Hernando D, Roldán-Alzate A (2019). “Segmentation and 3D Anatomical Renderings from Pelvic MRI Provide a Novel Method to Quantify Clinically Relevant Features of the Bladder and Prostate.” National Institute of Diabetes and Digestive and Kidney Diseases Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Kansas City, MO, December 4-6, 2019.
    25. Broman MM, Lanman NA, Vickman RE, Franco OE, Hayward SW, Henry GH, Strand DW, Ratliff TL (2019). “Immune Cell Interactions in Benign Prostatic Hyperplasia.” National Institute of Diabetes and Digestive and Kidney Diseases Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Kansas City, MO, December 4-6, 2019.
    26. Bonnemaison ML, Gharaee-Kermani M, Macoska JA (2019). “Prostate Fibrosis is Coupled to a Mesenchymal IL-4/IL-3 Autocrine Loop.” National Institute of Diabetes and Digestive and Kidney Diseases Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Kansas City, MO, December 4-6, 2019.
    27. Ortiz Hernandez CJ, Ricke WA (2019). “Role of Estrogens in Fibrosis and Myofibroblast Phenoconversion of Prostate Stromal Cells National Institute of Diabetes and Digestive and Kidney Diseases Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Kansas City, MO, December 4-6, 2019.
    28. Liu TT, Ricke EA, Strand DW, Dhir R, Ricke WA (2019). “Estrogen Mediated Racial Disparity in Men with Benign Prostatic Hyperplasia.” National Institute of Diabetes and Digestive and Kidney Diseases Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Kansas City, MO, December 4-6, 2019.
    29. Liu TT, Ricke WA (2019). “Aging Alters Steroid Hormone Metabolism and Exacerbates Lower Urinary Tract Dysfunction in Mice.” The Gerontological Society of America (GSA) Annual Meeting, Austin, TX, November 13-17, 2019.
    30. Ortiz Hernandez CJ, Ricke WA (2019). “Role of Estrogens in Fibrosis and Myofibroblast Phenoconversion of Prostate Stromal Cells.” Society for Basic Urologic Research (SBUR) Fall Symposium, New Orleans, LA, November 7-10, 2019.
    31. Liu TT, Ricke EA, Strand DW, Dhir R, Ricke WA (2019). “Estrogen Mediated Racial Disparity in Men with Benign Prostatic Hyperplasia.” Society for Basic Urologic Research (SBUR) Fall Symposium, New Orleans, LA, November 7-10, 2019.
    32. Popovics P, Awadallah WN, Kohrt S, Case TC, Miller NL, Ricke EA, Ramirz-Solano M, Liu Q, Matusik RJ, Ricke WA, Grabowska MM (2019). “Osteopontin Exacerbates the Inflammatory Environment in the Prostate.” Society for Basic Urologic Research (SBUR) Fall Symposium, New Orleans, LA, November 7-10, 2019.
    33. Bonnemaison ML, Gharaee-Kermani M, Macoska JA (2019). “Prostatic Fibrosis is Coupled to a Mesenchymal IL4/IL3 Autocrine Loop.” Society for Basic Urologic Research (SBUR) Fall Symposium, New Orleans, LA, November 7-10, 2019.
    34. Gao S, Chen S, Han D, Wang Z, Li M, Han W, Besschetnova A, Zhou F, Barrett D, Luong MP, Owiredu J, Liang Y, Ahmed M, Petricca J, Macoska JA, Corey E, Chen S, Balk SP, Housheng HH, Cai C (2019). “LSD1-mediated Demethylation of FOXA1 Regulates AR Cistrome in Prostate Cancer.” Society for Basic Urologic Research (SBUR) Fall Symposium, New Orleans, LA, November 7-10, 2019.
    35. Han W, Toure AA, Han D, Gao S, Cai C (2019). “A Preclinical Study of the Combination Treatment of High-dose Testosterone and CDK4/6 Inhibitors in CRPC.” Society for Basic Urologic Research (SBUR) Fall Symposium, New Orleans, LA, November 7-10, 2019.
    36. Hashemi A, Sack BS, Piper M, Cotellessa JF, Doyle C, Gharaee-Kermani M, Avery A, Cristofaro V, Sullivan MP, Burkhard FC, Monastyrskaia K, Macoska JA, Adam RM (2019). “Temporal Analysis of Signaling Events Leading to Bladder Remodeling after Spinal Cord Injury.” Society for Basic Urologic Research (SBUR) Fall Symposium, New Orleans, LA, November 7-10, 2019.
    37. Turco AE, Oakes SR, Rodgers A, Underriner C, Cadena MT, Peterson RE, Hernandez L, Hacker T, Tykocki N, Vezina CM (2019). “Exogenous Testosterone and Estradiol Prolong Prostate Smooth Muscle Relaxation via Downregulation of MYPT2: A Novel Utility for Genetically Encoded Calcium Receptors.” Society for Basic Urologic Research (SBUR) Fall Symposium, New Orleans, LA, November 7-10, 2019.
    38. Ruetten HM, Wehber M, Cole C, Cadena MT, Wegner KA, Romero MF, Wood MW, Colopy SA, Bjorling DE, Vezina CM (2019). “Fibroblasts Accumulate and Produce Collagen in Dogs Prone to Prostate Related Urinary Dysfunction.” Society for Basic Urologic Research (SBUR) Fall Symposium, New Orleans, LA, November 7-10, 2019.
    39. Ruetten HM, Cole C, Wehber M, Sandhu S, Oakes SR, Waller III K, Vezina CM (2019). “A Retrospective Medical Review of Benign Prostatic Hyperplasia in a Well-defined Population of Client-owned Dogs: Clinical Presentation, Prevalence of Concurrent Bacterial Infection, and Response to Treatment.” Society for Basic Urologic Research (SBUR) Fall Symposium, New Orleans, LA, November 7-10, 2019.
    40. Cadena MT, Zhu J, Wang P, Underriner C, Hernandez L, Tykocki N, Shen T, Barasch J, Romero MF, Vezina CM (2019). “Prostate Neuroendocrine Cell Serotonin Aids to Prevent Microbial Infection.” Society for Basic Urologic Research (SBUR) Fall Symposium, New Orleans, LA, November 7-10, 2019.
    41. Zwaans BMM, Wegner KA, Bartalone SN, Vezina CM, Chancellor MB, Lamb LE (2019). “Radiation Cystitis Modeling: A Comparative Study of Radiation Induced Bladder Fibrosis in Different Mouse Strains.” Society for Basic Urologic Research (SBUR) Fall Symposium, New Orleans, LA, November 7-10, 2019.
    42. Wiessner G, Batourina E, Rosselot C, Vezina CM, Schneider K, Mendelsohn C (2019). “Roles of Retinoid Signaling in the Developing Urothelium.” Society for Basic Urologic Research (SBUR) Fall Symposium, New Orleans, LA, November 7-10, 2019.
    43. Crowell, PD, Fox JJ, Hashimoto T, Diaz JA, Henry GH, Lowe MG, Wu YE, Strand DW, Goldstein AS (2019). “Expansion of Luminal Progenitor Cells in the Aging Mouse and Human Prostate.” Society for Basic Urologic Research (SBUR) Fall Symposium, New Orleans, LA, November 7-10, 2019.
    44. Broman MM, Lanman NA, Vickman RE, Hayward SW, Henry GH, Strand DW, Ratliff TL (2019). “Immune Cell Interactions in Benign Prostatic Hyperplasia.” Society for Basic Urologic Research (SBUR) Fall Symposium, New Orleans, LA, November 7-10, 2019.
    45. Wang Z, Xue B, Wu S, Tabatabaei S, WU C-L, Cheng Z, Xin L, Strand DW, Olumi AF, Wang Z (2019). “Obesity-associated Inflammation Induces Androgenic to Estrogenic Switch in the Prostate Gland.” Society for Basic Urologic Research (SBUR) Fall Symposium, New Orleans, LA, November 7-10, 2019.
    46. Lafin JT, Abe D, Ahmed M, Savelyeva A, Strand DW, Amatruda JF, Bagrodia A (2019). “Modeling Cisplatin Resistance in Testis Cancer with the Zebrafish.” Society for Basic Urologic Research (SBUR) Fall Symposium, New Orleans, LA, November 7-10, 2019.
    47. Joseph DB, Henry GH, Malewska A, Wegner KA, Roehrborn CG, Reese JC, Hutchinson RC, Vezina CM, Strand DW (2019). “Identification of Cognate Proximal Cell Types of the Mouse and human Prostate and their Enrichment in Human Benign Prostatic Hyperplasia.” Society for Basic Urologic Research (SBUR) Fall Symposium, New Orleans, LA, November 7-10, 2019.
    48. Binoy Joseph D, Henry GH, Malewska A, Hannan R, Raj GV, Strand DW (2019). “Urethral Epithelia Extend into the Proximal Prosate Stem Cell Niche and are Increased in Prostate Cancer.” Prostate Cancer Foundation Meeting, Carlsbad, CA, October 24, 2019.
    49. Ricke WA, McLean DT (2018). “FGF5 Increases Androgen Receptor Expression and Signaling in Prostate Cancer.” UW-Madison Prostate Research Group Seminar, Madison, WI, October 4, 2019.
    50. Ortiz Hernandez CJ, Ricke EA, Ricke WA (2019). “Estrogens Induce Fibrosis and Myofibroblast Phenoconversion in Prostate Stromal Cells.” University of Wisconsin-Madison Molecular and Cellular Pharmacology Training Program 15th Annual MCP Signal Transduction Research Training Symposium, Madison, WI, September 16, 2019.
    51. Vellky JE, Ricke WA (2019). “DDX3-Mediated Translational Regulation of Androgen Receptor in Prostate Cancer Progression.” American Urological Association Annual Meeting, Chicago, IL, May 3-6, 2019.
    52. Vellky JE, Ricke WA (2019). “DDX3-Mediated Translational Regulation of Androgen Receptor in Prostate Cancer Progression.” University of Wisconsin-Madison/UMASS Boston George M. O’Brien Center Spring Symposium, Madison, WI, April 11-12, 2019.
    53. Liu TT, Ricke WA (2018). “The Impact of Aging on the Lower Urinary Tract of Mice.” National Institute of Diabetes and Digestive and Kidney Diseases Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Ellicott City, MD, Dec 12-14, 2018.
    54. Keil KP, Sethi S, Bjorling DE, Lein PJ (2018). “Developmental Exposure to Polychlorinated Biphenyls (PCBs) Induces Bladder Inflammation, increased Nerve Density and Voiding Dysfunction in Young Adult Mice.” National Institute of Diabetes and Digestive and Kidney Diseases Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Ellicott City, MD, Dec 12-14, 2018.
    55. Gamat M, Malinowski RL, Steinke L, Roopra A, Marker PC (2018). “Connecting Development and Disease: Presenting a Potential Mouse Model for BPH.” National Institute of Diabetes and Digestive and Kidney Diseases Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Ellicott City, MD, Dec 12-14, 2018.
    56. Cunningham K, McLean DT, Ricke WA (2018). “Isolating Prostate Stem-like Cells in a Progressive Cell Line Model.” National Institute of Diabetes and Digestive and Kidney Diseases Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Ellicott City, MD, Dec 12-14, 2018.
    57. Bjorling DE, Wang Z, Gong Y, Hou J (2018). “MicroRNA-29a/b1 Inhibits Bladder Fibrosis and Supports Normal Bladder Function.” National Institute of Diabetes and Digestive and Kidney Diseases Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Ellicott City, MD, Dec 12-14, 2018.
    58. Macoska JA, Wang Z, Virta J, Zacharias N, Bjorling DE (2018). “CXCL12 Mediates Increased Prostatic Fibrosis in Mice Fed a High Fat Diet.” National Institute of Diabetes and Digestive and Kidney Diseases Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Ellicott City, MD, Dec 12-14, 2018.
    59. Liu TT, Ricke WA (2018). “The Impact of Age on the Lower Urinary Tract of Mice.” National Institute of Diabetes and Digestive and Kidney Diseases Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Ellicott City, MD, Dec 12-14, 2018.
    60. Ruetten HM, Zhang HL, Wegner KA, Wang P, Wang Z, Bjorling DE, Ricke WA, Marker PC, Vezina CM (2018). “Dose Size Matter? Reduced Prostate Size Alters Urinary Function in Male Mice.” National Institute of Diabetes and Digestive and Kidney Diseases Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Ellicott City, MD, Dec 12-14, 2018.
    61. Wegner KA, Guo J, McMahon JA, McMahon AP, Vezina CM (2018). “Characterization of Srd5a2creErt2Expression in the Mouse Prostate: A Potential Source of Stromal Progenitors.” National Institute of Diabetes and Digestive and Kidney Diseases Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Ellicott City, MD, Dec 12-14, 2018.
    62. Thomas S, Hao L, Greer T, Vezina CM, Bajpai S, Ashok A, Bieberich C, Ricke WA, Li L (2018). “The Urine Proteomics of Genetically-induced Lower Urinary Tract Dysfunction (LUTD) Mice.” National Institute of Diabetes and Digestive and Kidney Diseases Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Ellicott City, MD, Dec 12-14, 2018.
    63. Thomas S, Liu TT, Ricke WA (2018). “Monitoring Serum Steroids in a Hormone-induced Model of Lower Urinary Tract Dysfunction.” National Institute of Diabetes and Digestive and Kidney Diseases Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Ellicott City, MD, Dec 12-14, 2018.
    64. Henry GH, Malewska A, Joseph DB, Malladi VS, Lee J, Torrealba J, Mauck RJ, Gahan JC, Raj GV, Roehrborn CG, Hon GC, MacConmara MP, Reese JC, Hutchinson RC, Vezina CM, Strand DW (2018). “Building a Comprehensive Cellular Anatomy of the Normal and Diseased Human Prostate.” National Institute of Diabetes and Digestive and Kidney Diseases Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Ellicott City, MD, Dec 12-14, 2018.
    65. Ruetten HM, Wegner KA, Colopy S, Zhang HL, Sandhu S, Romero MF, Vezina CM (2018). “Impact of Age and Castration on Canine Prostate Collagen Organization.” National Institute of Diabetes and Digestive and Kidney Diseases Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Ellicott City, MD, Dec 12-14, 2018.
    66. Romero PZ, Holmes HL, Cadena MT, Vezina CM, Romero MF (2018). “NBCe1 in the Kidney and Lower Urogenital Tract.” National Institute of Diabetes and Digestive and Kidney Diseases Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Ellicott City, MD, Dec 12-14, 2018.
    67. Neuman SD, Vellky JE, Ihry RJ, Bashirullah A, Ricke WA (2018). “Using Mouse and Drosophilia Models to Dissect the Role of DDX3-dependent Translational Control in BPH.” National Institute of Diabetes and Digestive and Kidney Diseases Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Ellicott City, MD, Dec 12-14, 2018.
    68. McLean DT, Ricke WA (2018). “FGF5 Regulation of Androgen Receptor in Prostate Cells.” National Institute of Diabetes and Digestive and Kidney Diseases Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Ellicott City, MD, Dec 12-14, 2018.
    69. O’Driscoll CA, Wegner KA, Ruetten HM, Abler LL, Oakes SR, Bjorling DE, Ricke WA, Mascoska J, Marker PC, Vezina CM (2018). “Exogenous Hormone Exposure: A Potential Platform for Testing Interventional Therapies for Lower Urinary Tract Dysfunction in Male Mice.” National Institute of Diabetes and Digestive and Kidney Diseases Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Ellicott City, MD, Dec 12-14, 2018.
    70. Ricke WA, McLean DT (2018). “Fibroblast Growth Factor-5 Increases Androgen Receptor Expression and Signaling in the Prostate.” UW-Madison Prostate Research Group Seminar, Madison, WI, December 7, 2018.
    71. Ricke WA, Vellky JE (2018). “Post-transcriptional Regulation of Androgen Receptor by DDX3 as a Mechanism for CRPC.” Society for Basic Urologic Research (SBUR) Fall Symposium, Rancho Mirage, CA, November 2018.
    72. Cadena MT, Turco AE, Romero PZ, Holmes HL, Romero MF, Tykocki N, Vezina CM (2018). “Mouse Prostatic Neuroendocrine Cells Mediate Smooth Muscle Contraction.” Society for Basic Urologic Research (SBUR) Fall Symposium, Rancho Mirage, CA, November 2018.
    73. Ruetten HM, Zhang HL, Wegner KA, Wang P, Wang Z, Bjorling DE, Ricke WA, Marker PC, Vezina CM (2018). “Does Size Matter?: Reduced Prostate Size Alters Urinary Function in Male Mice.” Society for Basic Urologic Research (SBUR) Fall Symposium, Rancho Mirage, CA, November 2018.
    74. Wegner KA, Guo J, McMahon JA, McMahon AP, Vezina CM (2018). “Characterization of Srd5a2creErt2 Expression in the Mouse Prostate: A Potential Source of Stromal Progenitors.” Society for Basic Urologic Research (SBUR) Fall Symposium, Rancho Mirage, CA, November 2018.
    75. Unterberger CJ, Wegner KA, Malinowski RL, Vezina CM, Swanson SM, Marker PC (2018). “Role of Growth Hormone in Prostate Cancer Progression.” Society for Basic Urologic Research (SBUR) Fall Symposium, Rancho Mirage, CA, November 2018.
    76. Henry GH, Malewska A, Joseph DB, Malladi VS, Lee J, Torrealba J, Mauck RJ, Gahan JC, Raj GV, Roehrborn CG, Hon GC, MacConmara MP, Reese JC, Hutchinson RC, Vezina CM, Strand DW (2018). “Single Cell RNA Sequencing of the Normal Human Prostate Reveals Identity of Novel Stromal and Epithelial Cell Types.” Society for Basic Urologic Research (SBUR) Fall Symposium, Rancho Mirage, CA, November 2018.
    77. Joseph DB, Chandrashekar AS, Abler LL, Chu L-F, Thomson JA, Vezina CM (2018). “Epithelial Dnmt1Regulates Prostate Bud Formation and Differentiation by Maintaining Survival of Early Prostate Progenitors”. Society for Basic Urologic Research (SBUR) Fall Symposium, Rancho Mirage, CA, November 2018.
    78. Sandhu S, Joseph DB, Strand DW, Vezina CM (2018). “Immunohistochemical Comparison of Novel Epithelial and Stromal Cell Types in the Human and Mouse Prostate”. Society for Basic Urologic Research (SBUR) Fall Symposium, Rancho Mirage, CA, November 2018.
    79. Ruetten HM, Zhang HL, Wegner KA, Wang P, Wang Z, Bjorling DE, Ricke WA, Marker PC, Vezina CM (2018). “Does Size Matter?: Reduced Prostate Size Causes Urinary Dysfunction in Male Mice.” American College of Veterinary Pathology Annual Meeting, Washington, DC, November 2018.
    80. Ricke WA, Vellky JE (2018). “DDX3 Expression and Localization in Prostate Cancer Progression.” UW-Madison Prostate Research Group Seminar, Madison, WI, October 5, 2018.
    81. Zhang HL, Ruetten HM, Wegner KA, Vezina CM (2018). “Does Size Matter?: Reduced Prostate Size Causes Urinary Dysfunction in Male Mice.” 3rd Annual Symposium for the Summer Program in Undergraduate Urologic Research (SPUUR), Madison, WI, Aug 12, 2018.
    82. Mueller BR, Wegner KA, Vezina CM (2018). “Prostate Extracellular Matrix Morphology Associates with Lower Urinary Tract Dysfunction in Male Mice.” 3rd Annual Symposium for the Summer Program in Undergraduate Urologic Research (SPUUR), Madison, WI, Aug 12, 2018.
    83. Sandhu S, Joseph DB, Strand DW, Vezina CM (2018). “Immunohistochemical Comparison of Novel Epithelial and Stromal Cell Types in the Human and Mouse Prostate.” 3rd Annual Symposium for the Summer Program in Undergraduate Urologic Research (SPUUR), Madison, WI, Aug 12, 2018.
    84. Romero PZ, Holmes HL, Cadena MT, Vezina CM, Romero MF (2018). “Nbce1 in the Kidney and Lower Urogenital Tract.” 3rd Annual Symposium for the Summer Program in Undergraduate Urologic Research (SPUUR), Madison, WI, Aug 12, 2018.
    85. Romero PZ, Holmes HL, Cadena MT, Vezina CM, Romero MF. “Nbce1 in the Kidney and Lower Urogenital Tract.” NIDDK KUH Summer Undergraduate Research Conference, Boston, MA, August 1-3, 2018.
    86. Ricke WA, Li L, Thomas S (2018). “Collagenase Digestion Deepens Coverage of Extracellular Matrix in Urinary Proteomics.” Wisconsin Human Proteomics Symposium, Madison, WI, August 2018.
    87. Ruetten HM, Wegner KA, Colopy S, Zhang HL, Sandhu S, Romero MF, Vezina CM (2018). “Impact of Age and Castration on Canine Prostate Collagen Organization.” 2018 Therio Conference, Milwaukee, WI, August 2018.
    88. Sack B, Piper M, Cotellessa J, Doyle C, Gharaee-Kermani M, Avery A, Mahmood F, Cristofaro V, Sullivan M, Macoska JA, Adam R (2018). “Expression Profiling of Experimental Neurogenic Bladder Reveals Decreased b3-Adrenergic Receptor Expression That Can Be Reversed By Inoside Treatment.” MP56-07. J.Urol.Vol.199, No. 4S, Supplement, May 20, 2018.
    89. Ricke WA, Jeong CH, Liu TT (2018). “The Impact of Age on the Lower Urinary Tract of Mice.” Society for Basic Urologic Research (SBUR) Spring Symposium, San Francisco, CA, May 2018.
    90. Sack BS, Piper M, Cotellessa JF, Doyle C, Gharaee-Kermani M, Avery A, Mahmood F, Cristofaro V, Sullivan MP, Macoska JA, Adam RM (2018). “Expression Profiling of Experimental Neurogenic Bladder Reveals Decreased beta 3-AR Expression That Can Be Reversed By Inoside Treatment.” American Urological Association (AUA) Annual Meeting, Boston, MA, May 12-16, 2018.
    91. Zhang HL, Vezina CM (2018). “Castration Reduces Duration and Increases Frequency of Urination.” University of Wisconsin Undergraduate Research Symposium, Madison, WI, April 2018.
    92. Ricke WA, Ricke EA, Walker I, Jeong CH, Thomas S, Liu TT (2018). “Altered steroidogenesis on Estrogen Receptor Activation in Benign Prostatic Hyperplasia”. University of Wisconsin-Madison/UMASS Boston George M. O’Brien Center Spring Symposium, Madison, WI, April 2018.
    93. Li L, Ricke WA, Steinke L, Hyman S, Delaney K, Hao L, Thomas S (2018). “Proteomics by Mass Spectrometry for Molecular Insights into Lower Urinary Tract Dysfunction due to Endocrine Disruption in Mice.” University of Wisconsin-Madison/UMASS Boston George M. O’Brien Center Spring Symposium, Madison, WI, April 2018.
    94. Macoska JA, Ricke WA, Uchtmann KS (2018). “Prostate Collagen Deposition is Associated with the Clinical Progression of LUTD and LUTS Among MTOPS Trial Participants.” University of Wisconsin-Madison/UMASS Boston George M. O’Brien Center Spring Symposium, Madison, WI, April 2018.
    95. Ricke WA, Vellky JE (2018). “Post-transcriptional Regulation of Androgen Receptor by DDX3 in Prostate Cancer Progression.” University of Wisconsin-Madison/UMASS Boston George M. O’Brien Center Spring Symposium, Madison, WI, April 2018.
    96. Skelton PB, Ucthmann KS, Ricke WA (2018). “3D Visualization of Mouse Prostatic Urethra.” University of Wisconsin-Madison/UMASS Boston George M. O’Brien Center Spring Symposium, Madison, WI, April 2018.
    97. Ricke WA, Vellky JE (2018). “Post-transcriptional Regulation of Androgen Receptor by DDX3 in Prostate Cancer Progression.” American Association for Cancer Research (AACR), Chicago, IL, April 2018.
    98. Ricke WA, Vellky JE, Cunningham K, McLean DT (2018). “Androgen Receptor Expression Through an FGF5 and YAP1 Driven Mechanism.” American Association for Cancer Research (AACR), Chicago, IL, April 2018.
    99. Ruetten HM, Wegner KA, Zhang HL, Sandhu S, Romero MF, Wood MW, Marker PC, Strand DW, Colopy S, Vezina CM (2018). “Impact of Age and Castration on Canine Prostate Collagen Organization.” Abstract for poster and/or oral presentation, 6th Annual University of Wisconsin-Madison School of Veterinary Medicine-Phi Zeta Research Day, Madison, WI, April 2018.
    100. Liu TT, Thomas S, Jeong CH, Walker I, Ricke EA, Ricke WA (2018). “Altered Steroidogenesis on Estrogen Receptor Activation in Benign Prostatic Hyperplasia.” The Endocrine Society (ENDO) 100th Annual Meeting, Chicago, IL, March 17-20, 2018.
    101. Coker A, Vellky JE, Wynder JL, Bradfield C, Ricke WA (2018). “Evaluating the Effects of Environmental Estrogen Induced Activation of Non-Genomic Signaling in Human Prostate Cells.” Society of Toxicology Annual Meeting, San Antonio, TX, March 11-15, 2018.
    102. Jeong CH, Wynder JL, Thomas S, Lamarre NS, Wang Z, Bjorling DE, Ricke WA (2018). “Exposure to Bisphenols Causes Lower Urinary Tract Dysfunction in Mice Through an ER Alpha-Dependent Mechanism.” Society of Toxicology Annual Meeting, San Antonio, TX, March 11-15, 2018.
    103. Li L, Ricke WA, Steinke L, Hyman S, Delaney K, Hao L, Thomas S (2018). “Proteomics by Mass Spectrometry for Molecular Insights into Lower Urinary Tract Dysfunction due to Endocrine Disruption in Mice”. 7thAnnual International Meeting of Young Environmental Scientists of the Society of Environmental Toxicology and Chemistry, Madison, WI, March 2018.
    104. Wegner KA, Turco AE, Wang P, Bjorling DE, Peterson RE, Vezina CM (2018). “In Utero and Lactational (IUL) TCDD Exposure Causes Lower Urinary Dysfunction in Adult Male C57BL/6J Mice.” Abstract for poster presentation, Society of Toxicology Annual Meeting, San Antonio, TX, March 2018.
    105. Sack BS, Piper M, Cotellessa JF, Doyle C, Gharaee-Kermani M, Avery A, Mahmood F, Cristofaro V, Sullivan M, Macoska JA, Adam RM (2018). “Expression Profiling of Experimental Neurogenic Bladder Reveals Decreased β3-Adrenergic Receptor Expression that can be Reversed by Inosine Treatment”. Society for Urodynamics and Female Urology (SUFU) Annual Meeting, February 27 – March 3, 2018, Austin, TX.
    106. Ruetten HM, Wegner KA, Joseph D, Colopy S, Sullivan R, Vezina CM (2017). “Collagen Architecture of Canine and Murine Prostate: Impact of Age and Androgen Deprivation.” Abstract for poster presentation. Society for Basic Urologic Research (SBUR) 2017 Fall Symposium, Tampa, FL, November 2017.
    107. Li L, Ricke WA, Marker PC, Frost D, Hao L, Thomas S (2017). “A Proteomic Fingerprint of Hormone-Induced Lower Urinary Tract Dysfunction in Mice.” Society for Basic Urologic Research (SBUR) 2017 Fall Symposium, Tampa, FL, November 2017.
    108. Ricke WA, Ricke EA, Jeong CH, Liu TT (2017). “The Impact of Altered Steroidogenesis on Estrogen Receptor Activation in Benign Prostatic Hyperplasia Progression.” Society for Basic Urologic Research (SBUR) 2017 Fall Symposium, Tampa, FL, November 2017.
    109. Ricke WA, Vellky JE (2017). “Hormonal Modulation of DDX3 and its Implications for Translational Regulation in Prostate Cancer.” Society for Basic Urologic Research (SBUR) 2017 Fall Symposium, Tampa, FL, November 2017.
    110. Wegner KA, Guo J, McMahon JA, Maeda N, Wang P, Bjorling DE, Marker PC, McMahon AP, Vezina CM (2017). “Pro-fibrotic Signaling in Prostate Stroma Increases Prostate Collagen Fiber Density and Disrupts Normal Urinary Function in Male Mice.” Abstract for poster presentation, Society for Basic Urologic Research (SBUR) 2017 Fall Symposium, Tampa, FL, November 2017.
    111. Ruetten HM, Colopy S, Sullivan R, Wegner KA, Chandraskekar A, Vezina CM (2017). “Collagen Architecture of the Prostate in Neutered and Intact Canines.” Abstract for poster presentation, American College of Veterinary Pathologists (ACVP) & American Society for Veterinary Clinical Pathology (ASVCP) Concurrent Annual Meeting, Vacouver, British Columbia, Canada, November 2017.
    112. Ricke WA, Vellky JE, McLean DT (2017). “Androgen Regulation of Fibroblast Growth Factor 5 In Prostate Cancer.” Gordon Research Conference, Newry, Maine, August 2017.
    113. Li L, Ricke WA, Marker PC, Frost D, Hao L, Thomas S (2017). “A Proteomic Fingerprint of Hormone-Induced Lower Urinary Tract Dysfunction in Mice.” American Society for Mass Spectrometry, Indianapolis, IN, June 2017.
    114. Patalano-Salsman S, Rodriguez-Nieves JA, Almanza D, Avery A, Judell-Halfpenney A, Riley T, Macoska JA (2017). “CXCL12-CXCR4 Axis Activation Promotes COP II Vesicle-Mediated Secretion of Collagen by Prostate Myofibroblasts.” MP17-09. J. Urol. Vol. 197, No. 4S, Supplement, Friday, May 12, 2017.
    115. Gharaee-Kermani M, Macoska JA (2017). “TH2 Cytokines Promote Myofibroblast Phenoconversion and Prostatic Fibrosis.”  Urol. Vol. 197, No. 4S, Supplement, Friday, May 12, 2017.
    116. Ricke WA, Macoska JA, James TT, Wyndner JL, Walker I, Liu TT (2017). “The Identification of Estrogen Receptor Gene Networks in Benign Prostatic Hyperplasia.” American Urological Association (AUA), Boston, MA, May 2017.
    117. Ricke WA, Macoska JA, James TT, Wyndner JL, Walker I, Liu TT (2017). “The Identification of Estrogen Receptor Gene Networks in Benign Prostatic Hyperplasia.” University of Wisconsin-Madison/UMASS Boston George M. O’Brien Center Spring Symposium: “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease”, Madison, WI, May 2017.
    118. Macoska JA (2017). “Role of G-Protein Coupled Receptors in Lower Urinary Tract Fibrosis.”   University of Wisconsin-Madison/UMASS Boston George M. O’Brien Center Spring Symposium: “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease”, Madison, WI, May 2017.
    119. Li L, Ricke WA, Marker PC, Frost D, Hao L, Thomas S (2017). “A Proteomic Fingerprint of Hormone-Induced Lower Urinary Tract Dysfunction in Mice.” University of Wisconsin-Madison/UMASS Boston George M. O’Brien Center Spring Symposium: “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease”, Madison, WI, May 2017.
    120. Ricke WA, Timms BG, Vom Saal FS, Achenreiner A, John LM, Uchtmann KS (2017). “Fetal Bisphenol A Exposure Alters Urethra Morphology and Collagen Content of One Year-Old Rats: Findings from the NIEHS/FDA CLARITY-BPA Research Program.” University of Wisconsin-Madison/UMASS Boston George M. O’Brien Center Spring Symposium: “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease”, Madison, WI, May 2017.
    121. Vom Saal FS, Taylor J, Stahlhut R, Timms BG, Uchtmann KS, Ricke WA (2017). “Fetal Bisphenol A Exposure Alters Body Weight and Male Urogenital Tract Morphology At Birth: Findings From the NIEHS/FDA CLARITY Research Program.” University of Wisconsin-Madison/UMASS Boston George M. O’Brien Center Spring Symposium: “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease”, Madison, WI, May 2017.
    122. Bathke K, Trevena RL, Cadena MT, Wegner KA, Turco AE, Vezina CM (2017). “Classification of Gli1 Expressing Cell Lineages Within Mouse Prostate.” Abstract for poster presentation, University of Wisconsin-Madison/UMASS Boston George M. O’Brien Center Spring Symposium: “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease”, Madison, WI, May 2017.
    123. Shea MP, Wegner KA, O’Leary KA, Schuler LA (2017). “Collagen Density and mTOR Inhibition Alter Cancer Stemness and Plasticity of ER+ Mammary Carcinomas.” Abstract for poster presentation, University of Wisconsin-Madison/UMASS Boston George M. O’Brien Center Spring Symposium: “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease”, Madison, WI, May 2017.
    124. Wegner KA, Keil KP, Wang Z, Wang P, Bjorling DE, Vezina CM (2017). “Genetic Background Influences Susceptibility of Male Mice to Hormone-induced Urinary Dysfunction.” Abstract for poster presentation, University of Wisconsin-Madison/UMASS Boston George M. O’Brien Center Spring Symposium: “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease”, Madison, WI, May 2017.
    125. Ricke WA, Vellky JE, McLean DT (2017). “Androgen Regulation of Fibroblast Growth Factor 5 in Prostate Cancer.” Society for Basic Urologic Research (SBUR), Boston, MA, May 2017.
    126. Wynder, JL (2017). “Bisphenol-A Induces Lower Urinary Tract Dysfunction in Adult Male Mice”. University of Wisconsin-Madison Molecular and Environmental Toxicology Center Annual Retreat, Madison, WI, May 25, 2017.
    127. Ricke WA, Macoska JA, James TJ, Wynder JL, Liu TT (2017). “The Role of Estrogen Receptor Activation in Benign Prostatic Hyperplasia.” Society for Basic Urologic Research (SBUR), Boston, MA, May 2017.
    128. Wegner KA, Keil KP, Wang Z, Wang P, Bjorling DE, Vezina CM (2017). “Genetic Background Influences Susceptibility of Male Mice to Hormone-induced Urinary Dysfunction.” Abstract for poster presentation, University of Wisconsin Molecular & Environmental Toxicology Spring Symposium, Madison, WI, May 2017.
    129. Ruetten HM, Vezina C (2017). “Prostatic Areas of Disease Show Changes in Collagen Fiber Thickness, Diameter, Density, and Orientation.” Abstract for poster presentation, 5th Annual University of Wisconsin-Madison School of Veterinary Medicine-Phi Zeta Research Day, Madison, WI, April 2017.
    130. Patalano-Salsman S, Rodrigeuz-Nieves JA, Almanza D, Avery A, Riley T, Macoska JA (2017). “CXCL12-CXCR4 Axis Activation Promotes COP II Vesicle-Mediated Secretion of Collagen by Prostate Myofibroblasts.” Injury, Inflammation and Fibrosis Keystone Symposium, Snowbird, UT, March 26-30, 2017.
    131. Patalano-Salsman S, Rodriguez-Nieves JA, Almanza D, Avery A, Judell-Halfpenney A, Riley T, Macoska JA (2016). “CXCL12-CXCR4 Axis Activation Promotes Cop Ii Vesicle-Mediated Secretion Of Collagen By Prostate Myofibroblasts.” Society for Basic Urologic Research (SBUR) Annual Meeting, Nov 10-13, 2016, Scottsdale, AZ.
    132. Ricke WA, McSweeney S, Vellky JE (2016). “Expression of Housekeeping Genes across Prostate Cancer Progression.” Society for Basic Urologic Research (SBUR) Annual Meeting, Nov 10-13, 2016, Scottsdale, AZ.
    133. Oakes SR, Wegner KA, Eliceiri K, Vezina CM (2016). “High Thoroughput Computer-Based Analysis of Void Spot Assay Data.” Abstract for poster presentation, Society for Basic Urologic Research (SBUR) Annual Meeting, Nov 10-13, 2016, Scottsdale, AZ.
    134. Wegner KA, Keil KP, Wang Z, Wang P, Bjorling DE, Vezina CM (2016). “Genetic Background Influences Susceptibility of Male Mice to Hormone-induced Urinary Dysfunction.” Abstract for poster presentation, Society for Basic Urologic Research (SBUR) Annual Meeting, Nov 10-13, 2016, Scottsdale, AZ.
    135. Trevena RL, Sullivan R, Wegner KA, Esquibel CR, Eliceiri K, Vezina CM (2016). “Deep Prostate Tissue Immunohistochemical Staining and Fluorescent Confocal Scanning for 3-Dimensional Microenvironment Analysis.” Abstract for poster presentation, Society for Basic Urologic Research (SBUR) Annual Meeting, Nov 10-13, 2016, Scottsdale, AZ.
    136. Ricke WA, Vezina CM, Peterson RE, Moore RW, Ricke EA (2016). “In Utero and Lactational TCDD Exposure Increases Prostatic Estrogen Receptor Alpha and Secondary Complications Associated with Bladder Outlet Obstruction in Mice.” 36thInternational Symposium on Halogenated Persistent Organic Pollutants, Florence, Italy, August-September 2016.
    137. Nicholson TM, Wynder JL, Ricke WA (2016). “The Environmental Estrogen Bisphenol-A is Implicated in Hormonal Induction of Benign Prostatic Hyperplasia in Adult Male Mice.” Urology Research Day, University of Washington, Seattle, WA, June 2016.
    138. Ricke WA, Jeffery J, McLean DT, Cunningham K (2016). “In Vivo Modeling of Metastasis Using a Prostate Cancer Progression Cell Line.” Midwestern Preclinical Imaging Consortium, Madison, WI, May 2016.
    139. Ricke WA, Jeffery J, McLean DT, Cunningham K (2016). “In Vivo Modeling of Metastasis Using a Prostate Cancer Progression Cell Line.” Society for Basic Urological Research (SBUR), San Diego, CA, May 2016.
    140. Vom Saal FS, Taylor J, Stahlhut R, Timms BG, Uchtmann KS, Ricke WA (2016). “Fetal Bisphenol A Exposure Alters Body Weight and Male Urogenital Tract Morphology At Birth: Findings from the NIEHS/FDA CLARITY-BPA Research Program.” University of Wisconsin-Madison/UMASS Boston George M.O’Brien Center Symposium: The Environmental Impact on Urologic Health and Disease, Madison, WI, April 2016.
    141. Trevena R, Sullivan R, Wegner KA, Vezina CM, Vokoun C, Eliceiri K, Joseph DB (2016). “Optimization of Whole-Tissue Immunohistochemical Staining and Fluorescence Confocal Scanning for 3-D Prostatic Microenvironmental Analysis.” University of Wisconsin-Madison/UMASS Boston George M.O’Brien Center Symposium: The Environmental Impact on Urologic Health and Disease, Madison, WI, April 2016.
    142. Jeong CH, Vezina CM, Ricke WA (2016). “Alterations of DNA Methyltransferase in BPH-1 Derived Prostate Cancer Progression Model Cell Lines.” University of Wisconsin-Madison/UMASS Boston George M.O’Brien Center Symposium: The Environmental Impact on Urologic Health and Disease, Madison, WI, April 2016.
    143. Lamarre NS, Wynder JL, Uchtmann KS, Liu TT, Wang Z, Vezina CM, Ricke WA, Bjorling DE (2016). “The Effects of Bisphenol A on Urinary Bladder Function.” University of Wisconsin-Madison/UMASS Boston George M.O’Brien Center Symposium: The Environmental Impact on Urologic Health and Disease, Madison, WI, April 2016.
    144. Thomas S, Hao L, Greer T, Vezina CM, Bajpal S, Ashok A, Bieberich CJ, Ricke WA, Li L (2016). “The Urine Proteomes of Genetically-Induced Lower Urinary Tract Dysfunction (LUTD) in Mice.” University of Wisconsin-Madison/UMASS Boston George M.O’Brien Center Symposium: The Environmental Impact on Urologic Health and Disease, Madison, WI, April 2016.
    145. Trevena R, Sullivan R, Wegner KA, Vezina CM, Esquibel CR, Eliceiri K, Joseph DB (2016). “Optimization of Whole-Tissue Immunohistochemical Staining and Fluorescent Confocal Scanning for 3-D Prostatic Microenvironmental Analyses.” Abstract for poster presentation, University of Wisconsin-Madison/UMASS Boston George M.O’Brien Center Symposium: The Environmental Impact on Urologic Health and Disease, Madison, WI, April 2016.
    146. Oakes SR, Eliceiri K, Abler LL, Wegner KA, Vezina CM (2016). “Computer-Based High-Throughput Urinary Function Analysis.” Abstract for poster presentation, University of Wisconsin-Madison/UMASS Boston George M.O’Brien Center Symposium: The Environmental Impact on Urologic Health and Disease, Madison, WI, April 2016.
    147. Joseph DB, Keil KP, Abler LL, Vezina CM (2016). “A Map of DNA Methyltransferase Enzyme Expression in the Mouse Prostate During its Development and in Response to Prostate Injury.” University of Wisconsin-Madison/UMASS Boston George M.O’Brien Center Symposium: The Environmental Impact on Urologic Health and Disease, Madison, WI, April 2016.
    148. Cadena MT, Wegner KA, Bushman W, Ricke WA, Vezina CM (2016). “Elucidating Patterns of Smooth Muscle Contractility in Prostatic Urethral Tissue.: University of Wisconsin-Madison/UMASS Boston George M.O’Brien Center Symposium: The Environmental Impact on Urologic Health and Disease, Madison, WI, April 2016.
    149. Oakes SR, Eliceiri K, Abler LL, Wagner KA, Vezina CM (2016). “Computer-Based High-Throughput Urinary Function Analysis.” University of Wisconsin-Madison/UMASS Boston George M.O’Brien Center Symposium: The Environmental Impact on Urologic Health and Disease, Madison, WI, April 2016.
    150. Oakes SR, Eliceiri K, Abler LL, Wagner KA, Vezina CM (2016). “Computer-Based High-Throughput Urinary Function Analysis.” University of Wisconsin-Madison Undergraduate Research Symposium, Madison, WI April 2016.
    151. Joseph DB, Keil KP, Abler LL, Vezina CM (2016). “A Map of DNA Methyltransferase Enzyme Expression in the Mouse Prostate During its Development and in Response to Prostate Injury.” WARF Discovery Challenge Symposium, Madison, WI April 2016.
    152. Wynder JL, Nicholson T, Lamarre N, Waldman A, vom Saal FS, Vezina CM, Bjorling DE, Ricke WA (2017). “The Environmental Estrogen Bishpenol-A Induces Lower Urinary Tract Dysfunction in Adult Male Mice”, Society of Toxicology National Meeting, Baltimore, MD, March 13, 2016.
    153. Macoska JA (2016). “Urinary Obstruction and Fibrosis”, Plenary Talk. Society for Urodynamics and Female Urology (SUFU) Annual Meeting, New Orleans, LA, February 23-27, 2016.
    154. Ricke WA, Vellky JE (2015). “BOP1 Expression and Localization in Benign Prostatic Disease and Prostate Cancer Progression.” Society for Basic Urologic Research (SBUR), Ft. Lauderdale, FL, November 12-15, 2015.
    155. Lingjun L, Ricke WA, Bieberich C, Ashok A, Bajpai S, Vezina C, Greer T, Hao L, Thomas S (2015). “The Urine Proteomics of Genetically-Induced Lower Urinary Tract Dysfunction (LUTD) in Mice.” Society for Basic Urologic Research (SBUR), Ft. Lauderdale, FL, November 12-15, 2015.
    156. Gharaee-Kermani M, Moore BB, Macoska JA (2015). “Resveratrol-Mediated Repression And Reversion Of Prostatic Myofibroblast Phenoconversion.” Society for Basic Urologic Research (SBUR), Ft. Lauderdale, FL, November 12-15, 2015.
    157. Rodriguez-Nieves, Gharaee-Kermani M, Macoska JA (2015). “CXCL12/CXCR4-Axis Activation Mediates Prostate Myofibroblast Phenoconversion Through Non-Canonical EGFR/MEK/ERK Signaling.” Society for Basic Urologic Research (SBUR), Ft. Lauderdale, FL, November 12-15, 2015.
    158. Wegner KA, Keil KP, Oakes SR, Edokpolor KS, Ricke WA, Vezina CM (2015).  “Characterization of Stroma in Normal Mouse Prostate/Urethra and Mice with Urethral Obstruction.” Abstract for poster presentation, Society for Basic Urologic Research (SBUR), Ft. Lauderdale, FL, November 12-15, 2015.
    159. Wegner KA, Vezina CM (2015). “Characterization of Stroma in Normal Mouse Prostate/Urethra and Mice with Urethral Obstruction.” Society for Basic Urologic Research (SBUR), Ft. Lauderdale, FL, November 12-15, 2015.
    160. Jeong CH, Vezina CM, Ricke WA (2015). “Alterations of DNA Methyltransferase in BPH-1 Derived Prostate Cancer Progression Model Cell Lines.” Society for Basic Urologic Research (SBUR), Ft. Lauderdale, FL, November 12-15, 2015.
    161. Bauman TM, Vezina CM, Halberg RB, Huang W, Peterson RE, Ricke WA (2015). “Expression and Co-localization of Beta-Catenin and Lymphoid Enhancing Factor-1 in Prostate Cancer Progression.” Society for Basic Urologic Research (SBUR), Ft. Lauderdale, FL, November 12-15, 2015.
    162. Wynder JL, Nicholson T, Wood RW, Ricke WA (2015). “Testosterone and Bisphenol A Exposure Induces Increased Prostate and Bladder Mass of Male Mice.” University of Wisconsin-Madison Molecular and Environmental Toxicology Center Annual Retreat, Madison, WI, June 17, 2015.
    163. Ricke WA, Vellky JE, McLean DT (2015). “Fibroblast growth factor 5 increases expression through prostate cancer progression.” Society for Basic Urologic Research (SBUR), New Orleans, LA, May 2015.
    164. Bauman TM, Ricke EA, Huang W, Ricke WA (2015). “A Tissue Specific Role for Ligand Independent Arv7 Signaling in Benign Prostate Pathogenesis.” American Urological Association (AUA), New Orleans, LA, May 2015.
    165. Nicholson TM, Wynder JL, Ricke WA (2015). “Bladder Fibrosis in Male Mice Treated with Testosterone and Estradiol is Not Prevented by the Selective Estrogen Receptor Modulator Raloxifene.” American Urological Association (AUA), New Orleans, LA, May 2015.
    166. Hao L, Greer T, Zhong X, Page D, Lee S, Vezina CM, Ricke WA, Marker PC, Bjorling DE, Bushman W, Li L (2015). “Combining DiLeu Isobaric Labeling and Label-free Approaches for Metabolite Quantification and Biomarker Discovery of Lower Urinary Tract Symptoms (LUTS).” 63rdAnnual ASMS Conference on Mass Spectrometry and Allied Topics, St. Louis, MO, May 2015.
    167. Hao L, Greer T, Vezina CM, Ricke WA, Marker PC, Bjorling DE, Bushman W, Li L (2015). “Identification of Potential Metabolite Biomarkers of Lower Urinary Tract Symptoms (LUTS) in Mouse and Human Urine.” University of Wisconsin-Madison/UMASS Boston Spring Symposium: Role of Fibrosis in Signaling and Lower Urinary Tract Disease, Madison, WI, April 2015.
    168. Wynder JL, Nicholson T, Wood RW, Ricke WA (2015). “Testosterone and Bisphenol A Exposure Induces Increased Prostate and Bladder Mass of Male Mice”, University of Wisconsin-Madison/UMASS Boston Spring Symposium: Role of Fibrosis in Signaling and Lower Urinary Tract Disease, Madison, WI, April 2015.
    169. Ricke WA, Lee C, Clapper T, Schneider A, Moore RW, Keil KP, Abler LL, Wynder JL, López Alvarado A, Beaubrun I, Vo J, Peterson RE, Vezina CM (2015). “Fetal TCDD Exposure Increases Adult Male Mouse susceptibility to Urinary Dysfunction.” The 54thAnnual Meeting of the Society of Toxicology, San Diego, CA, March 2015.
    170. Nicholson TM, Bauman T, Ricke WA (2014). “Bladder Fibrosis in Male Mice Treated with Testosterone and Estradiol is Not Prevented by the Selective Estrogen Receptor Modulator Raloxifene.” Society for Basic Urologyic Research (SBUR), Dallas, TX, November 2014.
    171. Gamat M, Parkhurst L, Steinke L, Marker PC (2014). “Ornithine Decarboxylase Activity is Required for Prostatic Bud Initiation.” 6thGreat Lakes Nuclear Receptor Conference (GLNRC), Madison, WI, October 17-18, 2014.
  • SCIENTIFIC PRESENTATIONS/OUTREACH
    1. 2020 November, Society for Basic Urologic Research Annual Meeting: Cellular Interactions and Identities in Urologic Biology, Virtual Meeting, November 12, 2020. “Mouse Models of Prostatic Collagen Accumulation”, Dr. Chad Vezina.
    2. 2020 November, Society for Basic Urologic Research Annual Meeting: Cellular Interactions and Identities in Urologic Biology, Virtual Meeting, November 12, 2020. “Aging-mediated Cellular Changes Lead to Prostatic Fibrosis: A Lower Urinary Tract Dysfunction”, Dr. Teresa Liu.
    3. 2020 November, University of Wisconsin Prostate Research Group Meeting, Virtual Meeting, November 6, 2020. “Non-Invasive Comprehensive Assessment of BPH/LUTS”, Dr. Alejandro Roldán-Alzate.
    4. 2020 November, University of Wisconsin Prostate Research Group Meeting, Virtual Meeting, November 6, 2020. “Novel Magnetic Resonance Imaging Methods”, Dr. Diego Hernando.
    5. 2020 October, UW-Madison/UTSW/U.Mass-Boston Fall Symposium “Lower Urinary Tract Function Testing in Mice”, Virtual Meeting, October 29, 2020. “Uroflometry”, Dr. Dale Bjorling.
    6. 2020 October, UW-Madison/UTSW/U.Mass-Boston Fall Symposium “Lower Urinary Tract Function Testing in Mice”, Virtual Meeting, October 29, 2020. “Q&A”, Dr. Will Ricke.
    7. 2020 October, UW-Madison/UTSW/U.Mass-Boston Fall Symposium “Lower Urinary Tract Function Testing in Mice”, Virtual Meeting, October 29, 2020. “Q&A”, Drs. Kim Keil-Steitz & Chad Vezina.
    8. 2020 October, NIDDK Female Urethra Webinar Series: Session 3, Virtual Meeting, October 14, 2020. “The Role of Hormones: Lessons Learned from the Animal Kingdom”, Hannah Ruetten.
    9. 2020 October, University of Wisconsin Prostate Research Group Meeting, Virtual Meeting, October 2, 2020. “Fibroblast Growth Factor-5 (FGF-5) Promotes AR Nuclear Localization and Ligand-Independent Activation via the YAP/TAZ Pathway”, Dalton McLean.
    10. 2020 July, PCF Journal Club, Virtual Meeting, July 2, 2020. “Urethral Luminal Epithelia are Castration-insensitive Cells of the Proximal Prostate”, Dr. Douglas Strand.
    11. 2020 May, GUDMAP Monthly Meeting, Virtual Meeting, May 26, 2020. “Building a Cellular Anatomy of the Human and Mouse Prostate”, Dr. Douglas Strand.
    12. 2020 April, Duke University School of Medicine Multidisciplinary Benign Urology Research Day 2020, Virtual Meeting, April 24, 2020. “Role of Estrogens in Fibrosis and Myofibroblast Phenoconversion of Prostate Stromal Cells” (1-minute flash talk), Christian Ortiz Hernandez.
    13. 2020 April, Duke University School of Medicine Multidisciplinary Benign Urology Research Day 2020, Virtual Meeting, April 24, 2020. “Prostatic osteopontin expression is associated with symptomatic benign prostatic hyperplasia” (2-minute flash talk), Dr. Petra Popovics.
    14. 2020 April, Duke University School of Medicine Multidisciplinary Benign Urology Research Day 2020, Virtual Meeting, April 24, 2020. “Stromal Estrogen Receptor-alpha is Involved in the Development of Lower Urinary Tract Dysfunction” (1-minute flash talk), Dr. Debra Garvey.
    15. 2020 April, Duke University School of Medicine Multidisciplinary Benign Urology Research Day 2020, Virtual Meeting, April 24, 2020. “Steroid Hormone Metabolism Mediated Racial Disparity in Men with Benign Prostatic Hyperplasia” (2-minute flash talk), Dr. Teresa Liu.
    16. 2020 April, Duke University School of Medicine Multidisciplinary Benign Urology Research Day 2020, Virtual Meeting, April 24, 2020. “An Immunohistochemical Prostate Cell Identification Key Indicates that Aging Shifts Procollagen 1A1 Production from Myofybroblasts to Fibroblasts in Dogs Prone to Prostate-related Urinary Dysfunction” (1-minute flash talk), Hannah Ruetten.
    17. 2020 March, Northshore P20 Meeting, Chicago, IL, March 2, 2020. “Building a Cellular Anatomy of Human Prostate Disease”, Dr. Douglas Strand.
    18. 2020 February, Nephrology Grand Rounds, UTSW, Dallas, TX, Feburary 28, 2020. “Building a Cellular Anatomy of Human Prostate Disease: Insight for Kidney Stone Disease”, Dr. Douglas Strand.
    19. 2020 February, University of Wisconsin School of Veterinary Medicine, Comparative Biomedical Science Seminar Series, Madison, WI. “Challenging Dogma: A Story of Prostates and Urinary Function”, Hannah Ruetten.
    20. 2020 January, University of Wisconsin & University of Massachusetts-Boston O’Brien Center Innovative Idea Incubator Internal Seminar Series, Madison, WI, January 14, 2020. “The Collagen Producing Cell – Fibroblast, Myofibroblast, or Other?”, Hannah Ruetten & Christian Ortiz Hernandez.
    21. 2019 December, Hamon Center WIPs, UTSW, Dallas, TX, December 19, 2019. “Androgen-independent Luminal Progenitors are Derived from the Prostatic Urethra”, Dr. Douglas Strand.
    22. 2019 December, National Institute of Diabetes and Digestive and Kidney Diseases Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Kansas City, MO, December 4-6, 2019. “Overview of Cell Types in the Prostate”, Dr. Chad Vezina.
    23. 2019 December, National Institute of Diabetes and Digestive and Kidney Diseases Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Kansas City, MO, December 4-6, 2019. “Fibroblasts Accumulate and Produce Collagen in Dogs Prone to Prostate Related Urinary Dysfunction” (Oral Presentation, Poster Award Winner), Hannah Ruetten.
    24. 2019 December, National Institute of Diabetes and Digestive and Kidney Diseases Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Kansas City, MO, December 4-6, 2019. “Estrogen Mediated Racial Disparity in Men with Benign Prostatic Hyperplasia.”, Dr. Teresa Liu.
    25. 2019 December, National Institute of Diabetes and Digestive and Kidney Diseases Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Kansas City, MO, December 4-6, 2019. “Aging Exacerbates Lower Urinary Tract Dysfunction and Causes Epigenetic Modifications Altering the Sex Steroid Hormone Environment in Mice,”, Dr. Teresa Liu.
    26. 2019 December, National Institute of Diabetes and Digestive and Kidney Diseases Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Kansas City, MO, December 4-6, 2019. “Increased Expression of Osteopontin in the Prostate is Associated with the Clinical Progression of BPH,” Petra Popovics.
    27. 2019 December, National Institute of Diabetes and Digestive and Kidney Diseases Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Kansas City, MO, December 4-6, 2019. “Role of Estrogens in Fibrosis and Myofibroblast Phenoconversion of Prostate Stromal Cells,” Christian Ortiz Hernandez.
    28. 2019 December, National Institute of Diabetes and Digestive and Kidney Diseases Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Kansas City, MO, December 5, 2019. “Single Cell RNA Sequencing for Cell Discovery,” Douglas Strand.
    29. 2019 December, National Institute of Diabetes and Digestive and Kidney Diseases Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Kansas City, MO, December 4-6, 201 “Identification of Cognate Proximal Cell Types of the Mouse and Human Prostate and their Enrichment in Human Benign Prostatic Hyperplasia,” Dr. Douglas Strand.
    30. 2019 December, National Institute of Diabetes and Digestive and Kidney Diseases Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Kansas City, MO, December 4-6, 2019. “Prostate Fibrosis is Coupled to a Mesenchymal IL-4/IL-3 Autocrine Loop,” Mathilde Bonnemaison.
    31. 2019 December, National Institute of Diabetes and Digestive and Kidney Diseases Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Annual Meeting, Kansas City, MO, December 4-6, 2019. “Segmentation and 3D Anatomical Renderings from Pelvic MRI Provide a Novel Method to Quantify Clinically Relevant Features of the Bladder and Prostate,” Dr. Alejandro Roldán-Alzate.
    32. 2019 November, University of Wisconsin School of Veterinary Medicine, First Year Veterinary Histology Course, Madison, WI, November 2019. “Male Reproductive Histology-Research Correlate: Following the Green Dye”, Hannah Ruetten.
    33. 2019 November, Rock Valley Veterinary Medical Association November Meeting, Janesville, WI, November 2019, Hannah Ruetten.
    34. 2019 November, Society for Basic Urologic Research (SBUR) Fall Symposium, New Orleans, LA, November 7-10, 2019. “Osteopontin Exacerbates the Inflammatory Environment in the Prostate”, Dr. Petra Popovics.
    35. 2019 November, Society for Basic Urologic Research (SBUR) Fall Symposium, New Orleans, LA, November 8, 2019. “A Retrospective Medical Record Review of Benin Prostatic Hyperplasia in a Well-Defined Population of Client-Owned Dogs: Clinical Presentation, Prevalence of Concurrent Bacterial Infection, and Response to Treatment”, Hannah Ruetten.
    36. 2019 November, Society for Basic Urologic Research (SBUR) Fall Symposium, New Orleans, LA, November 8, 2019. “Fibroblasts Accumulate and Produce Collagen in Dogs Prone to Prostate Related Urinary Dysfunction”, Hannah Ruetten.
    37. 2019 November, Society for Basic Urologic Research (SBUR) Fall Symposium, New Orleans, LA, November 8, 2019. “Leadership in Benign Urology”, Dr. William Ricke.
    38. 2019 October, PCF Meeting, Carlsbad, CA, October 24, 2019. “Proximal Epithelia are Increased in Prostate Cancer, but are they Progenitors?”, Dr. Douglas Strand.
    39. 2019 October, University of Wisconsin Prostate Research Group Meeting, Madison, WI, October 4, 2019. “FGF5 Increases Androgen Receptor Expression and Signaling in Prostate Cancer”, Dalton McLean.
    40. 2019 October, University of Wisconsin Prostate Research Group Meeting, Madison, WI, October 4, 2019. “Under Pressure: Deciphering the Role of Prostate Smooth Muscle in Urinary Dysfunction”, Anne Turco.
    41. 2019 October, Columbia O’Brien Urology Center Symposium, New York, NY, October 2019. “University of Wisconsin George M. O’Brien Center (U54): Cellular and Molecular Mediators of Fibrosis in the Development of Lower Urinary Tract Dysfunction”, Dr. William Ricke
    42. 2019 September, University of Wisconsin Developmental Endocrinology Research Group, Madison, WI, September 2019. “Prostate Inflammation Increases Collagen and Voiding Dysfunction” (Seminar Presentation), Hannah Ruetten.
    43. 2019 July, National Veterinary Scholars Symposium, Worcester, MA, July 2019. “Impact of Sex, Androgens, and Prostate Size on C57BL6/J Urinary Physiology: Gross and Histologic Assessment” (Poster Presentation), Hannah Ruetten.
    44. 2019 June, STP 38th Annual Symposium, Raleigh, NC, June 2019. “Impact of Sex, Androgens, and Prostate Size on C57Bl6/J Mouse Urinary Physiology: Functional Assessment of a New Platform for Toxicological Testing” (Poster Presentation), Hannah Ruetten (Conference Travel Award Winner).
    45. 2019 June, STP 38th Annual Symposium, Raleigh, NC, June 2019. “Impact of Sex, Androgens, and Prostate Size on C57BL6/J Mouse Urinary Physiology: Gross and Histologic Assessment of a New Platform for Toxicological Testing”, Hannah Ruetten (Conference Travel Award Winner).
    46. 2019 June, STP 38th Annual Symposium, Raleigh, NC, June 2019. “Impact of Sex, Androgens, and Prostate Size on C57Bl6/J Mouse Urinary Physiology: Functional Assessment of a New Platform for Toxicological Testing” (Poster Presentation), Kyle Wegner (Conference Travel Award Winner).
    47. 2019 June, The Mayo Clinic of Rochester Nephrology Summer Undergraduate Research Program, Rochester, MN, June 2019. “Benign Prostate Disease: What It Is and Why You Should Care”, Dr. Chad Vezina.
    48. 2019 June, University of Pittsburgh O’Brien Benign Urology Center Symposium, Pittsburgh, PA, June 11, 2019. “To Protect and Serve: A New Paradigm for an Old Prostate Cell”, Dr. Chad Vezina
    49. 2019 May, American Urological Association and Society for Basic Urologic Research Basic Sciences Symposium: “Cell Types of Development, Homeostasis, and Disease in the Urogenital Tract”, Chicago, IL, May 2019. “Social (and Antisocial) Cell Signaling Networks in the Urinary Tract”, Dr. Chad Vezina.
    50. 2019 May, American Urological Association and Society for Basic Urologic Research Basic Sciences Symposium: “Cell Types of Development, Homeostasis, and Disease in the Urogenital Tract”, Chicago, IL, May 2019. “DDX3-Mediated Translational Regulation of Androgen Receptor in Prostate Cancer Progression”, Jordan Vellky.
    51. 2019 May, American Urological Association and Society for Basic Urologic Research Basic Sciences Symposium: “Cell Types of Development, Homeostasis, and Disease in the Urogenital Tract”, Chicago, IL, May 2019. “Establishing a Negative Feedback loop between FGF5 and AR in prostate cancer”, Dalton McLean and Katelin Cunningham.
    52. 2019 May, University of Wisconsin Prostate Research Group Meeting, Madison, WI, May 3, 2019. “Impact of Sex, Androgens, and Prostate Size on Mouse Urinary Function”, Hannah Ruetten.
    53. 2019 April, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Molecular and Cellular Mechanisms of Fibrosis”, Madison, WI, April 11-12, 2019. “Housekeeping Genes and Rigor & Reproducibility”, Jordan Vellky.
    54. 2019 April, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Molecular and Cellular Mechanisms of Fibrosis”, Madison, WI, April 11-12, 2019. “Ring Around the Urethra: Do SRD5A2+ Fibroblasts Cause LUTS?”, Dr. Douglas Strand.
    55. 2019 April, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Molecular and Cellular Mechanisms of Fibrosis”, Madison, WI, April 11-12, 2019. “To Be or Not to Be: How Does a Prostate Cell Decide to Cause Fibrosis?”, Dr. Chad Vezina.
    56. 2019 April, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Molecular and Cellular Mechanisms of Fibrosis”, Madison, WI, April 11-12, 2019. “The Big Squeeze: The Role of Prostate Smooth Muscle Contraction in Urinary Obstruction”, Anne Turco.
    57. 2019 April, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Molecular and Cellular Mechanisms of Fibrosis”, Madison, WI, April 11-12, 2019. “From Mice to Men: Activation of the CXCL12/CXCL4 Axis in Prostatic Fibrosis”, Dr. Jill Macoska.
    58. 2019 April, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Molecular and Cellular Mechanisms of Fibrosis”, Madison, WI, April 11-12, 2019. “Emerging MRI Techniques: New Tools for Research and the Clinic”, Dr. Diego Hernando.
    59. 2019 April, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Molecular and Cellular Mechanisms of Fibrosis”, Madison, WI, April 11-12, 2019. “Age-Related Changes in the Urinary System – MRI Assessment”, Dr. Alejandro Roldán-Alzate.
    60. 2019 April, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Molecular and Cellular Mechanisms of Fibrosis”, Madison, WI, April 11-12, 2019. “Estrogen Receptor Expression and Steroid Hormone Metabolism in Benign Prostatic Hyperlasia”, Dr. Teresa Liu.
    61. 2019 April, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Molecular and Cellular Mechanisms of Fibrosis”, Madison, WI, April 11-12, 2019. “Are All Men Destined to get BPH?”, Dr. William Ricke.
    62. 2019 April, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Molecular and Cellular Mechanisms of Fibrosis”, Madison, WI, April 11-12, 2019. “MRI-based Method for Analyzing Lower Urinary Tract Dysfunction in Adult Male Mice”, Dalton McLean.
    63. 2019 April, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Molecular and Cellular Mechanisms of Fibrosis”, Madison, WI, April 11-12, 2019. “Exploring Collagen Changes in C57BL/6J Mice with Bacterial-induced Prostate Inflammation”, Brett Mueller.
    64. 2019 April, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Molecular and Cellular Mechanisms of Fibrosis”, Madison, WI, April 11-12, 2019. “Osteopontin: A Key Link Between Inflammation and Prostatic Fibrosis”, Dr. Petra Popovics.
    65. 2019 April, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Molecular and Cellular Mechanisms of Fibrosis”, Madison, WI, April 11-12, 2019. “Developmental Exposure to Polychlorinated Biphenyls (PCBs) Induces Bladder Inflammation, Increased Nerve Density and Voiding Dysfunction in Young Adult Mice”, Dr. Kim Keil.
    66. 2019 April, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Molecular and Cellular Mechanisms of Fibrosis”, Madison, WI, April 11-12, 2019. “Translational Control in Steroid Hormone Signaling: Insights from Drosophilia”, Dr. Sarah Neuman.
    67. 2019 April, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Molecular and Cellular Mechanisms of Fibrosis”, Madison, WI, April 11-12, 2019. “Rodent Urodynamics: What’s the Point?”, Dr. Dale Bjorling.
    68. 2019 April, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Molecular and Cellular Mechanisms of Fibrosis”, Madison, WI, April 11-12, 2019. “Impact of Sex, Androgens, and Prostate Size on C57BL6/J Urinary Function” (Poster), Hannah Ruetten.
    69. 2019 April, 7th Annual University of Wisconsin SVM-Phi Zeta Research Day, Madison, WI, April 10, 2019. “Impact of Sex, Androgens, and Prostate Size on C57BL6/J Urinary Function” (Oral Presentation), Hannah Ruetten.
    70. 2019 April, University of Wisconsin Carbone Cancer Center Retreat, Madison, WI, April 4, 2019. “Impact of Sex, Androgens, and Prostate Size on C57BL6/J Urinary Function”, Hannah Ruetten.
    71. 2019 March, University of Wisconsin Developmental Endocrinology Research Group, Madison, WI, March 2019. “Impact of Sex, Androgens, and Prostate Size on C57BL6/J Mouse Urinary Function” (Seminar Presentation), Hannah Ruetten.
    72. 2019 January, University of Florida Department of Physiological Sciences, Gainsville, FL, January 2019. “The Mouse as a Preclinical Model for Urology: Mechanisms of Prostate and Lower Urinary Tract Symptoms (LUTS)”, Dr. Chad Vezina.
    73. 2018 December, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Conference, Ellicott City, Maryland, December 2018. “Exogenous Hormone Exposure: A Potential Platform for Testing Interventional Therapies for Lower Urinary Tract Dysfunction in Male Mice”, Chelsea A. O’Driscoll.
    74. 2018 December, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Conference, Ellicott City, Maryland, December 2018. “FGF5 Regulation of Androgen Receptor in Prostate Cells”, Dalton McLean.
    75. 2018 December, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Conference, Ellicott City, Maryland, December 2018. “Building a Comprehensive Cellular Anatomy of the Normal and Diseased Human Prostate”, Dr. Douglas Strand.
    76. 2018 December, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Conference, Ellicott City, Maryland, December 2018. “Impact of Age and Castration on Canine Prostate Collagen Organization”, Hannah Ruetten.
    77. 2018 December, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Conference, Ellicott City, Maryland, December 2018. “Does Size Matter? Reduced Prostate Size Alters Urinary Function in Male Mice”, Helen Zhang.
    78. 2018 December, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Conference, Ellicott City, Maryland, December 2018. “Isolating Prostate Stem-like Cells in a Progressive Cell Line Model”, Katelin Cunningham.
    79. 2018 December, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Conference, Ellicott City, Maryland, December 2018. “Developmental Exposure to Polychlorinated Biphenyls (PCBs) Induces Bladder Inflammation, Increased Nerve Density, and Voiding Dysfunction in Young Adult Mice.”, Dr. Kimberly Keil.
    80. 2018 December, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Conference, Ellicott City, Maryland, December 2018. “Characterization of Srd5a2creErt2 Expression in the Mouse Prostate: A Potential Source of Stromal Progenitors”, Kyle Wegner.
    81. 2018 December, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Conference, Ellicott City, Maryland, December 2018. “Connecting Development and Disease: Presenting A Potential Mouse Model for BPH”, Melissa Gamat.
    82. 2018 December, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Conference, Ellicott City, Maryland, December 2018. “New Techniques to Measure Coordinated Ca2+ Signals, Micromotions, and Transient Pressure Events in the Mouse Urinary Bladder”, Dr. Nathan Tykocki (University of Vermont).
    83. 2018 December, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Conference, Ellicott City, Maryland, December 2018. “The Urine Proteomics of Genetically-induced Lower Urinary Tract Dysfunction (LUTD) Mice”, Sam Thomas.
    84. 2018 December, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Conference, Ellicott City, Maryland, December 2018. “Monitoring Serum Steroids in a Hormone-Induced Model of Lower Urinary Tract Dysfunction”, Sam Thomas.
    85. 2018 December, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Conference, Ellicott City, Maryland, December 2018. “Using Mouse and Drosophila Models to Dissect the Role of DDX3-dependent Translational Control in BPH”, Dr. Sarah Neuman.
    86. 2018 December, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Conference, Ellicott City, Maryland, December 2018. “The Impact of Age on the Lower Urinary Tract of Mice”, Dr. Teresa Liu.
    87. 2018 December, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Conference, Ellicott City, Maryland, December 2018. “Mind Over Matter – Healthy Bowels, Healthy Bladder: A Randomized Controlled Trial”, Dr. Heidi Brown.
    88. 2018 December, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Conference, Ellicott City, Maryland, December 2018. “CXCL12 Mediates Increased Prostatic Fibrosis in Mice Fed a High Fat Diet”, Dr. Jill Macoska.
    89. 2018 December, Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Conference, Ellicott City, Maryland, December 2018. “MicroRNA-29a/b1 Inhibits Bladder Fibrosis and Supports Normal Bladder Function”, Dr. Dale Bjorling.
    90. 2018 November, Society for Basic Urologic Research (SBUR) Fall Symposium Trainee Workshop, Palm Springs, CA. “Formulating a career development plan to maximize training productivity”, Dr. Chad Vezina.
    91. 2018 November, Society for Basic Urologic Research (SBUR) Fall Symposium Trainee Workshop, Palm Springs, CA. “Role of O’Brien Centers in Benign Urology Research”, Dr. Will Ricke.
    92. 2018 August, Jackson Laboratories Workshop on Techniques in Modeling Human Cancer in Mice, Bar Harbor, ME. “Prostate Cancer: Clinical Problems, Research Resources and Opportunities”, Dr. Chad Vezina
    93. 2018 July, UMASS-Boston, “Connecting Cellular Behaviors to Prostatic Disease”, Dr. Chad Vezina.
    94. 2018 July, The Mayo Clinic of Rochester Nephrology Summer Undergraduate Research Program, Rochester, MN, “Benign Prostate Disease: What It Is and Why You Should Care”, Dr. Chad Vezina.
    95. 2018 June, External Expert Panel (EEP) Meeting, Bethesda, MD, “Progress and Future of the UW-Madison & UM-Boston O’Brien Center”, Dr. William Ricke.
    96. 2018 June, External Expert Panel (EEP) Retreat, Bethesda, MD, “Progress and Future of the UW-Madison & UM-Boston O’Brien Center”, Dr. William Ricke.
    97. 2018 June, Urology Research Day, University of Washington, Seattle, WA, June 16, 2018. “Defining Endpoints of Recovery of Urinary Health after Prostatectomy”, Dr. Tristan Nicholson.
    98. 2018 May, University of Wisconsin Undergraduate Research Symposium, Madison, WI. “Understanding the Role of Prostate Fibrosis in Mouse Models of Hormone-Induced Urinary Dysfunction”, Brett Mueller.
    99. 2018 April, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Cellular Functions in Urology”, Madison, WI, April 20-21, 2018. “Identification of Cell Types and Pathways in Normal and Diseased States”, Dr. William Ricke.
    100. 2018 April, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Cellular Functions in Urology”, Madison, WI, April 20-21, 2018. “Urinary Flow Dynamics in BPH – Effects of Bladder Neck Angle.”, Dr. Alejandro Roldán-Alzate.
    101. 2018 April, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Cellular Functions in Urology”, Madison, WI, April 20-21, 2018. “A Genetic Toolbox to Spy on Mouse Prostate Stromal Cells in Situ”, Dr. Chad Vezina.
    102. 2018 April, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Cellular Functions in Urology”, Madison, WI, April 20-21, 2018. “Modeling and Treating Fibrosis in the Urinary Tract”, Dr. Paul Marker.
    103. 2018 April, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Cellular Functions in Urology”, Madison, WI, April 20-21, 2018. “Altered Steroidogenesis on Estrogen Receptor Activation in Benign Prostatic Hyperplasia”, Dr. Teresa Liu.
    104. 2018 April, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Cellular Functions in Urology”, Madison, WI, April 20-21, 2018. “Impact of Age and Castration on Prostate Collagen Organization”, Hannah Ruetten.
    105. 2018 April, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Cellular Functions in Urology”, Madison, WI, April 20-21, 2018. “What can the UW-Madison/U.Mass-Boston O’Brien Center Do for You”, Dr. Dale Bjorling.
    106. 2018 March, Society of Toxicology National Meeting, San Antonio, TX, March 13, 2018. “Exposure to Bisphenols Causes Lower Urinary Tract Dysfunction in Male Mice through an ER Alpha-Dependent Mechanism”, Dr. Jalissa Wynder (Nguyen) & Dr. Clara Jeong.
    107. 2018 February, University of Puget Sound, Tacoma, WA, Chemistry, “Studying Cell Signaling in Complex Environments Using Open Microfluidics”, Dr. Ashleigh Theberge.
    108. 2018 January, University of Wisconsin Developmental Endocrinology Research Group, Madison, WI. “Novel Endpoints and Mouse Strains in Prostate Research”, Dr. Kyle Wegner.
    109. 2018 January, University of Wisconsin Molecular and Environmental Toxicology Center Seminar Series, Madison, WI. “Urinary Complications of Benign Prostatic Disease: Impact of Fetal and Neonatal Environment”, Dr. Kyle Wegner.
    110. 2017 November, Veterinary Histology, School of Veterinary Medicine, University of Wisconsin-Madison, Madison WI. “Prostate Histology Research Correlate”, Hannah Ruetten.
    111. 2017 November, Society of Toxicology Midwest Regional Chapter Annual Meeting, Chicago, IL. “Urinary Complications of Benign Prostatic Disease: Impact of Fetal and Neonatal Environment”, Dr. Kyle Wegner.
    112. 2017 November, University of Wisconsin-Madison Molecular and Environmental Toxicology Center, Madison, WI, November 2, 2017. “Investigating the Role of Environmental Estrogens in Lower Urinary Tract Dysfunction”, Dr. Jalissa Wynder (Nguyen).
    113. 2017 October, Southern University’s 6th Annual Clarke Symposium, Baton Rouge, LA, October 5, 2017. “My Journey Towards a Career in Toxicology”, Dr. Jalissa Wynder (Nguyen).
    114. 2017 October, University of Wisconsin Developmental Endocrinology Research Group, Madison, WI. “Collagen Architecture of the Prostate: Impact of Age and Androgen Status”, Hannah Ruetten.
    115. 2017 October, University of Wisconsin Developmental Endocrinology Research Group, Madison, WI. “A Nightmare in the Prostate”, Dr. Kyle Wegner.
    116. 2017 September, Santa Clara University, Santa Clara, CA, Chemistry, “Studying Cell Signaling in Complex Environments Using Open Microfluidics”, Dr. Ashleigh Theberge.
    117. 2017 August, O’Brien Center Retreat, Mount Morris, WI, August 2017. “Progress and Future of the UW-Madison & UM-Boston O’Brien Center”, Dr. William Ricke.
    118. 2017 July, University of Wisconsin & University of Massachusetts-Boston O’Brien Research Center Summer Program for Undergraduates in Urologic Research, Madison, WI. “Toxicology: Overview and Career Options/Imaging Demonstration”, Dr. Kyle Wegner.
    119. 2017 June, External Expert Panel (EEP) Meeting, Bethesda, MD, “Progress and Future of the UW-Madison & UM-Boston O’Brien Center”, Dr. William Ricke.
    120. 2017 June, External Expert Panel (EEP) Retreat, Bethesda, MD, “Progress and Future of the UW-Madison & UM-Boston O’Brien Center”, Dr. William Ricke.
    121. 2017 June, Northwest Regional Meeting – American Chemical SocietyBiochemistry Session, Corvallis, OR, “Microscale Culture Systems to Probe Small Molecule Signaling”, Dr. Ashleigh Theberge.
    122. 2017 June, Northwest Regional Meeting – American Chemical Society Analytical Chemistry Session, Corvallis, OR, “Open Microfluidics for Chemical Analysis of Organotypic Cell Cultures”, Dr. Ashleigh Theberge.
    123. 2017 May, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease”, Madison, WI, May 22-24, 2017. “Opportunities and Challenges for Modeling BPH and LUTS in Rodents”, Dr. Paul Marker.
    124. 2017 May, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease”, Madison, WI, May 22-24, 2017. “Linking Lower Urinary Tract Function and Structure”, Dr. Dale Bjorling.
    125. 2017 May, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease”, Madison, WI, May 22-24, 2017. “Mass Spectrometry-based Urinary Proteomics”, Sam Thomas.
    126. 2017 May, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease”, Madison, WI, May 22-24, 2017. “Urinary Flow Dynamics – An MR Based Computational Modeling Approach”, Dr. Alejandro Roldán-Alzate.
    127. 2017 May, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease”, Madison, WI, May 22-24, 2017. “Role of G-Protein Coupled Receptors in Lower Urinary Tract Fibrosis”, Dr. Jill Macoska.
    128. 2017 May, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease”, Madison, WI, May 22-24, 2017. “Identification of Estrogen Regulated Gene Networks in BPH”, Dr. Teresa Liu.
    129. 2017 May, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease”, Madison, WI, May 22-24, 2017. “What is BPH and What Roles Might Estrogen Be Playing?”, Dr. Will Ricke.
    130. 2017 May, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease”, Madison, WI, May 22-24, 2017. “Androgen Regulation of FGF5 and its Role in the Prostate”, Dalton McLean.
    131. 2017 May, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease”, Madison, WI, May 22-24, 2017. “Pinpointing Cellular Origins and Physiological Consequences of Prostate Fibrosis”, Dr. Chad Vezina.
    132. 2017 May, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease”, Madison, WI, May 22-24, 2017. “Harnessing Lineage Tracing to Study Hormonal Responses in the Prostate”, Diya Binoy Joseph.
    133. 2017 May, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease”, Madison, WI, May 22-24, 2017. “Measurement of Multi-steroid Hormones in Mouse Serum using LC-MS/MS”, Clara Jeong.
    134. 2017 May, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease”, Madison, WI, May 22-24, 2017. “Quantitative MRI Techniques for the Assessment of BPH: Background and Proposed Research”, Dr. Diego Hernando.
    135. 2017 May, UW-Madison/U.Mass-Boston O’Brien Center Spring Symposium: “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease”, Madison, WI, May 22-24, 2017. “Deciphering the Influence of Diabesity and Intermittent Hypoxia on the Male Environment in Urinary Tract Dysfunction”, Dr. Lisa Abler.
    136. 2017 May, University of Wisconsin Developmental Endocrinology Research Group, Madison, WI. “One Health Approach to Studying Benign Prostatic Hyperplasia”, Hannah Ruetten.
    137. 2017 May, University of Wisconsin-Madison Summer Program for Undergraduate Urology Research (SPUUR), Madison, WI, May 25, 2017. “How to Get the Most Out of a Summer Internship”, Dr. Jalissa Wynder (Nguyen).
    138. 2017 May, University of Wisconsin Molecular and Environmental Toxicology Center Seminar Series, Madison, WI. “Unraveling the Prostate Collagen Network”, Dr. Kyle Wegner.
    139. 2017 May, University of Washington, Bioengineering, Seattle, WA. “Studying Cell Signaling in Complex Environments Using Open Microfluidics”, Dr. Ashleigh Theberge.
    140. 2017 May, Children’s Hospital, Harvard University, Boston, MA. “Fibrosis as a Mediator of Lower Urinary Tract Dysfunction”, Dr. William Ricke.
    141. 2017 April, University of Wisconsin Developmental Endocrinology Research Group, Madison, WI. “Objective Collagen Detection in Thin Sections”, Dr. Kyle Wegner.
    142. 2017 March, University of Wisconsin Laboratory for Optical and Computational Instrumentation Seminar Series, Madison, WI. “Mesoscale Imaging of Stromal Elements and Interactions in Histologic Preparations”, Dr. Kyle Wegner.
    143. 2017 March, University of California, Berkeley, Bioengineering, Berkeley, CA, “Studying Cell Signaling in Complex Environments Using Open Microfluidics”, Dr. Ashleigh Theberge.
    144. 2017 March, University of Massachusetts-Boston, Boston, MA. “Understanding the Molecular Mechanism of Estrogens in Pathogenesis”, Dr. William Ricke.
    145. 2017 February, University of Wisconsin Developmental Endocrinology Research Group, Madison, WI. “Prostatic Collagen Architecture in Neutered and Intact Canines”, Hannah Ruetten.
    146. 2017 January, Resident Seminar, Department of Urology, University of Washington, Seattle, WA, January 25, 2017. “Estrogen Receptor-alpha is a Key Mediator and Therapeutic Target in Benign Prostatic Hyperplasia”, Dr. Tristan Nicholson.
    147. 2017 January, University of Toronto, Mechanical and Industrial Engineering, Toronto, Canada, “Studying Cell Signaling in Complex Environments Using Open Microfluidics”, Dr. Ashleigh Theberge.
    148. 2016 December, EMBS Micro and Nanotechnology in Medicine (IEEE Conference), Waikoloa, HI, “Examining Cellular Signaling in Complex Environments with Microscale Systems”, Dr. Ashleigh Theberge.
    149. 2016 December, Urology Program Directors’ Meeting, NIDDK, Pacific Grove, CA. “Estrogen Action in the Development of Fibrosis”, Dr. William Ricke.
    150. 2016 November, Society for Basic Urologic Research Annual Meeting, Scottsdale, AR, “Examining Cell Signaling in Complex Environments with Microscale Systems”, Dr. Ashleigh Theberge.
    151. 2016 October, University of Wisconsin Carbone Cancer Center Translational Imaging Group, Madison, WI. “Mesoscale Imaging of Stromal Elements and Interactions in Histologic Preparations”, Dr. Kyle Wegner.
    152. 2016 September, University of Wisconsin Developmental Endocrinology Research Group, Madison, WI. “Genetic Background Influences Susceptibility of Male Mice to Hormone-Induced Urinary Dysfunction”, Dr. Kyle Wegner.
    153. 2016 September, University of Wisconsin-Department of Urology Grand Rounds, Madison, WI, September 2016. “Modeling Prostate Disease in Mice and Cell Culture”, Dr. William Ricke.
    154. 2016 August, O’Brien Center Retreat, Mount Morris, WI, August 2016. “Progress and Future of the UW-Madison & UM-Boston O’Brien Center”, Dr. William Ricke.
    155. 2016 August, University of Wisconsin Comparative Biomedical Sciences Departmental Meeting, Minoqua, WI. “The Role of Prostate Fibrosis in Male Urinary Dysfunction”, Dr. Kyle Wegner.
    156. 2016 July, University of Wisconsin Developmental Endocrinology Research Group, Madison, WI. “New Findings in Prostate Fibrosis”, Dr. Kyle Wegner.
    157. 2016 July, Pacific Northwest National Laboratory, Richland, WA, “Studying Cell Signaling in Complex Environments Using Open Microfluidics”, Dr. Ashleigh Theberge.
    158. 2016 June, University of Wisconsin-Madison Endocrinology and Reproductive Physiology Annual Symposium, Madison, WI. “Unraveling the Connection Between Prostate and Urinary Dysfunction”, Dr. Chad Vezina.
    159. 2016 June, External Expert Panel (EEP) Meeting, Bethesda, MD, “Progress and Future of the UW-Madison & UM-Boston O’Brien Center”, Dr. William Ricke.
    160. 2016 June, External Expert Panel (EEP) Retreat, Bethesda, MD, “Progress and Future of the UW-Madison & UM-Boston O’Brien Center”, Dr. William Ricke.
    161. 2016 May, American Urologic Association, Plenary Session, San Diego, CA, May 8, 2016. “Patient Stratification in the Treatment of BPH”, Dr. William Ricke.
    162. 2016 April, Duke University, Multidisciplinary Benign Urology Research Day, KURe and PMRC, Durham, NC, April 29, 2016. “Hormonal Regulation and Fibrosis in the Lower Urinary Tract”, Dr. William Ricke.
    163. 2016 April, University of Wisconsin/UMASS Boston George M. O’Brien Center Symposium on Environmental Impact on Urologic Health and Disease, Madison, WI. April 4-5, 2016. “Estrogen Induction of LUTD in Mice”, Dr. William Ricke.\
    164. 2016 April, University of Wisconsin/UMASS Boston George M. O’Brien Center Symposium on Environmental Impact on Urologic Health and Disease,Madison, WI. “Impact of AHR Signaling on Benign Urinary Function”, Dr. Chad Vezina.
    165. 2016 April, University of Wisconsin/UMASS Boston George M. O’Brien Center Symposium on Environmental Impact on Urologic Health and Disease, Madison, WI. April 4-5, 2016. “IUL TCDD Exacerbates LUTD in Mice”, Dr. Chad Vezina.
    166. 2016 April, University of Wisconsin/UMASS Boston George M. O’Brien Center Symposium on Environmental Impact on Urologic Health and Disease, Madison, WI. “Picrosirius Red: A Versatile Tool for Analyzing Collagen in the Lower Urinary Tract”, Dr. Kyle Wegner.
    167. 2016 April, University of Wisconsin/UMASS Boston George M. O’Brien Center Symposium on Environmental Impact on Urologic Health and Disease, Madison, WI. April 4-5, 2016. “The Role of Bisphenol A in LUTD”, Jalissa Wynder.
    168. 2016 April, University of Wisconsin/UMASS Boston George M. O’Brien Center Symposium on Environmental Impact on Urologic Health and Disease, Madison, WI. April 4-5, 2016. “BPA Exposure and Associated Gene Expression Changes in Prostate Cancer”, Jordan Vellky.
    169. 2016 April, University of Wisconsin/UMASS Boston George M. O’Brien Center Symposium on Environmental Impact on Urologic Health and Disease, Madison, WI. April 4-5, 2016. “Background and Collaborations”, Dr. Dale Bjorling.
    170. 2016 April, University of Wisconsin/UMASS Boston George M. O’Brien Center Symposium on Environmental Impact on Urologic Health and Disease, Madison, WI. April 4-5, 2016. “Investigating the Role of DNA Methylation in Prostate Development and Disease”, Diya Binoy Joseph.
    171. 2016 April, University of Wisconsin/UMASS Boston George M. O’Brien Center Symposium on Environmental Impact on Urologic Health and Disease, Madison, WI. April 4-5, 2016. “SERMs and BPH”, Dr. Teresa Liu.
    172. 2016 March (Stephen ‘Royal’ Oakes), University of Wisconsin & University of Massachusetts-Boston O’Brien Research Center Seminar Series, Madison WI. “Computer-Based High-Throughput Urinary Function Analysis”, Stephen ‘Royal’ Oakes.
    173. 2016 March, University of Wisconsin & University of Massachusetts-Boston O’Brien Research Center Seminar Series, Madison WI. “Large Sample Tissu eArrays and Picrosirius Red: Useful Tools for Prostate Histological Analysis”, Dr. Kyle Wegner.
    174. 2016 March, Pittcon, Symposium: Quantifying the Tumor Microenvironment, Atlanta, GA, “Examining Cellular Signaling in Complex Environments with Microscale Systems”, Dr. Ashleigh Theberge.
    175. 2016 February, The Society for Urodynamics and Female Urology (SUFU) Annual Meeting, New Orleans, LA, February 23-27, 2016. “Urinary Obstruction and Fibrosis”, Dr. Jill Macoska.
    176. 2016 February, University of Wisconsin Molecular and Environmental Toxicology Center Seminar Series, Madison, WI. “Developmental Origins of Adult Disease: Effects of Fetal Dioxin Exposure on Adult Prostate Disease Progression”, Dr. Kyle Wegner.
    177. 2016 January, Fred Hutchinson Cancer Research Center, Program in Prostate Cancer Research (PPCR), Seattle, WA, “Studying Cell Signaling in Complex Environments Using Open Microfluidics”, Dr. Ashleigh Theberge.
    178. 2015 December, University of Massachusetts Boston, Boston, MA, December 7, 2015. “Identifying Molecular Mechanisms of Prostate Cancer Using Transposon-Mediated Mutagenesis and Mouse Models”, Dr. Paul Marker.
    179. 2015 December, University of Wisconsin Developmental Endocrinology Research Group, Madison, WI. “The Role of Beta Catenin in Benign Prostatic Disease”, Dr. Kyle Wegner.
    180. 2015 December, University of Wisconsin Prostate Researchers Group, Madison, WI. “The Role of Beta Catenin in Benign Prostatic Disease”, Dr. Kyle Wegner.
    181. 2015 November, National Institute of Environmental Health Sciences, Consortium Linking Academic and Regulatory Insights on BPA Toxicity (CLARITY-BPA), Durham, NC, November 2015. “Estrogenic Effects of BPA on the Lower Urinary Tract of Postnatal Day 1 Rats”, Dr. William Ricke.
    182. 2015 November, Society for Basic Urologic Research (SBUR) Fall Symposium, Ft. Lauderdale, FL. “Inflammation of the Lower Urinary Tract”, Dr. Dale Bjorling.
    183. 2015 November, Society for Basic Urologic Research (SBUR) Fall Symposium, Ft. Lauderdale, FL. “The Influence of Intermittent Hypoxia and Diabetes on Lower Urinary Tract Function”, Dr. Chad Vezina.
    184. 2015 November, Columbia University: Symposium on The Genetic Origins and Complications of Urinary Tract Abnormalities, New York, NY. “A Role for DNA Methylation in Prostate Development and Urinary Function”, Dr. Chad Vezina.
    185. 2015 October, University of Illinois Chicago Medical School (Rockford satellite), Rockford, IL, October 7, 2015. “Identifying molecular mechanisms of prostate cancer and BPH using mouse models”, Dr. Paul Marker.
    186. 2015 September, Urology Program Directors Meeting, Wisconsin K12cure Program, Madison, WI, September 2015. “University of Wisconsin K12cure Training Program”, Dr. Dale Bjorling.
    187. 2015 September, NIH/NIDDK Urology Developmental Centers Meeting, Madison, WI. “Estrogen Action in Urinary Dysfunction”, Dr. William Ricke.
    188. 2015 September, NIH/NIDDK Urology Developmental Centers Meeting, Madison, WI. “Roles of Beta-Catenin in Urinary Dysfunction”, Dr. Chad Vezina.
    189. 2015 September, NIDDK Urology Developmental Centers Meeting, Madison, WI, “Probing Paracrine Signaling in Benign Prostatic Hyperplasia with New Microfluidic Methods”, Dr. Ashleigh Theberge.
    190. 2015 August, O’Brien Center Retreat, Mount Morris, WI, August 2015. “Progress and Future of the UW-Madison & UM-Boston O’Brien Center”, Dr. William Ricke.
    191. 2015 June, NIH/NIDDK Urology Centers Steering Committee Meeting, Bethesda, MD, June 2015. “Overview of O’Brien Center”, Dr. William Ricke.
    192. 2015 June, External Expert Panel (EEP) Meeting, Bethesda, MD, “Progress and Future of the UW-Madison & UM-Boston O’Brien Center”, Dr. William Ricke.
    193. 2015 June, External Expert Panel (EEP) Retreat, Bethesda, MD, “Progress and Future of the UW-Madison & UM-Boston O’Brien Center”, Dr. William Ricke
    194. 2015 June, Gordon Research Conference on the Physics and Chemistry of Microfluidics, West Dover, VT, “Metabolomics at the Microscale”, Dr. Ashleigh Theberge.
    195. 2015 May, American Urological Association Basic Science Symposium, New Orleans, LA, May 15 2015. “Estrogen Regulation in the Prostate”, Dr. William Ricke.
    196. 2015 May, American Urological Association, New Orleans, LA, May 15 2015. “Estrogen Regulation in BPH and the Lower Urinary Tract”, Dr. William Ricke.
    197. 2015 May, University of Wisconsin Developmental Endocrinology Research Group, Madison, WI. “The Role of Prostate Fibrosis in Lower Urinary Dysfunction”, Dr. Kyle Wegner.
    198. 2015 April, University of Wisconsin/UMASS Boston George M. O’Brien Urology Research Symposium, Madison,WI, April 8-9, 2015. “Fibrosis of the Lower Urinary Tract: An Alternative to Prostate Hyperplasia in LUTD”, Dr. William Ricke.
    199. 2015 April, University of Wisconsin/UMASS Boston George M. O’Brien Urology Research Symposium, Madison,WI, April 8-9, 2015. “CXCL12-Mediated Non-canonical Signaling Promotes Myofibroblast Phenoconversion in the Prostate”, Dr. Jill Macoska.
    200. 2015 February, Clark-Atlanta University, Atlanta, GA, February 6, 2015. “Hormone Action and Paracrine Interactions in Prostate Carcinogenesis”, Dr. William Ricke.
    201. 2015 February, University of Wisconsin Developmental Endocrinology Research Group, Madison, WI. “A New Direction: Prostate Fibrosis”, Dr. Kyle Wegner.
    202. 2015 February, University of Chicago, Chicago IL. “Mapping the Developing Mouse Prostate to Reveal New Ductal Growth Mechanisms: A Focus on DNA Methylation”, Dr. Chad Vezina.
    203. 2015 February, Pathology Student Seminar, University of Rochester, Rochestern, NY, February 3, 2015. “Estrogen Receptor-alpha is a Key Mediator and Therapeutic Target in Benign Prostatic Hyperplasia”, Dr. Tristan Nicholson.
    204. 2015 February, University of North Carolina, Chapel Hill, Department of Biomedical Engineering, Chapel Hill, NC, “Studying Cell Signaling in Complex Environments Using Open Microfluidics”, Dr. Ashleigh Theberge.
    205. 2015 February, University of California, Davis, Department of Chemistry, Davis, CA, “Studying Cell Signaling in Complex Environments Using Open Microfluidics”, Dr. Ashleigh Theberge.
    206. 2015 January, University of Wisconsin-Madison Prostate Cancer Research Group Meeting, Madison, WI, January 9, 2015. “Estrogen Receptors in Benign Prostatic Hyperplasia”, Dr. Tristan Nicholson.
    207. 2015 January, University of Utah, Department of Biochemistry, Salt Lake City, UT, “Studying Cell Signaling in Complex Environments Using Open Microfluidics”, Dr. Ashleigh Theberge.
    208. 2015 January, Indiana University, Department of Chemistry, Bloomington, IN, “Studying Cell Signaling in Complex Environments Using Open Microfluidics”, Dr. Ashleigh Theberge.
    209. 2015 January, University of Washington, Department of Chemistry, Seattle, WA, “Studying Cell Signaling in Complex Environments Using Open Microfluidics”, Dr. Ashleigh Theberge.
    210. 2014 December, University of Wisconsin-Madison Vertebrate Development Biology Group Presentation, Madison, WI, December 16, 2014. “Environmental Estrogens and BPH”, Dr. Jalissa Wynder (Nguyen).
    211. 2014 December, NIH/NIDDK Urology Developmental Centers Meeting, Pacific Grove, CA. “Urinary Biomarkers of Lower Urinary Tract Symptoms (LUTS) in Men”, Dr. Paul Marker.
    212. 2014 December, NIDDK Urology Developmental Centers Meeting, Asilomar, CA, “Examining Microenvironmental Regulation of Angiogenesis in Benign Prostatic Hyperplasia with Microscale Culture”, Dr. Ashleigh Theberge
    213. 2014 December, NIH/NIDDK Urology Developmental Centers Meeting, Pacific Grove, CA. “Developmental Mapping of the Prostate”, Dr. Chad Vezina.
    214. 2014 December, University of Wisconsin-Madison, Department of Biomedical Engineering, Madison, WI, “Studying Cell Signaling in Complex Environments Using Open Microfluidics”, Dr. Ashleigh Theberge.
    215. 2014 November, Society for Basic Urologic Research (SBUR) Fall Meeting, Dallas, TX, November 13-16, 2014. “Estrogen Regulation of Fibrosis in Lower Urinary Tract Dysfunction”, Dr. William Ricke.
    216. 2014 November, School of Veterinary Medicine, University of Wisconsin-Madison, WI, “Prostate Research in the Vezina Lab: Past, Present, and Future”, Dr. Chad Vezina.
    217. 2014 November, Society for Basic Urologic Research Fall Symposium, Dallas, TX, “Microscale Metabolomics Platform for Studying Cell Signaling in Benign Prostatic Hyperplasia”, Dr. Ashleigh Theberge.
    218. 2014 October, University of Wisconsin Department of Urology Uehling Lectures, Madison, WI, October 24, 2014. “Hormones and BPH: Glandular Growth and/or Fibrosis”, Dr. William Ricke.
    219. 2014 October, Association of Underrepresented Minority Fellows Symposium (AUMF), Cleveland, OH, October 18, 2014. “Testosterone and Bisphenol A Exposure Induces Increased Prostate Mass of Male Mice”, Dr. Jalissa Wynder (Nguyen).
    220. 2014 October, University of Wisconsin-Madison Molecular and Environmental Toxicology Center Annual Retreat, Madison, WI, October 16, 2014. “Bisphenol A Exposure and Prostate Disease”, Dr. William Ricke, Dr. Tristan Nicholson, & Dr. Jalissa Wynder (Nguyen).
    221. 2014 May, Vanderbilt Center for Benign Urologic Diseases, Nashville, TN. May 2014. “Emerging Players in Urinary Dysfunction: Epigenetics and Sleep Apnea”, Dr. Chad Vezina.
  • HOSTED SYMPOSIA & SEMINARS
    1. November 11, 2020, Teresa Liu, PhD (K01 Scholar, UW-Madison Department of Urology), UW O’Brien Center Innovative Idea Incubator (I3) Seminar (virtual) – “Age and BPH: What is Aging?”
    2. October 29, 2020, Dale Bjorling, DVM (UW-Madison, School of Veterinary Medicine), UW-Madison/UTSW/U.Mass-Boston Fall Symposium “Lower Urinary Tract Function Testing in Mice” (virtual) – “Uroflowmetry”
    3. October 29, 2020, William Ricke, PhD (UW-Madison, Department of Urology), UW-Madison/UTSW/U.Mass-Boston Fall Symposium “Lower Urinary Tract Function Testing in Mice” (virtual) – “Q&A”
    4. October 29, 2020, Warren Hill, PhD (Harvard University), UW-Madison/UTSW/U.Mass-Boston Fall Symposium “Lower Urinary Tract Function Testing in Mice” (virtual) – “Void Spot Assay”
    5. October 29, 2020, Chad Vezina, PhD (UW-Madison, Department of Comparative Biosciences), UW-Madison/UTSW/U.Mass-Boston Fall Symposium “Lower Urinary Tract Function Testing in Mice” (virtual) – “Q&A”
    6. October 29, 2020, Kim Keil Steitz, PhD (UW-Madison, School of Veterinary Medicine), UW-Madison/UTSW/U.Mass-Boston Fall Symposium “Lower Urinary Tract Function Testing in Mice” (virtual) – “Q&A”
    7. October 29, 2020, Matt Fraser, PhD (Duke University), UW-Madison/UTSW/U.Mass-Boston Fall Symposium “Lower Urinary Tract Function Testing in Mice” (virtual) – “Cystometry”
    8. October 29, 2020, Maryrose Sullivan, PhD (Harvard University), UW-Madison/UTSW/U.Mass-Boston Fall Symposium “Lower Urinary Tract Function Testing in Mice” (virtual) – “Q&A”
    9. October 29, 2020, Mike Ruggieri, SR (Temple University), UW-Madison/UTSW/U.Mass-Boston Fall Symposium “Lower Urinary Tract Function Testing in Mice” (virtual) – “In Vitro Testing”
    10. October 29, 2020, Rosalyn Adam, PhD (Harvard University), UW-Madison/UTSW/U.Mass-Boston Fall Symposium “Lower Urinary Tract Function Testing in Mice” (virtual) – “Q&A”
    11. CROSS–DISCIPLINE INTERACTION: October 14, 2020, LaTasha Crawford, VMD, PhD, DACVP (UW-Madison, School of Veterinary Medicine), UW O’Brien Center Innovative Idea Incubator (I3) Seminar (virtual)
    12. CROSS–DISCIPLINE INTERACTION: September 9, 2020, Alejandro Roldán-Alzate, PhD (UW-Madison, Departments of Mechanical Engineering and Radiology), UW O’Brien Center Innovative Idea Incubator (I3) Seminar (virtual)
    13. May 12, 2020, Matthew Grimes, MD (UW-Madison, Department of Urology), UW O’Brien Center Innovative Idea Incubator (I3) Seminar (virtual)
    14. CROSS–DISCIPLINE INTERACTION: April 21, 2020, Paul Marker, PhD & Chris Unterberger (UW-Madison, School of Pharmacy), UW O’Brien Center Innovative Idea Incubator (I3) Seminar (virtual)
    15. March 24, 2020, Dan Gralnek, MD & Chris Manakas, MD (UW-Madison, Department of Urology), UW O’Brien Center Innovative Idea Incubator (I3) Seminar (virtual)
    16. CROSS–DISCIPLINE INTERACTION: February 18, 2020, Zunyi Wang, PhD (UW-Madison, School of Veterinary Medicine), UW O’Brien Center Innovative Idea Incubator (I3) Seminar -“Collagen Synthesis by Urothelial Cells”
    17. CROSS–DISCIPLINE INTERACTION: January 14, 2019, Hannah Ruetten (UW-Madison, Department of Pathobiological Sciences) & Christian Ortiz-Hernandez (UW-Madison, Department of Urology), UW O’Brien Center Innovative Idea Incubator (I3) Seminar
    18. CROSS–DISCIPLINE INTERACTION: December 17, 2019, Kimberly Keil Stietz, PhD (UW-Madison, School of Veterinary Medicine), UW O’Brien Center Innovative Idea Incubator (I3) Seminar
    19. CROSS–DISCIPLINE INTERACTION: November 19, 2019, William Ricke, PhD (UW-Madison, Department of Urology) & Diego Hernando, PhD (UW-Madison, Department of Radiology and Medical Physics), UW O’Brien Center Innovative Idea Incubator (I3) Seminar
    20. November 13, 2019, Nathan Tykocki, PhD (Michigan State University), UW O’Brien Center Invited Speaker Seminar – “When Spice Isn’t Nice: TRPV1 Channels in Bladder Physiology and Dysfunction”
    21. November 1, 2019, Magdalena Grabowska, PhD (Case Western Reserve University), UW-Madison Prostate Research Group (PRG) Meeting – “Elucidating NFIB Contributions to Prostatic Diseases”
    22. October 15, 2019, Douglas Strand, PhD (UT-Southwestern), UW O’Brien Center Innovative Idea Incubator (I3) Seminar
    23. October 9, 2019, Lori Birder, PhD (University of Pittsburgh School of Medicine), UW O’Brien Center Invited Speaker Seminar – “Aging Associated Changes in Oxidative Stress and Metabolic Processes in the Bladder Wall”
    24. September 17, 2019, William Ricke, PhD (UW-Madison, Department of Urology) & Chad Vezina, PhD (UW-Madison, Department of Comparative Biosciences), UW O’Brien Center Innovative Idea Incubator (I3) Seminar
    25. June 26, 2019, Michael Freeman, PhD (Cedars-Sinai Medical Center), UW O’Brien Center Invited Speaker Seminar – “Androgen Receptor-Indifferent Prostate Cancer”
    26. May 22, 2019, Aria Olumi, MD (Beth Israel Deaconess Medical Center and Harvard Medical School), UW O’Brien Center Invited Speaker Seminar – “Epigenetic Changes in 5-Alpha Reductase 2 – Opportunities for Personalized Care for Management of Prostatic Disease”
    27. CROSS-DISCIPLINE INTERACTION: May 15, 2019, Kristen Malecki, PhD, MPH(UW-Madison, Population Health Sciences), UW O’Brien Center Internal Speaker Seminar – “Translating Research for Human Health and the Environment – An Epidemiologist’s Perspective”
    28. May 1, 2019, Adam Klausner, MD (Virginia Commonwealth University), UW O’Brien Center Invited Speaker Seminar – “Urodynamics 2.0 – Novel Technologies for the Evaluation of Voiding Dysfunction”
    29. CROSS-DISCIPLINE INTERACTION: April 17, 2019, Melissa Skala, PhD (UW-Madison, Biomolecular Engineering), UW O’Brien Center Internal Speaker Seminar – “Metabolic Imaging of Cellular Heterogeneity in Cancer”
    30. CROSS–DISCIPLINE INTERACTION: April 12, 2019, Matt Conklin, PhD (UW-Madison, Department of Cell and Regenerative Biology), UW/UMB O’Brien Center Spring Symposium “Molecular and Cellular Mechanisms of Fibrosis” – “Methods for Decoding the Collagen ECM in Prostate Cancer and BPH: Out of Many Fibers, A Biomarker?”
    31. April 12, 2019, Petra Popovics, PhD (Case Western Reserve University), UW/UMB O’Brien Center Spring Symposium “Molecular and Cellular Mechanisms of Fibrosis” – “Osteopontin: A Key Link Between Inflammation and Prostatic Fibrosis”
    32. INTERACTION WITH COLUMBIA O’BRIEN CENTER: April 12, 2019, Nicholas Steers, PhD (Columbia University), UW/UMB O’Brien Center Spring Symposium “Molecular and Cellular Mechanisms of Fibrosis” – “Elucidating the Origin and Function of Bladder Resident Macrophages”
    33. INTERACTION WITH GRADUATE TRAINEE: April 12, 2019, Jordan Vellky (PhD Candidate, UW-Madison Cancer Biology Program), UW/UMB O’Brien Center Spring Symposium “Molecular and Cellular Mechanisms of Fibrosis” – “Housekeeping Genes and Rigor & Reproducibility”
    34. April 12, 2019, Scott Gabrielsen, MD (Baylor College of Medicine), UW/UMB O’Brien Center Spring Symposium “Molecular and Cellular Mechanisms of Fibrosis” – “Finding the Needle in the Haystack: Harnessing Big Data to Identify Novel Causes of Male Infertility”
    35. April 12, 2019, Kim Keil, PhD (UW-Madison, School of Veterinary Medicine, Department of Surgical Sciences), UW/UMB O’Brien Center Spring Symposium “Molecular and Cellular Mechanisms of Fibrosis” – “Developmental Exposure to Polychlorinated Biphenyls (PCBs) Induces Bladder Inflammation, Increased Nerve Density and Voiding Dysfunction in Young Adult Mice”
    36. April 12, 2019, Adriane Sinclair, PhD (UCSF), UW/UMB O’Brien Center Spring Symposium “Molecular and Cellular Mechanisms of Fibrosis” – “Hypospadias in Humans and Mice”
    37. CROSS–DISCIPLINE INTERACTION: April 12, 2019, Sarah Neuman, PhD (UW-Madison, School of Pharmacy), UW/UMB O’Brien Center Spring Symposium “Molecular and Cellular Mechanisms of Fibrosis” – “Translational Control in Steroid Hormone Signaling: Insights from Drosophilia”
    38. April 12, 2019, Dale Bjorling, DVM (UW-Madison, School of Veterinary Medicine), UW/UMB O’Brien Center Spring Symposium “Molecular and Cellular Mechanisms of Fibrosis” – “Rodent Urodynamics: What’s the Point?”
    39. CROSS NIH INSTITUTE INTERACTION: April 11, 2019, Kristina Penniston, PhD(NIH/NIDDK), UW/UMB O’Brien Center Spring Symposium “Molecular and Cellular Mechanisms of Fibrosis” – “Synergistic Interdisciplinary Research Interactions in Benign Urology: How Can We Be More Like Bacteria?”
    40. April 11, 2019, Douglas Strand, PhD (UT-Southwestern), UW/UMB O’Brien Center Spring Symposium “Molecular and Cellular Mechanisms of Fibrosis” – “Ring Around the Urethra: Do SRD5A2+ Fibroblasts Cause LUTS?”
    41. April 11, 2019, Chad Vezina, PhD (UW-Madison, Department of Comparative Biosciences), UW/UMB O’Brien Center Spring Symposium “Molecular and Cellular Mechanisms of Fibrosis” – “To Be or Not to Be: How Does a Prostate Cell Decide to Cause Fibrosis?”
    42. INTERACTION WITH GRADUATE TRAINEE: April 11, 2019, Anne Turco (PhD Candidate, UW-Madison METC Program), UW/UMB O’Brien Center Spring Symposium “Molecular and Cellular Mechanisms of Fibrosis” – ”The Big Squeeze: The Role of Prostate Smooth Muscle Contraction in Urinary Obstruction”
    43. April 11, 2019, Jill Macoska, PhD (University of Massachusetts-Boston), UW/UMB O’Brien Center Spring Symposium “Molecular and Cellular Mechanisms of Fibrosis” – “From Mice to Men: Activation of the CSCL12/CXCL4 Axis in Prostatic Fibrosis”
    44. INTERACTION WITH U.PITTSBURGH O’BRIEN CENTER: April 11, 2019, Pradeep Tyagi, PhD (University of Pittsburgh), UW/UMB O’Brien Center Spring Symposium “Molecular and Cellular Mechanisms of Fibrosis” – “Insights from the Link Between Adipokine Levels in Urine and the Obesity of BPH Patients”
    45. April 11, 2019, Scott Bauer, MD (UCSF), UW/UMB O’Brien Center Spring Symposium “Molecular and Cellular Mechanisms of Fibrosis” – “Using Large Observational Studies to Study Mechanisms of BPH/LUTS”
    46. April 11, 2019, Balakrishna Lokeshwar, PhD (Augusta University), UW/UMB O’Brien Center Spring Symposium “Molecular and Cellular Mechanisms of Fibrosis” – “The Interleukin-8 Axis in the Development of BPH”
    47. CROSS-DISCIPLINE INTERACTION: April 11, 2019, Diego Hernando, PhD (UW-Madison, Department of Radiology and Medical Physics), UW/UMB O’Brien Center Spring Symposium “Molecular and Cellular Mechanisms of Fibrosis” – “Emerging MRI Techniques: New Tools for Research and the Clinic”
    48. INTERACTION WITH UW-MADISON K12: April 11, 2019, Teresa Liu, PhD (K12 Scholar, UW-Madison), UW/UMB O’Brien Center Spring Symposium “Molecular and Cellular Mechanisms of Fibrosis” – “Estrogen Receptor Expression and Steroid Hormone Metabolism in Benign Prostatic Hyperplasia”
    49. April 11, 2019, Will Ricke, PhD (UW-Madison, Department of Urology), UW/UMB O’Brien Center Spring Symposium “Molecular and Cellular Mechanisms of Fibrosis” – “Are All Men Destined to Get BPH?”
    50. INTERACTION WITH GRADUATE TRAINEE: April 11, 2019, Dalton McLean(PhD Candidate, UW-Madison Cancer Biology Program), UW/UMB O’Brien Center Spring Symposium “Molecular and Cellular Mechanisms of Fibrosis” – “MRI-Based Method for Analyzing Lower Urinary Tract Dysfunction in Adult Male Mice”
    51. INTERACTION WITH TRAINEE: April 11, 2019, Brett Mueller (UW-Madison), UW/UMB O’Brien Center Spring Symposium “Molecular and Cellular Mechanisms of Fibrosis” – “Exploring Collagen Changes in C57BL/6J Mice with Bacterial-induced Prostate Inflammation”
    52. April 11, 2019, Jeremy Duffield, MD, PhD, FRCP (Vertex Pharmaceuticals), UW/UMB O’Brien Center Spring Symposium “Molecular and Cellular Mechanisms of Fibrosis” – “Cellular and Molecular Mechanisms Underlying Solid Organ Fibrosis: What to Target and Why?”
    53. April 1, 2019, Aaron Mickle, PhD (Washington University School of Medicine), UW O’Brien Center Invited Speaker Seminar – “Optogenetic Neuromodulation of Bladder Pain and Function”
    54. March 28, 2019, Beatrice Knudsen, MD, PhD (Cedars-Sinai Medical Center), UW O’Brien Center Invited Speaker Seminar – “Computational Pathology and the Tumor Microenvironment”
    55. March 20, 2019, Timothy Ratliff, PhD (Purdue University Center for Cancer Research), UW O’Brien Center Invited Speaker Seminar – “Contributions of Inflammation to Benign Prostate Hyperplasia”
    56. CROSS-DISCIPLINE INTERACTION: January 16, 2019, Lauren Michael, MS(UW-Madison Center for High Throughput Computing), UW O’Brien Center Internal Speaker Seminar – “Accelerate Your Research with Scalable Computing: Resources on Campus and Beyond”
    57. CROSS-DISCIPLINE INTERACTION: December 19, 2018, Heidi Dvinge, PhD(UW-Madison, Biomolecular Chemistry), UW O’Brien Center Internal Speaker Seminar – “Prevalence and Function of Nuclear Receptor Isoforms in Cancer”
    58. December 12, 2018, Petra Popovics, PhD (Case Western Reserve University), UW O’Brien Center Invited Speaker Seminar – “Molecular Links Between Chronic Inflammation and Benign Prostatic Hyperplasia”
    59. December 10, 2018, Hari Koul, PhD (LSUHSC), UW O’Brien Center Invited Speaker Seminar – “Role of PDEF in Prostate Luminal Epithelium”
    60. November 14, 2018, Sara Roccabianca, PhD (Michigan State University), UW O’Brien Center Invited Speaker Seminar – “Extracellular Matrix Remodeling in the Urinary Bladder Wall in Two Animal Models of Type 2 Diabetes”
    61. October 11, 2018, Marc Cox, MSPH, PhD (University of Texas at El Paso), UW O’Brien Center Invited Speaker Seminar – “Molecular Chaperones and Cochaperones in Hormone-Dependent Physiology and Disease”
    62. October 10, 2018, Gerard Apodaca, PhD (University of Pittsburgh), UW O’Brien Center Invited Speaker Seminar – “Umbrella Cells: Life in a Liquid Environment”
    63. CROSS-DISCIPLINE INTERACTION: October 3, 2018, Tony Goldberg, DVM, PhD (UW Madison, Department of Pathobiological Sciences), UW O’Brien Center Internal Speaker Seminar – “Metabiome of Male Lower Urinary Tract Syndrome: An Epidemiological and Ecological Study”
    64. September 12, 2108, Carolyn Best, PhD (American Urological Association), UW O’Brien Center Invited Speaker Seminar – “The AUA and Urology Care Foundation: Providing Opportunities to Advance Urology Research”
    65. August 29, 2018, Andrey Shaw, PhD (Genentech Inc.), UW O’Brien Center Invited Speaker Seminar – “A Single Cell Sequencing View of the Glomerulus in Health and Disease”
    66. April 21, 2018, Heidi Wendell Brown, MD (UW-Madison, Department of OB/GYN), UW/UMB O’Brien Center Spring Symposium “Cellular Functions in Urology” – “Marketing Continence Promotion in the Community: The “Sell-ular” Level
    67. April 21, 2018, Tatyana Sysoeva, PhD (Duke University), UW/UMB O’Brien Center Spring Symposium “Cellular Functions in Urology” – “Regulation of Conjugative Transfer of B-lactam Resistance from Uropathogenic Strains of Escerichia Coli”
    68. April 21, 2018, Maryellen Kelly, CPNP, CNP (Duke University), UW/UMB O’Brien Center Spring Symposium “Cellular Functions in Urology” – “Diabetes and the Pediatric Lower Urinary Tract”
    69. April 21, 2018, Michael Wood, DVM, PhD (UW-Madison, Department of Pathobiological Sciences), UW/UMB O’Brien Center Spring Symposium “Cellular Functions in Urology” – “Urothelial Response to Targeted Soluble and Membrane Bound IL-6 Signaling”
    70. April 21, 2018, Miguel Verbitsky, PhD (Columbia University), UW/UMB O’Brien Center Spring Symposium “Cellular Functions in Urology” – “Large-scale CNV Analysis Provides Insight Into the Genomic Architecture of Congenital Anomalies of the Kidney and Urinary Tract”
    71. INTERACTION WITH MAYO O’BRIEN CENTER: April 21, 2018, Marcelino Rivera, MD (Mayo Clinic), UW/UMB O’Brien Center Spring Symposium “Cellular Functions in Urology” – “Improving Stone Disease Treatment by Accurate Phenotyping and Risk Stratification”
    72. April 21, 2018, Dale Bjorling, DVM (UW-Madison, School of Veterinary Medicine), UW/UMB O’Brien Center Spring Symposium “Cellular Functions in Urology” – “What Can the UW-Madison/U Mass-Boston O’Brien Center Do For You?”
    73. April 20, 2018, Brian Van Le, MD (UT Southwestern), UW/UMB O’Brien Center Spring Symposium “Cellular Functions in Urology -, “Current Paradigms for Understanding and Managing Benign Prostatic Hyperplasia”
    74. April 20, 2018, Douglas Strand, PhD (UT Southwestern), UW/UMB O’Brien Center Spring Symposium “Cellular Functions in Urology” – “A Cellular Atlas of the Human Prostate”
    75. April 20, 2018, Will Ricke, PhD (UW-Madison, Department of Urology), UW/UMB O’Brien Center Spring Symposium “Cellular Functions in Urology” – “Identification of Cell Types and Pathways in Normal and Disease States”
    76. April 20, 2018, Jill Macoska, PhD (University of Massachusetts-Boston), UW/UMB O’Brien Center Spring Symposium “Cellular Functions in Urology” – “CXCL12/CXCR4-Mediated Procollagen Secretion is Coupled to Cullin-RING Ubiquitin Ligase Activation”
    77. CROSS-DISCIPLINE INTERACTION: April 20, 2018, Jacques Galipeau, MD (UW-Madison, Hematology/Oncology), UW/UMB O’Brien Center Spring Symposium “Cellular Functions in Urology” – “Translational Use of MSCs in Urology”
    78. CROSS-DISCIPLINE INTERACTION: April 20, 2018, Alejandro Roldán-Alzate, PhD (UW-Madison, Departments of Mechanical and Biomedical Engineering), UW/UMB O’Brien Center Spring Symposium “Cellular Functions in Urology” – “Urinary Flow Dynamics in BPH – Effects of Bladder Neck Angle”
    79. April 20, 2018, Chad Vezina, PhD (UW-Madison, Department of Comparative Biosciences), UW/UMB O’Brien Center Spring Symposium “Cellular Functions in Urology” – “A Genetic Toolbox to Spy on Mouse Prostate Stromal Cells in Situ”
    80. April 20, 2018, Li Xin, PhD (Baylor University), UW/UMB O’Brien Center Spring Symposium “Cellular Functions in Urology” – “Inflammation and Prostate Epithelial Lineage Hierarchy”
    81. INTERACTION WITH GRADUATE TRAINEE: April 20, 2018, Mark Cadena (PhD Candidate, UW-Madison), UW/UMB O’Brien Center Spring Symposium “Cellular Functions in Urology” – “Neuroendocrine Cells: Mediators of Prostate Smooth Muscle Contractility”
    82. CROSS–DISCIPLINE INTERACTION: April 20, 2018, Sheena Kerr (UW-Madison, Department of Biomedical Engineering), UW/UMB O’Brien Center Spring Symposium “Cellular Functions in Urology” – “Development of a Microscale Organotypic Model of Prostate Cancer”
    83. April 20, 2018, Paul Marker, PhD (UW-Madison, School of Pharmacy), UW/UMB O’Brien Center Spring Symposium “Cellular Functions in Urology” – “Modeling and Treating Fibrosis in the Urinary Tract”
    84. INTERACTION WITH UW-MADISON K12: April 20, 2018, Teresa Liu, PhD (K12 Scholar, UW-Madison), UW/UMB O’Brien Center Spring Symposium “Cellular Functions in Urology” – “Altered Steroidogenesis on Estrogen Receptor Activation in Benign Prostatic Hyperplasia”
    85. INTERACTION WITH GRADUATE TRAINEE: April 20, 2018, Sam Thomas (PhD Candidate, UW-Madison METC Program), UW/UMB O’Brien Center Spring Symposium “Cellular Functions in Urology” – “Proteomics by Mass Spectrometry for Molecular Insights into Hormone-Induced Lower Urinary Tract Dysfunction in Mice”
    86. INTERACTION WITH GRADUATE TRAINEE: April 20, 2018, Hannah Ruetten(PhD Candidate, UW-Madison Comparative Biomedical Sciences Program), UW/UMB O’Brien Center Spring Symposium “Cellular Functions in Urology” – “Impact of Age and Castration on Prostate Collagen Organization”
    87. INTERACTION WITH U.PITTSBURGH O’BRIEN CENTER: April 20, 2018, Zhou Wang, PhD (University of Pittsburgh), UW/UMB O’Brien Center Spring Symposium “Cellular Functions in Urology” – “Inflammation, Androgen Signaling, and Luminal Epithelial Barrier Dysfunction in BPH”
    88. March 7, 2018, Jianghui Hou, PhD (Washington University), O’Brien Center Invited Speaker Seminar – “MicroRNA, Kidney, and Bladder Diseases”
    89. October 11, 2017, Charles Bieberich, PhD (University of Maryland), O’Brien Center Invited Speaker Seminar – “Pelvic Pain, Proliferation, and PIN: Consequences of Chronic Prostatic Inflammation in a Mouse Model”
    90. INTERACTION WITH UW-MADISON K12: May 24, 2017, Heidi Wendell Brown, MD (K12 Scholar, UW-Madison), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “How SHAIP is Shaping Up”
    91. INTERACTION WITH COLUBMIA O’BRIEN CENTER: May 24, 2017, Jonathan Barasch, MD, PhD (Columbia University), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “An Iron Defense Against UTI”
    92. May 24, 2017, Lindsay Hampson, MD (UCSF), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Improving Transitional Urology Care”
    93. May 24, 2017, Adriane Sinclair, PhD (UCSF), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Analysis of Gene Expression in Human Penile Development”
    94. INTERACTION WITH U.PITTSBURGH O’BRIEN CENTER: May 24, 2017, Laura Pascal, PhD (University of Pittsburgh), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “E-cadherin Downregulation and Increased Luminal Epithelial Permeability in BPH”
    95. May 24, 2017, Adam Szafran, MD, PhD (Baylor College of Medicine), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Using Cellular Imaging to Investigate the Role of Nuclear Receptor Expression and Mitochondria in Hypospadias”
    96. May 24, 2017, Mike Wood, DVM, PhD, DACVIM (UW-Madison, Department of Medical Sciences), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Classic IL-6 Signaling Mitigates Urothelial Infection”
    97. CROSS–DISCIPLINE INTERACTION: May 24, 2017, Diego Hernando, PhD (UW-Madison, Department of Radiology and Medical Physics), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Quantitative MRI Techniques for the Assessment of BPH: Background and Proposed Research”
    98. May 24, 2017, Lisa Abler, PhD (UW-Madison, Department of Comparative Biosciences), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Deciphering the Influence of Diabesity and Intermittent Hypoxia on the Male Environment in Urinary Tract Dysfunction”
    99. May 23, 2017, Dolores Lamb, PhD, HCLD (Baylor College of Medicine), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Exploring Novel Alterations in Steroid Hormone Receptor Signaling that Underlie Human Congenital Genitourinary Anomalies”
    100. CROSS-DISCIPLINE INTERACTION: May 23, 2017, Joan Jorgensen, DVM, PhD(UW-Madison, Department of Pharmacology), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Development of Individual Male Urogenital Tract Components Require Distinct Threshold Concentrations of Fetal Testosterone”
    101. May 23, 2017, Larry Baskin, MD (UCSF), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Hormonal Control of Genital Development”
    102. May 23, 2017, Fred vom Saal, PhD (University of Missouri), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Estradiol and Estrogenic Chemicals Modulate Androgen Action During Prostate Development”
    103. May 23, 2017, Paul Cooke, PhD (University of Florida), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Role of Membrane Estrogen Receptor 1 in the Development and Function of the Male Reproductive Tract”
    104. May 23, 2017, Chad Vezina, PhD (UW-Madison, Department of Comparative Biosciences), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Pinpointing Cellular Origins and Physiological Consequences of Prostate Fibrosis”
    105. INTERACTION WITH GRADUATE TRAINEE: May 23, 2017, David Lung (PhD Candidate, UW-Madison McArdle Cancer Biology Program), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Investigating the Mechanism of Estrogen Receptor α Regulation by Paracrine Interactions”
    106. May 23, 2017, Brett Johnson, MD (UW-Madison, Department of Urology), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “One in Six Hypogonadal Men Treated with Clomiphene Citrate Need Combination Therapy with an Aromatase Inhibitor”
    107. INTERACTION WITH UNIVERSITY OF PITTSBURGH O’BRIEN CENTER: May 23, 2017, Don DeFranco, PhD (University of Pittsburgh), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Opposing Roles for Cox-2 in Regulating Estrogen Receptor Beta Function in the Prostate”
    108. CROSS–DISCIPLINE INTERACTION: May 23, 2017, Linda Schuler, VMD, PhD(UW-Madison, Department of Comparative Biosciences), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Hormone-ECM Collusion in Breast Cancer”
    109. May 23, 2017, Lisa Arendt, PhD (UW-Madison, Department of Comparative Biosciences), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Obesity and Erα: Selecting for Hormonal Responsiveness?”
    110. INTERACTION WITH GRADUATE TRAINEE: May 23, 2017, Diya Binoy Joseph (PhD Candidate, UW-Madison Cellular and Molecular Biology Program), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Harnessing Lineage Tracing to Study Hormonal Responses in the Prostate”
    111. CROSS-DISCIPLINE INTERACTION: May 23, 2017, Elaine Alarid, PhD (UW-Madison, Department of Oncology), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Postranslational Dynamics of ER and Its Paradoxical Roles in Cancer”
    112. CROSS–DISCIPLINE INTERACTION: May 23, 2017, Pamela Kreeger, PhD (UW-Madison, Department of Biomedical Engineering), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Computational Modeling of Cell Signaling Networks”
    113. May 23, 2017, Clara Jeong, PhD (UW-Madison, Department of Urology), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Measurement of Multi-steroid Hormones in Mouse Serum using LC-MS/MS”
    114. INTERACTION WITH GRADUATE TRAINEE: May 23, 2017, Kyle Helzer (PhD Candidate, UW-Madison McArdle Cancer Biology Program), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Investigating the Effects of Phosphorylation on the DNA Binding Properties of Erα”
    115. May 22, 2017, Kyle Richards, MD (UW-Madison, Department of Urology), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “BPH: Androgens, Estrogens, and Fibrosis”
    116. May 22, 2017, Paul Marker, PhD (UW-Madison, School of Pharmacy), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Opportunities and Challenges for Modeling BPH and LUTS in Rodents”
    117. INTERACTION WITH GRADUATE TRAINEE: May 22, 2017, Sam Thomas (PhD Candidate, UW-Madison METC Program, UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Mass Spectrometry-based Urinary Proteomics”
    118. INTERACTION WITH UW-MADISON K12: May 22, 2017, Alejandro Roldán-Alzate, PhD (K12 Scholar, UW-Madison), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Urinary Flow Dynamics – An MR Based Computational Modeling Approach”
    119. May 22, 2017, Claus Roehrborn, MD (UT Southwestern), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Steroid Hormones and Clinical LUTS/BPH: Correlations, Causations and Therapeutic Targets”
    120. May 22, 2017, Jill Macoska, PhD (University of Massachusetts-Boston), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Role of G-Protein Coupled Receptors in Lower Urinary Tract Fibrosis”
    121. CROSS-DISCIPLINE INTERACTION: May 22, 2017, Wei Xu, PhD (UW-Madison, Department of Oncology), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Next Generation ER and AR Blockers for Cancer Treatment”
    122. INTERACTION WITH UW-MADISON K12: May 22, 2017, Teresa Liu, PhD (K12 Scholar, UW-Madison), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Identification of Estrogen Regulated Gene Networks in BPH”
    123. CROSS-DISCIPLINE INTERACTION: May 22, 2017: Paul Lambert, PhD (UW-Madison, Department of Oncology), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Hormone Action in the Cervix”
    124. May 22, 2017, Will Ricke, PhD (UW-Madison, Department of Urology), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “What is BPH and What Roles Might Estrogen Be Playing?”
    125. INTERACTION WITH GRADUATE TRAINEE: May 22, 2017, Molly Morgan (PhD Candidate, UW-Madison METC Program), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Reconstructing the Tissue Microenvironment to Understand the Role of Estrogens in Prostate Disease Progression”
    126. May 22, 2017, Stephen Hammes, MD, PhD (University of Rochester), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Steroids and Inflammation: How Studying Androgen Signaling Leads to the Neutrophil”
    127. May 22, 2017, Jun Luo, PhD (Johns Hopkins Medical Center), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Androgen Receptor Splice Variants: From Biology to Utility”
    128. INTERACTION WITH GRADUATE TRAINEE: May 22, 2017, Dalton McLean(PhD Candidate, UW-Madison Cancer Biology Program), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Androgen Regulation of FGF5 and its Role in the Prostate”
    129. May 22, 2017, Jim Dalton, PhD (University of Michigan), UW/UMB O’Brien Center Spring Symposium “Steroid Hormone Pathways and Mechanisms of Action in Benign Urologic Disease” – “Selective Androgen Receptor Modulators (SARMs) as Prostate-sparing Anabolic Therapy”
    130. March 8, 2017, Praveen Thumbikat, DVM, PhD (Northwestern University), UW O’Brien Center Invited Speaker Seminar – “Mast Cells are Potential Mediators of Lower Urinary Tract Dysfunction”
    131. December 14, 2016, Scott Dehm, PhD (University of Minnesota Masonic Cancer Center), UW O’Brien Center Invited Speaker Seminar – “Truncated AR Variants and Resistance to AR-targeted Therapies”
    132. November 9, 2016, Donald Vander Griend, PhD (University of Chicago), UW O’Brien Center Invited Speaker Seminar – “Prostate Disease and Prostate Development: The Role of Sox2 and Atomic Bombs”
    133. INTERACTION WITH UW-MADISON K12: December 10, 2016, Teresa Liu, PhD(K12 scholar, UW-Madison), “The role of estrogen receptor activation on BPH progression”
    134. October 12, 2016, Maria Hadjifrangiskou, PhD (Vanderbilt University), “Oxygen Mediates Biofilm Formation in Uropathogenic E.Coli In Vitro and In Vivo”
    135. September 14, 2016, Omar Franco, MD, PhD (NorthShore University), “Understanding the ‘Cancer Village’ – A Practical Approach to Study Cellular Heterogeneity in Cancer”
    136. May 12, 2016, Jay Reeder, PhD (University of Rochester), “The Role of SCN9A in Pain Perception and Interstitial Cystitis”
    137. INTERACTION WITH EXTERNAL ADVISORY COMMITTEE (SITE VISIT):May 11, 2016, Mark T. Nelson, PhD (University Distinguished Professor and Chair, Department of Pharmacology, University of Vermont), “Non-Voiding Contractions Encode Essential Information on Urinary Bladder Fullness”
    138. INTERACTION WITH UW-MADISON K12: April 14, 2016, Michael Wood (K12 Scholar, UW-Madison), “Barrier Function in Bladder Disease”
    139. INTERACTION WITH UW-MADISON K12: April 5, 2016, Teresa Liu, PhD (K12 Scholar, UW-Madison), “Selective Estrogen Receptor Modulators and BPH”
    140. INTERACTION WITH GRADUATE TRAINEE: April 5, 2016, Megan Livingston(UW-Madison), “Utilizing Micro-scale Tools to Identify Key Factors in the Microenvironment”
    141. CROSS–DISCIPLINE INTERACTION: April 5, 2016, Wei Xu, PhD (UW-Madison, Department of Oncology), “Direct Estrogen Receptor Dimerization Using Chemical Probes”
    142. INTERACTION WITH GRADUATE TRAINEE: April 5, 2016, Diya Binoy Joseph(UW-Madison), “Investigating the Role of DNA Methylation in Prostate Development and Disease”
    143. CROSS–DISCIPLINE INTERACTION: April 5, 2016, John Denu (UW-Madison, Department of Biomolecular Chemistry), “Histone-typing as an Epigenetic Tool in Diagnosis and Treatment”
    144. INTERACTION WITH EXTERNAL ADVISORY COMMITTEE (SITE VISIT):April 5, 2016, Shuk-Mei Ho (University of Cincinnati), “BPA Effects on Methylation in Reproductive Tissues”
    145. CROSS–DISCIPLINE INTERACTION: April 5, 2016, Linda Schuler (UW-Madison), “Desmoplasia: Hijacking Hormones in Breast Cancer”
    146. INTERACTION WITH GRADUATE TRAINEE: April 4, 2016, Kyle Wegner (UW-Madison), Department of Comparative Biosciences, “Picrosirius Red: A Versatile Tool for Analyzing Collagen in the Lower Urinary Tract”
    147. April 4, 2016, Allison Brodbeck (UW-Madison) “Ultrasound Imaging of the Mouse Renal System”
    148. April 4, 2016, Lingjun Li (UW-Madison), “Developing Mass Spectrometry-based Omics Strategies for Candidate Biomarker Discovery in LUTS”
    149. INTERACTION WITH GRADUATE TRAINEE: April 4, 2016, Justine Coburn (UW-Madison), “ER and AhR Crosstalk in Breast Cancer”
    150. CROSS–DISCIPLINE INTERACTION: April 4, 2016, Weiping Tang (UW-Madison), “The Next Generation of SAhRM as Potential Therapeutics”
    151. INTERACTION WITH GRADUATE TRAINEE: April 4, 2016, Jordan Vellky (UW-Madison), “BPA Exposure and Associated Gene Expression Changes in Prostate Cancer“
    152. INTERACTION WITH GRADUATE TRAINEE: April 4, 2016, Jalissa Wynder(UW-Madison), “The Role of Bisphenol A in LUTD”
    153. April 4, 2016, Barry Timms (University of South Dakota), “The Role of Bisphenol-A in LUTDevelopment and LUTD”
    154. CROSS NIH INSTITUTE INTERACTION: April 4, 2016, Rick Woychik (Deputy Director, NIEHS),“Toxicological Insights for Future Research.
    155. April 4, 2016, Reginald Bruskewitz (UW-Madison), “Overview of BPH/LUTS: A Role for Compliance and Fibrosis”
    156. INTERACTION WITH TRAINEES: March 10, 2016, (mini-talks from Lisa Abler (scientist), Kyle Wegner(graduate student), Mark Cadena (Graduate Student) and Royal Oakes (Undergraduate)), “Urologic Research Tools in Development”
    157. INTERACTION WITH FORMER P20 CENTER: March 8, 2016, Anna Malykhina, PhD (Associate Professor of Urology University of Colorado School of Medicine), “The Role of Neural Circuits in Regulation of Lower Urinary Tract Function”
    158. February 10, 2016, Lingjun Li, PhD (Professor of Pharmaceutical Sciences and Chemistry, UW-Madison), “Developing Mass Spectometry-based Omics Strategies for Candidate Biomarker Discovery in Lower Urinary Tract Symptoms (LUTS) and Beyond”
    159. INTERACTION WITH FORMER WASHINGTON UNIVERSITY P20 CENTER:January 13, 2016, Jeffrey H. Miner, PhD, FASN (Professor of Medicine and of Cell Biology and Physiology, Washington University School of Medicine), “Roles of Basement Membranes in the Urogenital System”
    160. January 14, 2016, Neil Lamarre (Post-doctoral Fellow, Dale Bjorling Lab, UW-Madison), “Relevance of Lower Urinary Tract Function Testing in Mice to Humans”
    161. January 11, 2016: Jianfeng Xu, MD, DrPH (NorthShore University), “Pyramid Model for Precision Medicine of Cancer: Genomic-based Individualized Cancer Care from Prevention and Screening to Diagnosis and Treatment”
    162. INTERACTION WITH MAYO O’BRIEN CENTER:December 9, 2015, Michael F. Romero, PhD (Professor of Physiology & Biomedical Engineering and Nephrology & Hypertension, Mayo Clinic College of Medicine), “The Electrogenic Na+ Bicarbonate Cotransporter (NBCe1) – metabolic acidosis and glaucoma”
    163. October 14, 2015, Douglas Strand, PhD (UT Southwestern Medical Center), “Dissecting the Pathogenesis of Clinical BPH”
    164. May 6, 2015, Teresa Liu, PhD (University of Pittsburgh), “5α-reductase inhibition drives production of Erβ ligands via a COX-2 dependent mechanism in BPH”
    165. INTERACTION WITH COLUMBIA O’BRIEN CENTER: April 10, 2015, Cathy Mendelsohn (Professor of Urology, Pathology & Cell Biology,(Institute of Human Nutrition) and Genetics & Development, U54 O’Brien Urology Research Center Director, Columbia University), “Progenitors important for formation and regeneration of the urothelium, and their contribution to bladder cancer”
    166. April 9, 2015, Kevin Elicieri (UW-Madison), “Multiscale Imaging Approaches for Investigating ECMChanges in Disease”
    167. April 9, 2015, Wei Huang (UW-Madison), “Characterization of Fibrillar Collagens and Extracellular Matrix of Glandular Benign Prostatic Hyperplasia Nodules”
    168. April 9, 2015, Ben Humphreys (Harvard), “Resident Perivascular Cells and Organ Fibrosis”
    169. CROSS–DISCIPLINE INTERACTION: April 8, 2015, Paul Campagnola (UW-Madison, Department of Engineering), “High Resolution Imaging and Modeling Approaches to Study ECM Changes in Cancer, Fibrosis, and Connective Tissue Disorders”
    170. CROSS–DISCIPLINE INTERACTION: April 8, 2015, Linda Schuler (UW-Madison, Department of Comparative Biosciences), “Matric Stiffness: Recruitment of Hormones to the Dark Side of Breast Cancer”
    171. CROSS–DISCIPLINE INTERACTION: April 8, 2015, Patricia Keely, PhD (UW-Madison, Cell and Regenerative Biology), “Molecular changes of fibrosis during mammary gland pathogenesis”
    172. CROSS NIH INSTITUTE INTERACTION: April 8, 2015, Tom Wynn (NIAID), “Targeting immunological mechanisms of fibrosis”
    173. April 8, 2015, Jill Macoska, PhD (UMASSBoston), “CXCL12-mediated non-canonical signaling promotes myofibroblast phenoconversion in the prostate”
    174. March 9, 2015, Gail Risbridger, PhD (Professor, Director of Centre for Urologic Research and Monash University), “Patient Derived Xenografts: Preclinical Insights that Influence Clinical Practice”
    175. February 18, 2015, Rosalyn Adam, PhD (Harvard University), “Signaling networks in the bladder: implications for benign urologic disease”
    176. January 21, 2015, Simon W. Hayward, PhD (Vanderbilt University), “Inflammation and androgen receptor variant expression in benign prostatic hyperplasia”
  • SERVICE & LEADERSHIP

    Scientific Organizations – positions held

    WORKSHOPS

    • 2018-present (Vezina), Faculty Instructor, Workshop on Techniques in Modeling Human Cancer in Mice, The Jackson Laboratory, Bar Harbor MA

     COMMITTEES

    • 2020-present (Vezina), External Advisor
    • 2020-present (Vezina), Chair, UW-Madison Graduate Program in Clinical Investigation Admissions Committee
    • 2020 (Strand), Annual Meeting Planning Committee, CAIRIBU
    • 2020 (Vezina), Annual Meeting Planning Commiteee, Society of Basic Urologic Research (SBUR)
    • 2020 (Vezina), Don and Eula Coffey Award Committee Member, Society of Basic Urologic Research (SBUR)
    • 2019-present (Ricke), Dean’s Strategic Planning Committee, UW-Madison School of Medicine and Public Health
    • 2019-present (Vezina), Steering Committee Member, UW-Madison Endocrinology and Reproductive Physiology T32 Training Grant
    • 2018 (Vezina), Trainee Affairs Committee Member, Society of Basic Urologic Research (SBUR)
    • 2018 (Vezina), Finance Committee Member, Society of Basic Urologic Research (SBUR)
    • 2017-present (Ricke), Member, American Urological Association (AUA) Research, Education, Conferences, Communications (RECC) Committee
    • 2016 (Vezina), Program Committee, American Urological Association (AUA) Summer Research Conference “Targeting Epigenetics and Genome Regulation to Improve Urologic Health”, Lithicum, MD
    • 2016 (Vezina), Session Chair, Epigenetic Considerations for Bladder Dysfunction & Pain Syndromes, American Urological Association (AUA) Summer Research Conference “Targeting Epigenetics and Genome Regulation to Improve Urologic Health”, Lithicum, MD
    • 2016 (Macoska), Chair, Organizing Committee, 2016 Basic Science Symposium, American Urological Association Annual Meeting, San Diego, CA
    • 2015 (Vezina), Planning committee, Society for Basic Urologic Research (SBUR) Fall Meeting
    • 2015 (Vezina), Session Chair, Discussion Forum: Emerging Model Systems for Research. SBUR Fall Symposium, F. Lauderdale, FL
    • 2015 (Vezina), Session Chair, Cell-Specific Responses to Comorbidities in BPH. SBUR Fall Symposium, Ft. Lauderdale, FL
    • 2014-present (Ricke), U54 Symposium Organizing Committee, Chair
    • 2014-present (Ricke), Steering Committee, University of Wisconsin Molecular Environmental Toxicology Center
    • 2014-present (Ricke), Steering Committee, NIDDK Urology U54
    • 2014-present (Ricke), Steering Committee, University of Wisconsin George M. O’Brien Center
    • 2014-present (Ricke), Senior Executive Committee, University of Wisconsin George M. O’Brien Center
    • 2014 (Ricke), Representative, American Urological Association Office of Research
    • 2014 (Ricke), Consultant, NIDDK Centers, Norm Braveman Inc. – Future of Benign Urology
    • 2012-present (Ricke), Awards Committee, Society of Basic Urologic Research
    • 2011-present (Ricke), Abstraction Selection Committee, Society of Basic Urologic Research
    • 2011 (Ricke), Organizing Committee, Society of Basic Urologic Research
    • 2010-2013 (Ricke), Finance Committee, Society of Basic Urologic Research
    • 2008-2010 (Ricke), Executive Committee Board Member, Society of Basic Urologic Research

     BOARDS

    • 2020-present (Strand), Director at Large, Society for Basic Urologic Research
    • 2020-present (Ricke), Cancers, Editorial Board Member
    • 2019-2020 (Vezina), Midwest Regional Chapter of the Society of Toxicology, President
    • 2018 (Vezina), President Elect, Midwest regional chapter, Society of Toxicology
    • 2015 (Macoska), Past-President, the Society for Basic Urologic Research
    • 2014 (Macoska), President, the Society for Basic Urologic Research
    • 2014-present (Vezina), American Journal of Physiology – Renal, Editorial Board
    • 2013-present (Vezina), American Journal of Clinical and Experimental Urology, Editorial Board
    • 2012-present (Macoska), The Prostate, Editorial Board
    • 2012-present (Macoska), The Bladder, Editorial Board
    • 2008-2010 (Ricke), Board Member, Society for Basic Urologic Research

     MODERATOR

    • 2017 (Vezina), Invited Subject Matter Expert, responsible for creating an online training module for NIH K-series career development awards for the American Urological Association (AUA)
    • 2015 (Vezina), NIDDK Meeting, Baltimore, MD
    • 2015 (Ricke), NIDDK Centers Meeting, Baltimore, MD
    • 2015 (Ricke), AUA Meeting, New Orleans, LA
    • 2014 (Ricke), P20 Centers Directors Meeting Update, Pacific Grove, CA
    • 2014 (Ricke), Great Lakes Nuclear Receptor Meeting, Madison, WI

    ADVISORY ROLES

    • 2020-present (Vezina), External Advisor, NorthShore University / Indiana University P20 Center for Benign Urologic Research
    • 2019 (Macoska), Ad-Hoc Member, NIDDK Advisory Council
    • 2018-present (Vezina), External Advisor, Mayo Clinic of Rochester Nephrology Summer Undergraduate Research Fellowship Program

    OTHER

    • 2016-present (Vezina), Director, UW-Madison Summer Program in Undergraduate Urology Research
    • 2016-present (Vezina), Director, UW-Madison Molecular and Environmental Toxicology Program
    • 2019-present (Vezina), Associate Director, UW-Madison George M. O’Brien Benign Urology Research Center
    • 2017-present (Vezina), Associate Director, UW-Madison Toxicology T32 Training Grant
  • GRANT REVIEW ACTIVITIES
    • 2020 (Strand), Ad Hoc Reviewer, Belgian Foundation against Cancer
    • 2020 (Ricke), Ad Hoc Reviewer, NIH/NIDDK Special Emphasis Panels in Nephrology Small Business/Digestive Diseases
    • 2019 (Ricke), Chair, NIH/NIDDK DKUS SEP (Kidney, Urological and Hematological, review of R01 grants)
    • 2019-present (Vezina), Chair, NIH/NIDDK DDK-D Subcommittee (Kidney, Urological and Hematological, review of career development awards)
    • 2019 (Bjorling), NIH ZDK1 GRB-M (M1), Multidisciplinary Approach to Pelvic Pain, March 27, 2019
    • 2018-present (Bjorling), NIH ZDK1 GRB-G J1, NIDDK-KUH Fellowship Review Committee (meets 3x/year)
    • 2018 (Macoska), Member, Review Panel, ZDK1-GRB-3 George M. O’Brien Urology Cooperative Research Centers Program (U54)
    • 2018 (Macoska), Member, Review Panel, ZDK-GRB-S (M3), NIDDK Central Repository X01
    • 2018 (Macoska), Member, Review Panel, ZCA1 SRB-2, NCI CPACHE U54 and P20
    • 2018 (Macoska), Member, Review Panel, ZDK1 GRB-03 (01) U54 Urology Research Center Applications
    • 2018 (Bjorling), NIH ZDK1 GRB-6 (O2), P01 Application Urinary Tract Dysfunction
    • 2018 (Bjorling), NIH ZDK1 GRB-M (O1), P01 Application Bladder Physiology
    • 2018 (Bjorling), NIH Special Emphasis Panel ZRG1 IMST-D (80)
    • 2018 (Bjorling), USDA NCAC-02 program review
    • 2017 (Bjorling), NIH Special Emphasis Panel ZDK1 GRB-M (O2)
    • 2017 (Bjorling), NIH Panel ZRG1 IMST-U (80)
    • 2017 (Bjorling), Department of Defense, Urological Disorders, PRMPR program
    • 2016 (Macoska), Member, NIH/NIDDK Review Panel, 2016/10 ZRG1 DKUS-G (90) S Urologic and Urogynecologic Applications
    • 2016 (Macoska), Member, NIH/NIDDK Review Panel, 2016/10 ZDK1-GRB-3 (O2) 1 George M. O’Brien Urology Cooperative Research Centers Program (U54)
    • 2016 (Macoska), Member, NIH/NIDDK Review Panel, George M. O’Brien Urology Cooperative Research Centers Program (U54) NIH/NIDDK Review Panel, ZDK-GRB-S (M3)
    • 2016 (Vezina), NIH/NIDDK Special Emphasis Review Panel ZRG1 DKUS-G (90) S
    • 2016-2019 (Vezina), Standing Member, NIH/NIDDK DDK-D Panel
    • 2016 (Bjorling), NIH ZDK1 GRB-2 (M3) GUDMAP RFA
    • 2015-2018 (Ricke), University of Wisconsin-Madison ICTR/CTSA Pilot Awards Review
    • 2015 (Vezina), NIH/NIDDK Special Emphasis Review Panel ZDK1 GRB-S (O4)
    • 2015 (Macoska), Member, Review Panel, NIH/NIDDK ZDK1 GRB-3 (01), U54 Urology Research Center Applications
    • 2015, 2016 (Vezina), NIH/NIDDK DDK-D Subcommittee (Kidney, Urological and Hematological, review of career development awards)
    • 2015-2017 (Vezina), Department of Veterans Affairs Review Panel 10P9B/SURG
    • 2015 (Bjorling), NIH Special Emphasis Panel ZRG1 DKUS-N (90)
    • 2014 (Macoska), Member, Review Panel, NIH/NIDDK ZDK1 GRB-S (O5), Novel Methods for Measurement of Organ Fibrosis (U01)
    • 2014 (Macoska), Member, Review Panel, NIH/NIDDK ZDK1 GRB-S (M1), NIDDK Central Repositories Non-Renewable Sample Access
    • 2014 (Bjorling), NIH/NIDDK Urological and Urogynecological Sciences and Small Business Special Emphasis Panel, NIH/NIDDK ZRG1 DKUS-G (90)
    • 2014-present (Ricke), University of Wisconsin George M. O’Brien Center Pilot Project Program, Chair
    • 2014-2017 (Ricke), University of Wisconsin-Madison Molecular and Environmental Toxicology Center Grad Student Training Grant Selection
    • 2014-2017 (Ricke), University of Wisconsin-Madison Molecular and Environmental Toxicology Postdoctorate Training Grant Selection
    • 2016 (Ricke), ZCA1 RPRB-N (J1), P01 NCI Program Project Review III
    • 2016 (Ricke), ZCA1 RPRB-7(01) SPORE Review II
    • 2017 (Ricke), ZCA1 RPRB-7(M1) NCI SPORE II Review
    • 2017 (Ricke), ZDK1 GRB-3(02) Developmental Centers in Benign Urology (P20)
    • 2018 (Ricke), NIH/NIDDK Special Emphasis Review Panel ZRG1-DKUS-B(90) R01
  • GRANT APPLICATIONS

    Funded:

    1. 1 U24 KD127726 (Penniston, Kris (PI)), 2020, NIDDK, $750,000, Urology Centers Program Interactions Core (U24).
    2. 5 R01 DK115477 03 (Strand, Douglas W. (PI)), 2020, NIDDK, $385,960, Notch-mediated 5ARI Resistance in Human BPH.
    3. R01 DK107436 05 (Xin (PI); Strand, Douglas W. (Co-I)), 7/1/2020-6/30/2025, NIH/NIDDK, $15,245/year DC, Molecular Mechanisms of Initiation of Benign Prostatic Hyperplasia.
    4. American Urological Association Research Scholar Award #659333 ((Binoy Joseph, Diya (PI), Strand, Douglas W. (Mentor)), 7/2020-6/2022, $40,000 DC/yr. The Role of Novel Urethral Cell Types in Benign Prostatic Hyperplasia.
    5. Massachusetts Life Sciences (Macoska, Jill A. (PI)), 7/1/2020-6/31/2020, $388,324 (total DC). Next Gen Sequencing at the Next Level: The University of Massachusetts Boston CPCT Genomics Core.
    6. K12 (Grimes, Matthew (PI); Vezina, Chad M. (Co-Mentor)), 7/1/2020-6/30/2025, NIH/NIDDK, $139,420 DC/yr. Loss of CD44 Expression Drives Altered Collagen Structure in Lichen Sclerosus.
    7. R01 DK124067 01A1 (Jerde (PI); Strand, Douglas W. (Co-I)), 4/2020-3/2025, NIH/NIDDK, $16,809/year DC. Interleukin-1 and Steroid Signaling Drive Toxoplasma-induce Prostatic Hyperplasia.
    8. Boehringer Ingelheim (Bjorling, Dale E. (PI)), 4/1/2020-3/31/2021,$20,000. Short-term Research Training of Veterinary Students in Wisconsin.
    9. 1 S10 OD028670-01 (Weichert, Jamey (PI), Ricke, William A. (Major User)), 2020, OD, $598,202. UW Spect/CT Acquisition.
    10. 1 K01 AG059899-01A1 (Liu, Teresa (PI) & Ricke, William A. (Mentor)), 5/15/2020-4/30/2025, NIA, $130,950. Impact of Age on Altered Steroidogenesis and Estrogen Receptor Activation in Benign Prostatic Hyperplasia Progression.
    11. 1 F32 DK123880-01A1 (Bonnemaison, Mathilde (PI) & Macoska, Jill A. (Sponsor)), 4/01/2020-3/31/2023, NIDDK, $208,761. Promotion of Prostatic Fibrosis and Lower Urinary Tract Dysfunction Through a Mesenchymal IL-4/IL-13 Autocrine Loop.
    12. Massachusetts Life Sciences Center (Macoska, Jill A. (PI)), 4/1/2020-3/31/2020, $387,808 total DC. Center for Personalized Cancer Therapy (Capital Grant).
    13. F31 ES030968 (Turco, Anne (PI) & Vezina, Chad M. (Mentor)), 4/21/2020-4/20/2022, NIH/NIDDK, $31,466 DC/year. Developmental Origins of Prostate-related Urinary Dysfunction in Adult Males: TCDD Exposure Increases Prostatic Noradrenergic Innervation and Smooth Muscle Contraction.
    14. R01 CA245294 01 (Mani (PI); Strand, Douglas W. (Co-I)), 4/2020-3/2025,NIH/NCI, $7,196/year DC. 3D Genome Architecture and the Origins of Genomic Rearrangements in Prostate Cancer.
    15. 2R44-EB025729 (Brittain, Jean H. (PI); Hernando, D. (Co-I)), 10/1/2019-6/31/2021, NIBIB, $1,494,863. Quantitative Magnetic Resonance Imaging Phantoms.
    16. 2U54DK104310-06 (Ricke, William A.), 9/25/2019-7/31/2024, NIH, $5,999,998. Cellular and Molecular Mediators of Fibrosis in the Development of Urinary Tract Dysfunction.
    17. 5P50 CA101942-15 (McDermott (PI); Macoska, Jill A. (Project PI)), 9/1/2019-8/31/2020, NIH/NCI, $10,000 (total DC). DF/HCC Kidney Cancer SPORE DCA Awardee: Urinary Biomarkers Predictive of RCC Diagnosis and Prognosis.
    18. R01 DK118145 (Bjorling, Dale E. (Co-I); Jianghui, Hou (Co-I); Vezina, Chad M. (Co-I)), 4/30/2019-4/30/2023, NIH/NIDDK, $585,489 DC/yr. Regulation of Bladder Structure and Function by Micro-RNA29.
    19. F30DK122686-01 (Ruetten, Hannah (PI); Vezina, Chad M. (Mentor)), 9/5/2019-10/4/2021, NIH/NIDDK, $31,466 DC/yr. Prostate Inflammation Increases Collagen and Voiding Dysfunction.
    20. DK100022-06 (Popovics, Petra (awardee); Ricke, William A. (Mentor); Vezina, Chad M. (Co-Mentor)); 7/1/2019-6/30/2024, NIH, $75,000 salary/$40,000 research support. The Role of Osteopontin in Lower Urinary Tract Dysfunction.
    21. R21CA238105 (Marker, Paul C. (PI)), 2019-2021, NCI, $171,242. Growth Hormone Actions in Prostate Carcinogenesis.
    22. 2U54DK104310-06 (Vezina, Chad M. (MPI); Strand, Douglas W. (MPI)), 12/1/2019-11/30/2024, NIH/NIDDK, $233,055 FYTC. CTGF Drives Voiding Dysfunction Through Expression of Collagen in Periurethral SRD5A2+ Fibroblasts.
    23. 1 R13 DK121565 01 (Olumi, Aria (PI); Ricke, William A. (Co-I)), 2019,NIDDK, $10,000. 2019 AUA-SBUR Basic Sciences Symposium, Social (and Antisocial) Cell Signaling Networks in the Urinary Tract.
    24. 1R01DK120025-01 (Southard-Smith, Michelle (PI); Bjorling, Dale E. 2019,NIDDK, $382,499. Serotonin Signaling in Control of the Lower Urinary Tract.
    25. T32 ES007015 (Bradfield, Christopher (PI); Vezina, Chad M. (Co-PI, Deputy Director)), 7/01/2018-6/30/2023, NIH/NIEHS, $612,326 DC/year. Molecular & Environmental Toxicology Pre- and Postdoctoral Training Grant.
    26. R01 HD094759-01 (Hernandez, Laura (PI); Vezina, Chad M. (Co-I)), 7/20/2018–4/30/2023, NIH/NICHD, $214,283 DC for 2018-2019; Influence of SSRI Use during Pregnancy and Lactation on Maternal Bone Health.
    27. 1R21 Al1382501/in4686396UTMC (Arrizabalaga (PI); Strand, Douglas W. (Co-I)), 5/18/2018-4/30/2020, $234,528, Prostate Pathogenesis during Toxoplasma gondii
    28. U54 CA156734 PILOT (Macoska, Jill A. (PI)), 5/1/2018-8/31/2019, NIH/NCI, $160,000 (total DC). Validation of Urinary RNA Biomarkers Predictive for RCC Diagnosis.
    29. R01 DK117354 (Hernando, D. (PI)), 4/1/2018-3/31/2022, NIDDK, $629,148 TC/YR, MRI-based Quantitative Susceptibility Mapping of Hepatic Iron Overload.
    30. 1R35GM128648-01 (Theberge, Ashleigh (PI)), 2018-2023, NIH, $1,927,520 TC. Deciphering the Role of Chemical Signals in Inflammation with Open Microfluidic Functional Assays.
    31. 2P30CA014520-44 (Bailey, Howard H.), 2018-2023, NCI, $4,590,130 TC for 2018. UW Comprehensive Cancer Center Support.
    32. TL-1 (Ruetten, Hannah (PI); Vezina, Chad M. (Mentor)), 2018-2020, UW-Madison Clinical and Translational Research Center (IICTR), TL-1 Fellowship; $30,648 DC/year. Prostate Inflammation Drives Fibrosis and LUTD.
    33. Arnold and Mabel Beckman Foundation (Theberge, Ashleigh), 2018-2020,Arnold and Mabel Beckman Foundation, $600,000 DC. Uncovering Chemical Signals in Complex Cellular Environments with Open Microfluidic Methods.
    34. S10 OD025084 01 (Li, Lingjun (PI) & Ricke, William A. (Co-I)), 2018-2019,NIH, $598,208. Equipment Grant – Mass Spectrometry “Acquisition of a High Resolution High Speed Maldi Mass Spectrometer for Biomedical Research at UW-Madison.
    35. 3 U54 DK104310 05S1 (Ricke, William A. (PI)), 2018, NIDDK, $590,619. Mediators of Fibrosis in the Development of Lower Urinary Tract Dysfunction.
    36. 5 U54 DK104310-04 REVISED (Ricke, William A. (PI)), 2018, NIDDK, $264,498. Mediators of Fibrosis in the Development of Lower Urinary Tract Dysfunction – Interaction Core Development.
    37. U54 DK104310-04S2 PILOT (Strand, Douglas W. (PI)), 2018, NIDDK, $121,500. Protocol Development for Single Cell RNA Sequencing of Human Prostate.
    38. 1S10OD023526-01A1 (Matkowskyj, Kristina A (PI); Ricke, William A. (Major User)), 2018, NIH, $183,824. Equipment Grant – Automated Tissue Microarrayer.
    39. R01 DK115477-01 (Strand, Douglas W. (PI)), 2018, NIH/NIDDK, $1,919,132. Notch-mediated 5ARI Resistance in Human BPH.
    40. 5 T35 DK062709 13 (Mezrich, Joshua (PI); Ricke, William A. (Trainer)), 2018, NIDDK, $50,144. Surgery Summer Research Experience for Medical Students; Funded.
    41. 5 U54 DK104310-04 REVISED (Ricke, William A. (PI, Director), 2018, NIDDK, $264,498. Mediators of Fibrosis in the Development of Lower Urinary Tract Dysfunction – Interaction Core Development.
    42. R01ES001332 (Peterson, Richard (MPI); Vezina, Chad M. (MPI); Ricke, William A. (Co-I)), 8/01/2017-7/31/2022, NIH/NIEHS, $308,554 DC/year. Reproductive and Developmental Toxicity of Dioxin.
    43. 5K12DK100022 (Roldán-Alzate, Alejandro (Awardee); Ricke, William A. (Mentor)), 2017-2022, NIDDK, $75,000 salary/$40,000 research support. Non-invasive Assessment of Urinary Flow and Prostatic Urethral Stiffness in Benign Prostate Hyperplasia Using MRI.
    44. 5 R01 CA213293-02 (Xu, Wei (PI)), 2017-2022, NIH/NCI, $104,576. Protein Arginine Methylation in Chemotherapy Resistance.
    45. R01HD090660-01A1 (Theberge, Ashleigh), 2017-2022, NICHD, $353,209. Mediators for Dynamic Regulation of Star Transcription: Comparing Fetal and Adult Leydig Cells.
    46. F31ES028594-01A1 (Wegner, Kyle (PI); Vezina, Chad M. (Co-I)), 7/1/2017-6/30/2020, NIH/NIEHS, $31,466 DC/year. TCDD Reprograms Prostate Stroma and Causes Fibrosis to Induce Urinary Dysfunction.
    47. DK100022-06 (Hernando, Diego (awardee); Ricke, William A. (Mentor)); 4/1/2017-3/31/2018, NIH, $75,000 salary/$40,000 research support. Development and Validation of Advanced MRI Techniques for Assessment of Benign Prostatic Hyperplasia.
    48. 1UG3TR002158-01 (Theberge, Ashleigh), 2017-2019, NCATS & NIDDK, $46,574. A Microphysiological System for Kidney Disease Modeling and Drug Efficacy Testing.
    49. Kavli Microbiome Ideas Challenge Award (ASM, ACS & APS) (Theberge, Ashleigh), 2017-2018, Kavli Microbiome Ideas Challenge Award, $340,000. Deciphering Multikingdom Communication Molecules Using Engineered Cellular Traps.
    50. U01DK110807-02S1 Supplement (Vezina, Chad M. (PI); Cadena, Mark (Mentee)), 6/01/2017–5/31/2018, NIH/NIDDK, $65,741. Role of Prostate Neuroendocrine Cells in Homeostatic Regulation of Prostate Stroma.
    51. R01CA204320 (Shull, Jim (PI); Vezina, Chad M. (Co-I)), 1/1/2017-12/31/2018, NIH/NCI, $323,058 DC/year. Characterization of Emca4, the Rat Ortholog of the 8q24 Breast Cancer Risk Locus.
    52. 5R21CA195313—02 (Marker, Paul C. (PI)), 2017, NCI, $195,054. MAGI2 in Aggressive Prostate Cancer.
    53. 3 U54 DK104310 04S1 (Ricke, William A. (PI)), 2017, NIDDK, $99,203. Mediators of Fibrosis in the Development of Lower Urinary Tract Dysfunction.
    54. U01DK110807 (Vezina, Chad M. (PI)), 9/15/2016-5/31/2021, NIH/NIDDK, $179,728. Molecular and Fate Maps of Prostatic Stroma.
    55. U54 CA156734 (Macoska, Jill A. (PI); Colon-Carmona (Contact PI)), 9/01/2016-8/31/2021, NIH/NCI, $6,670,664 (total DC). (1/2) The University of Massachusetts, Boston – Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research.
    56. 2R01 DK077195-06 (Adam (PI); Macoska, Jill. A (Co-I)), 8/07/2016-6/30/2021, NIH/NIDDK, $56,207 DC/year. Mechanotransduction in Bladder Smooth Muscle.
    57. 2T35OD011078-06 (Bjorling, Dale E. (PI)), 4/1/2016-3/31/2021,DHS/PHS/NIH, $57,257 DC. Short-term Research Training of Veterinary Students in Wisconsin.
    58. RP170152 (Bagrodia (PI); Strand, Douglas W. (Co-I)), 12/1/2016-11/30/2020, Targeting the H NF4A and WNT/Beta-Catenin Pathways in Childhood Malignant Yolk Sac Tumors.
    59. W81XWH-16-1-0246 (Neuman, Sarah (PI); Ricke, William A. (Mentor)), 2018-2019, DoD/Army, $191,250. Effects of Phthalates on Androgen Receptor Regulation Associated with Castration-Resistant Prostate Cancer Development.
    60. W81XWH-16-1-0246 (Jeong, Clara (PI); Ricke, William A. (Mentor)), 2016-2018, DoD/Army, $191,250 TC/yr. Effects of Phthalates on Androgen Receptor Regulation Associated with Castration-Resistant Prostate Cancer Development.
    61. 3 U54 DK104310 03S1 (Ricke, William A. (PI)), 2016, NIDDK, $103,761. Mediators of Fibrosis in the Development of Lower Urinary Tract Dysfunction.
    62. 1R21CA195313-01A1 (Marker, Paul C. (PI)), 2016, NCI, $161,777. MAGI2 in Aggressive Prostate Cancer.
    63. 2P30CA014520-44 PILOT (Ricke, William A. (PI); Bashirullah, A. (Co-I); Vezina, Chad M. (Co-I)), 2016-2017, NCI, $12,500 direct. Identification of DDX3-RNA Binding Protein mRNAs in Prostate Cancer: Potential Roles in Castration Resistant Prostate Cancer.
    64. U54 DK104310 PILOT (Goldberg, Tony (PI); Li, Lingjun (Co-I); Penniston, Kristina (Co-I)), 2016, NIDDK, $150,000. Functional Metabiome of Lower Urinary Tract Syndrome.
    65. U54 DK104310 PILOT (VanderHorst, Veronique (PI)), 2016, NIDDK, $150,000. Neural Plasticity in Bladder outlet Obstruction.
    66. DK100022-06 (Bjorling, Dale E. (PI); Bushman, Wade A. (Co-I); Ricke, William A. (Mentor); Liu, Teresa (Awardee)), 9/1/2015-5/14/2020, NIH, $75,000 salary/$40,000 research support. The Role of Estrogen Receptor Activation on Benign Prostatic Hyperplasia Progression.
    67. 2R01 DK077195-06 (Adam (PI); Macoska, Jill A. (Co-I)), 8/07/2015-4/30/2019, NIH/NIDDK, $56,207 DC/year. Mechanotransduction in Bladder Smooth Muscle.
    68. 3 U54 DK104310 02S1 (Ricke, William A. (PI)), 2015, NIDDK, $50,000. Mediators of Fibrosis in the Development of Lower Urinary Tract Dysfunction.
    69. 5R01DK091193-10 (Marker, Paul C. (PI)), 2015, HIDDK, $322, 245. Steroid Hormones and SFRP1 in the Age-related Incidence of BPH and BOO.
    70. 1U54DK104310-06 (Ricke, William A. (PI); Bjorling, Dale E. (Biomed. Core Lead, Co-I), 9/24/2014-7/31/2024, DHHS/PHS/NIH, $42,425. Mediators of Fibrosis in the Development of Lower Urinary Tract Dysfunction.
    71. DK100022-06 (Theberge, Ashleigh (awardee); Ricke, William A. (Mentor); 3/1/2014-12/31/2015, NIH, $75,000 salary/$40,000 research support. The Role of Stromal Paracrine Signals in Angiotenesis in Benign Prostatic Hyperplasia.
    72. R01 DK099328 (Vezina, Chad M. (PI); Bjorling, Dale E. (Co-I)), 2014-2019,NIDDK, $327,338 DC. Role of DNA Methylation in Prostate Glandular Development and Urinary Function.
    73. 5 U54 DK104310-02 (Ricke, William A. (PI)), 9/24/14-7/31/19, NIDDK, $7,188,701. Mediators of Fibrosis in the Development of Lower Urinary Tract Dysfunction.
    74. 1K12DK100022-01 (Bjorling, Dale E. (PI), 8/1/2013-9/13/2023,DHHS/PHS/NIH, $582,275 DC. Wisconsin Multidisciplinary K12 Urologic Research Career Development Program.
    75. U01 ES020952 (vom Saal, Frederick (PI); Ricke, William A. (Co-I)), 2012-2017,NIEHS, $500,000 DC. Research Consortium for 2-Year Bisphenol A Toxicity Study “Lifetime Exposure to Bisphenol-A (BPA) and Urethral Malformations, Obstructive VoidingDisorder and Prostate Neoplasia: Cellular and Epigenetic Effects”.
    76. R01 DK093690 (Ricke, William A. (PI), 9/15/2011-7/31/2016, $215,000/FY DC. Estrogen Regulation in BPH and the Lower Urinary Tract.

     

    Pending:

    1. RC2 DKXXXXXX (Strand, Douglas W. (MPI); Vezina, Chad M. (MPI)), 7/1/2021-6/30/2026, NIH/NIDDK, $300,000 DC/year (to Vezina lab) & $360,000 DC/year (to Strand lab), Bedside to Bench Resources for Lower Urinary Tract Research.
    2. Subcontract to Columbia University U54 (Mendelson, Cathy; Barasch, Jonathan; Garavi, Ali (MPIs); Vezina, Chad M. (Co-I)), 7/1/2021-6/30/2026, NIH/NIDDK, $10,000 DC (to Vezina lab) & $10,000 DC (to Strand lab), Urethral Neuroendocrine Cells Protect against UTI.
    3. 1K01DK127150-01 (Popovics, Petra (PI); Ricke, William A. (Mentor); Vezina, Chad M. (Co-Mentor)), 9/1/2020—8/31/2025, NIH/NIDDK, $146,500 DC/year Osteopontin: A Novel Mediator of Prostatic Inflammation and Fibrosis.
    4. 1R21AR077566-01 (Zarrhingalam (PI); Macoska, Jill A. (Co-I)), 9/1/2020-3/31/2022, NIH/NIAMS, $275,000 (total DC), Identification of Gene Regulatory Mechanism Governing Fibroblast Phenotypic Plasticity.
    5. 5P50CA101942-15 (McDermott (PI); Macoska, Jill A. (Co-I); Bonventre (Co-I)), 9/1/2020-8/31/2021, NIH/NCI, $50,000 (DC), APOL1 Risk Alleles Synergize Myofibroblast Accumulation and RCC Tumor Growth and Progression
    6. GRANT1304773 (Ricke, William A. (PI)), 9/1/2020-8/31/2025, NIH, $0.00, Mitochondrial Dysfunction and Cellular Senescense Due to Aging Contributes to Prostatic Fibrosis in Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms (R01).
    7. GRANT13015251 (Ricke, William A. (PI)), 9/1/2020-8/31/2025, NIH, $0.00, Estrogen Pathways in the Development of Prostatic Fibrosis and Lower Urinary Tract Dysfunction (R01).
  • AWARDS
    • 11/2020, Diya Binoy Joseph (Strand Lab, Post-doctoral Research Fellow), 2020 Society of Basic Urologic Research virtual meeting travel award
    • 11/2020, Anne Turco (Vezina Lab, Graduate student), 2020 Society of Basic Urologic Research virtual meeting travel award
    • 5/2020, Teresa Liu (Ricke Lab, Assistant Scientist), NIH Mentored Research Scientist Development Award (K01) to study the “impact of age on altered steroidogenesis and estrogen receptor activation in benign prostatic hyperplasia progression”
    • 5/2020, Anne Turco (Vezina Lab, Graduate student), NIH F31 grant for her project entitled “Developmental Origins of Prostate-related Urinary Dysfunction in Adult Males: TCDD Exposure Increases Prostatic Noradrenergic Innervation and Smooth Muscle Contraction”
    • 5/2020, Asha Jain (Ricke lab, Undergraduate student), UW-Madison 2020-2021 Sophomore Research Scholarship
    • 5/2020, Thrishna Chathurvedula (Vezina lab, Undergraduate), 2020-2021 Hilldale Undergraduate/Faculty Research Fellowship
    • 4/2020, Anne Turco (Vezina lab, Graduate student), 2020 Dr. Eric A. Andreasen Graduate Student Award for Excellence in Research and Scholarship
    • 2/2020, Diya Binoy Joseph (Strand Lab, UT-Southwestern, Post-doctoral Researcher), 2020 Urology Care Foundation Research Scholar Award (Indian American Urological Association Sakti Das, MD Award)
    • 1/2020, Kyle Wegner (Vezina Lab, Graduate student), Wisconsin Initiative for Science Literacy Award for Communicating Graduate Chemistry Research to the Public
    • 12/2019, Anne Turco (Vezina Lab, Graduate student), Celebrating Women in Toxicology Award from the Women in Toxicology (WIT) Special Interest Group
    • 12/2019, Hannah Ruetten (Vezina Lab, Graduate student), Best Poster Award at the Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Meeting, Kansas City, MO
    • 12/2019, Livianna Myklebust (Ricke Lab, former SPUUR Intern), Best Poster Award at the Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Meeting, Kansas City, MO
    • 12/2019, Mathilde Bonnemaison (Macoska Lab, Post-Doctoral Fellow), Best Poster Award at the Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Meeting, Kansas City, MO
    • 11/2019, Nicholas Girardi, UW-Madison College of Letters and Science Trewartha Senior Thesis Research Grant recipient
    • 10/2019, Chad Vezina, 2019 University of Wisconsin-Madison Vilas Mid-Career Award
    • 10/2019, Anne Turco, Research Assistant/PhD Student (Vezina Lab), 2019 Zaman-Saroya Award (University of Wisconsin-Madison School of Pharmacy)
    • 09/2019, Hannah Ruetten, Research Assistant/DVM-PhD Student (Vezina Lab), Four Year National Institutes of Health Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship (F30)
    • 09/2019, Petra Popovics, K12 Scholar/Assistant Scientist (Ricke Lab), SBUR Travel Award and podium presentation selection
    • 09/2019, Teresa Liu, K12 Scholar/Assistant Scientist (Ricke Lab), SBUR Travel Award
    • 09/2019, Diya Binoy Joseph, Post-doctoral Researcher (Strand Lab, UT-Southwestern), SBUR Travel Award and podium presentation selection
    • 09/2019, Wanting Han, Graduate Student (Macoska Lab, University of Massachusetts-Boston), SBUR Travel Award and podium presentation selection
    • 09/2019, Mathilde Bonnemaison, Postdoctoral Researcher (Macoska Lab, University of Massachusetts-Boston), SBUR Travel Award
    • 06/2019, Livianna Myklebust, Research Assistant(Ricke Lab), Collaborating for the Advancement of Interdisciplinary Research in Benign Urology (CAIRIBU) Research Training and Development Award
    • 06/2019, Kyle Wegner, PhD Candidate (Vezina Lab), Travel Award Grant, Society of Toxicologic Pathology
    • 06/2019, Anne Turco, PhD Candidate (Vezina Lab), Travel Award Grant, Society of Toxicologic Pathology
    • 05/2019, William Ricke, 2019 Society of Toxicology Kenneth P. DuBois Award
    • 04/2019, Kyle Wegner, PhD Candidate (Vezina Lab), Student Travel Award, UW-Madison
    • 04/2019, Phinea Romero, Former SPUUR Undergraduate Intern (Vezina Lab), Robert Gunn Student Award, Experimental Biology Meeting, American Physiological Society
    • 04/2019, Diya Binoy Joseph (Vezina Lab), UW-Madison Cellular and Molecular Biology Graduate Program 2018 Exceptional Thesis Award
    • 03/2019, Phinea Romero, SPUUR Intern, Robert Gunn Student Award, American Physiological Society
    • 2019-present, Chad Vezina, Director, Molecular and Environmental Toxicology Center, University of Wisconsin-Madison
    • 2019, Kim Keil, PhD, 2019 Women in Toxicology Postdoctoral Achievement Award
    • 12/2018, Anne Turco, Research Associate (Vezina Lab), Society of Toxicology Supplemental Training for Education Program (STEP) Award
    • 12/2018, Chelsea O’Driscoll, Research Associate (Vezina Lab), Best Poster Award, Collaborating for the Advancement of Interdisciplinary  Research in Benign Urology (CAIRIBU) Meeting, Ellicott City, MD
    • 12/2018, Hannah Ruetten, Research Assistant (Vezina Lab), Best Poster Award, Collaborating for the Advancement of Interdisciplinary  Research in Benign Urology (CAIRIBU) Meeting, Ellicott City, MD
    • 11/2018, Dalton McLean, Graduate Student, Travel Award, SBUR, Palm Springs, CA: “Fibroblast Growth Factor-5 Increases Androgen Receptor Expression and Signaling in Prostate Cancer”
    • 10/2018, Anne Turco, Research Assistant (Vezina Lab), Eula and Donald S. Coffey Research Innovation Award, Society for Basic Urologic Research
    • 10/2018, Mark Cadena, Research Assistant (Vezina Lab), travel award to the 2018 Society for Basic Urologic Research Annual Meeting
    • 10/2018, Anne Turco, Research Assistant (Vezina Lab), travel award to the 2018 Society for Basic Urologic Research Annual Meeting
    • 10/2018, Kyle Wegner, Research Assistant (Vezina Lab), travel award to the 2018 Society for Basic Urologic Research Annual Meeting
    • 10/2018, Hannah Ruetten, Research Assistant (Vezina Lab), travel award to the 2018 Society for Basic Urologic Research Annual Meeting
    • 10/2018, Diya Binoy Joseph, Research Assistant (Vezina Lab), Cellular and Molecular Biology Travel Award
    • 04/2018, Hannah Ruetten, Research Assistant (Vezina Lab), Comparative Biomedical Sciences Spring Travel Award
    • 04/2018, Kyle Wegner, Research Assistant (Vezina Lab), Midwest Regional Chapter of the Society of Toxicology Young Investigator Award
    • 04/2018, Hannah Ruetten, Research Assistant (Vezina Lab), Institute of Clinical and Translational Research TL-1 clinical training grant
    • 03/2018, Kyle Wegner, Research Assistant (Vezina Lab), Eric Andreasen Memorial Award for Research Excellence
    • 03/2018, Kyle Wegner, Research Assistant (Vezina Lab), National Institutes of Health F31 Research Fellowship Award
    • 03/2018, Hannah Ruetten, Research Assistant (Vezina Lab), Comparative Biomedical Science Graduate Program Travel Award
    • 03/2018, Teresa Liu, K12 scholar (Ricke Lab), moderated poster session: “Altered steroidogenesis on estrogen receptor activation in benign prostatic hyperplasia”, ENDO, Chicago, IL
    • 2018, Ashleigh Theberge, former K12 Scholar (Ricke Lab), one of ten 2018 Beckman Young Investigator (BYI) Award recipients
    • 2018, Ashleigh Theberge, former K12 Scholar (Ricke Lab), NIH Maximizing Investigators’ Research Award (MIRA) for Early Stage Investigators (R35)
    • 2018, Jalissa Wynder (Nguyen), Post-doc (Ricke Lab), Burdock Group student travel award
    • 2018, Jalissa Wynder (Nguyen),Post-doc (Ricke Lab), Toxicologists of African Origin (TAO) travel award
    • 2018, Jalissa Wynder (Nguyen),Post-doc (Ricke Lab), Graduate Student Excellence Award from the Regulatory and Safety Evaluation Specialty Section (RSESS) of the Society of Toxicology
    • 11/2017, Kyle Wegner, Research Assistant (Vezina Lab), Society of Toxicology Supplemental Training for Education Program (STEP) Award
    • 09/2017, Diya Binoy Joseph, Research Assistant (Vezina Lab), Gregory F. Daniels Best Poster award, UW-Madison Stem Cell & Regenerative Medicine Center Fall Conference
    • 08/2017, Jordan Vellky, Graduate Student (Ricke Lab), Gordon Research Conference: Hormone-Dependent Cancers, Newry, ME: “Hormonal Modulation of DDX3 and its Implications for Translational Regulation in Prostate Cancer”
    • 08/2017, Jordan Vellky, Graduate Student (Ricke Lab), Funded by T32 Training Grant, Madison, WI
    • 08/2017, Dalton McLean, Graduate Student (Ricke Lab), Funded by T32 Training Grant, Madison, WI
    • 08/2017, Kyle Wegner, Research Assistant (Vezina Lab), Zaman-Saroya Award winner for excellence in research and scholarship (University of Wisconsin-Madison)
    • 08/2017, Anne Turco, Research Assistant (Vezina Lab), National Institutes of Health T32 training grant in Molecular and Environmental Toxicology
    • 08/2017, Diya Binoy Joseph, Scholar, Workshop on Epigenetics at the Van Andel Research Institute
    • 08/2017, Kyle Wegner, Research Assistant (Vezina Lab), cover art in J Histochem Cytochem
    • 07/2018, Mark Cadena, Research Assistant (Vezina Lab), two year research grant from the National Institutes of Health to support his studies of prostate neuroendocrine cells.
    • 04/2017, Stephen (Royal) Oakes, Undergraduate Researcher (Vezina Lab), Hilldale Undergraduate Research Fellowship
    • 02/2017, Anoop Chandrashekar, Undergraduate Researcher (Vezina Lab), National Merit Scholar Finalist
    • 2017, Ashleigh Theberge, former K12 Scholar (Ricke Lab), one of three worldwide recipients of the Kavli Microbiome Ideas Challenge Award (ASM, ACS & APS)
    • 2017, Jalissa Wynder (Nguyen),Post-doc (Ricke Lab), Invited Speaker at Southern University’s Wilbur B. Clarke Chemistry Symposium
    • 2017, Jalissa Wynder (Nguyen),Post-doc (Ricke Lab), ILSI North America Summer Fellow
    • 2017-present, William Ricke, CoLeader, Tumor Microenvironment, Senior Leadership-UW Carbone Cancer Center
    • 2017-present, William Ricke, Member, Research, Education, Conferences , Communications (RECC) Committee, American Urological Association
    • 09/2019, Hannah Ruetten, Research Assistant (Vezina Lab), four year National Institutes of Health Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship (F30)
    • 11/2016, Dalton McLean, Graduate Student (Ricke Lab), Travel Award, SBUR, Scottsdale, AZ: “In vivo Modeling of Metastasis Using a Prostate Cancer Progression Model”
    • 09/2016, Mark Cadena, Research Assistant (Vezina Lab), Society for Basic Urologic Research Fall Meeting Travel Award.
    • 09/2016, Diya Binoy Joseph, Research Assistant (Vezina Lab), Society for Basic Urologic Research Fall Meeting Travel Award.
    • 09/2016, Diya Binoy Joseph, Research Assistant (Vezina Lab), Cellular and Molecular Biology Travel award
    • 09/2016, Stephen (Royal) Oakes, Undergraduate Researcher (Vezina Lab), UW-Madison College of Engineering Frederick J. Mancheski Scholarship
    • 09/2016, Diya Binoy Joseph, Research Assistant (Vezina Lab), American Urological Association Summer Research Conference Travel Award
    • 08/2016, Jordan Vellky, Graduate Student (Ricke Lab), Funded by T32 Training Grant, Madison, WI
    • 08/2016, Dalton McLean, Graduate Student (Ricke Lab), Funded by T32 Training Grant, Madison, WI
    • 05/2016, William Ricke, Plenary talk, American Urological Association, San Diego, CA
    • 05/2016, Chad Vezina, Zoetis Award for Veterinary Research Excellence 04/2016, Stephen (Royal) Oakes, Undergraduate Researcher (Vezina Lab), Sophomore Undergraduate Research Fellowship
    • 2016-present, William Ricke, Affiliate Associate Professor, Division of Pharmaceutical Sciences, University of Wisconsin-Madison School of Pharmacy
    • 2016-present, Ashleigh Theberge, former K12 Scholar (Ricke Lab), Assistant Professor of Chemistry and Adjunct Assistant Professor of Urology, University of Washington
    • 2016-present, Chad Vezina, Director, Summer Program in Undergraduate Urologic Research (SPUUR), University of Wisconsin-Madison
    • 11/2015, Jordan Vellky, Graduate Student (Ricke Lab), Travel Award, SBUR, Ft. Lauderdale, FL: “BOP1 Expression and Localization in Benign Prostatic Disease and Prostate Cancer Progression”
    • 06/2015, Helene Altmann, Undergraduate Researcher (Vezina Lab), Promega International Scientific Internship Scholarship
    • 06/2015, Bill Mulligan, Undergraduate Researcher (Vezina Lab), Barry Goldwater Federal Scholarship
    • 06/2015, Bill Mulligan, Undergraduate Researcher (Vezina Lab), Rhoades Scholarship Finalist
    • 06/2015, Helene Altmann, Undergraduate Researcher (Vezina Lab), Covance Laboratories Pharmacology and Toxicology Excellence Award
    • 02/2015, William Ricke, Associate Professor, Clark-Atlanta University Lecture, Atlanta, GA, Graduate student and postdoc association, “Hormone action and paracrine interactions in prostatic carcinogenesis”
    • 2015, Tristan Nicholson, former Graduate Student (Ricke Lab), MD with Distinction in Research, PhD Pathology, University of Rochester School of Medicine and Dentisry
    • 2015, Tristan Nicholson, Graduate Student (Ricke Lab), Robert E. Kates Award for excellence in clinical medicine and research, University of Rochester School of Medicine and Dentistry
    • 2015, Tristan Nicholson, Graduate Student (Ricke Lab), Glasgow-Rubin Citation for graduating 1stin Class of 2015, University of Rochester School of Medicine and Dentistry
    • 2015, Jalissa Wynder (Nguyen),Post-doc (Ricke Lab), Edward Bouchet Graduate Honor Society Inductee
    • 2015-present, William Ricke, UW Medical Foundation Professor of Urologic Research, Endowed Professorship
    • 2015-present, Teresa Liu, K12 Scholar (Ricke Lab), Investigator, NIH K Career Development Award Scholar, Department of Urology, University of Wisconsin-Madison
    • 2015-present, Chad Vezina, Associate Professor, Dept. Comparative Biosciences, University of Wisconsin-Madison
    • 2015-present, Chad Vezina, Adjunct Associate Professor, Dept. Urology, University of Wisconsin-Madison School of Medicine and Public Health
    • 2015-present, Chad Vezina, Affiliate Associate Professor, Division
    • 11/2014, Kimberly Keil, Research Assistant (Vezina Lab), Society of Basic Urology Research Travel Award
    • 04/2014, Helene Altmann, Undergraduate Researcher (Vezina Lab), Hilldale Undergraduate Research Fellowship
    • 04/2014, Bill Mulligan, Undergraduate Researcher (Vezina Lab), Hilldale Undergraduate Research Fellowship
    • 04/2014, Kimberly Keil, Research Assistant (Vezina Lab), NSF Graduate Research Fellowship
    • 04/2014, Kimberly Keil, Research Assistant (Vezina Lab), Richard F. Marsh Outstanding Graduate Student Award
    • 2014-present, William Ricke, University of Wisconsin, George M. O’Brien Center Director
    • 2014-2016, Jalissa Wynder (Nguyen),Post-doc (Ricke Lab), NIEHS (T32) Pre-doctoral Traineeship in Environmental Toxicology
    • 2014-2015, Dr. Ashleigh Theberge, K12 Scholar (Ricke Lab), Investigator, NIH K Career Development Award Scholar, Departments of Biomedical Engineering and Urology, University of Wisconsin-Madison
    • 2014, Jalissa Wynder (Nguyen),Post-doc (Ricke Lab), Travel award for Underrepresented Minority Fellows Symposium (AUMF)
    • 1988-present, Dale Bjorling, Associate Professor, University of Wisconsin, Department of Surgical Sciences
    • 1988-2011, Dale Bjorling, Department Chair, University of Wisconsin, Department of Surgical Sciences
    • 1994-present, Dale Bjorling, Professor, University of Wisconsin, Department of Surgical Sciences
    • 2008-present, Dale Bjorling, Professor, University of Wisconsin, Department of Urology
    • 2011-present, Dale Bjorling, Associate Dean for Research, University of Wisconsin, School of Veterinary Medicine